Original Article
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
N Engl J Med 2009; 360:961-972March 5, 2009
- Abstract
Background
Percutaneous coronary intervention (PCI) involving drug-eluting stents is increasingly used to treat complex coronary artery disease, although coronary-artery bypass grafting (CABG) has been the treatment of choice historically. Our trial compared PCI and CABG for treating patients with previously untreated three-vessel or left main coronary artery disease (or both).
Methods
We randomly assigned 1800 patients with three-vessel or left main coronary artery disease to undergo CABG or PCI (in a 1:1 ratio). For all these patients, the local cardiac surgeon and interventional cardiologist determined that equivalent anatomical revascularization could be achieved with either treatment. A noninferiority comparison of the two groups was performed for the primary end point — a major adverse cardiac or cerebrovascular event (i.e., death from any cause, stroke, myocardial infarction, or repeat revascularization) during the 12-month period after randomization. Patients for whom only one of the two treatment options would be beneficial, because of anatomical features or clinical conditions, were entered into a parallel, nested CABG or PCI registry.
Results
Most of the preoperative characteristics were similar in the two groups. Rates of major adverse cardiac or cerebrovascular events at 12 months were significantly higher in the PCI group (17.8%, vs. 12.4% for CABG; P=0.002), in large part because of an increased rate of repeat revascularization (13.5% vs. 5.9%, P<0.001); as a result, the criterion for noninferiority was not met. At 12 months, the rates of death and myocardial infarction were similar between the two groups; stroke was significantly more likely to occur with CABG (2.2%, vs. 0.6% with PCI; P=0.003).
Conclusions
CABG remains the standard of care for patients with three-vessel or left main coronary artery disease, since the use of CABG, as compared with PCI, resulted in lower rates of the combined end point of major adverse cardiac or cerebrovascular events at 1 year. (ClinicalTrials.gov number, NCT00114972.)
Media in This Article
Figure 1
Enrollment and Randomization of Patients with Previously Untreated Three-Vessel or Left Main Coronary Artery Disease in the SYNTAX Trial.Figure 2
Rates of Outcomes among the Study Patients, According to Treatment Group.Article Activity
- Article
Coronary-artery bypass grafting (CABG) was introduced in 1968 and rapidly became the standard of care for symptomatic patients with coronary artery disease.1 Advances in coronary surgery (e.g., off-pump CABG, smaller incisions, enhanced myocardial preservation, use of arterial conduits, and improved postoperative care) have reduced morbidity, mortality, and rates of graft occlusion.2-6
Percutaneous coronary intervention (PCI) was introduced in 1977.7 Experience with this approach, coupled with improved technology, has made it possible to treat increasingly complex lesions and patients with a history of clinically significant cardiac disease, risk factors for coronary artery disease, coexisting conditions, or anatomical risk factors.8,9 Several trials comparing PCI involving bare-metal stents with CABG in patients with multivessel disease (e.g., the Arterial Revascularization Therapies Study Part I [ARTS I], the Medicine, Angioplasty, or Surgery Study for Multivessel Coronary Artery Disease [MASS II; Current Controlled Trials number, ISRCTN66068876], the Argentine Randomized Study of Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in Patients with Multiple Vessel Disease [ERACI-II], and the Angina with Extremely Serious Operative Mortality Evaluation [AWESOME]) showed similar survival rates but higher revascularization rates among patients with bare-metal stents at 5 years. Others have shown a significant long-term survival advantage with surgery (e.g., the Stent or Surgery [SOS] study).10-12 Studies comparing PCI involving drug-eluting stents with CABG have generally been smaller and nonrandomized.13-24
Data from randomized, controlled trials of drug-eluting stents as compared with bare-metal stents have shown significant reductions in the rate of repeat intervention, with similar rates of death and myocardial infarction.25 These improvements have led to expanded use of PCI in patients with complex coronary anatomical features, though most randomized trials comparing drug-eluting stents and bare-metal stents excluded such patients. According to current guidelines,26 CABG remains the treatment of choice for patients with severe coronary artery disease, including those with left main coronary artery disease and those with three-vessel disease. There is a lack of data from adequately powered randomized trials of PCI in such patients. Thus, PCI is being performed in this group without adequate support from evidence-based medicine and randomized clinical trials.27
In the Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial, we assessed the optimal revascularization strategy for patients with previously untreated three-vessel or left main coronary artery disease and defined the populations of patients for whom only one revascularization method will be effective.
Methods
Study Design
The SYNTAX trial is a prospective, clinical trial conducted in 85 sites and approved by the institutional review board at each participating center. The study had an “all-comers” design involving the consecutive enrollment of all eligible patients with three-vessel or left main coronary artery disease at sites in 17 countries in Europe and the United States. The study design has been described previously.28 Criteria for study and registry enrollment and outcome data are described in the Supplementary Appendix. The authors designed the study, as part of their role on the steering committee, in collaboration with the sponsor, Boston Scientific. The sponsor was involved in collection and source verification of the data, with oversight by an independent clinical events committee. The sponsor's biostatisticians performed the analyses; however, data analyses were verified independently by a statistician on the data and safety monitoring committee. The authors wrote the manuscript and vouch for the completeness and accuracy of the data gathering and analysis.
Selection and Randomization of Patients
A local interventional cardiologist and cardiac surgeon at each site prospectively evaluated eligible patients with previously untreated three-vessel coronary disease and those with left main coronary artery disease (alone or with one-, two-, or three-vessel disease). Inclusion and exclusion criteria are listed in the Methods section of the Supplementary Appendix. Patients in whom it was determined that equivalent anatomical revascularization could be achieved with either CABG or PCI involving Taxus Express paclitaxel-eluting stents (Boston Scientific) were randomly assigned to undergo one of the two treatment options by means of an interactive voice-responding system. Randomization was stratified at each site according to the presence or absence of left main coronary artery disease and medically treated diabetes (diabetes for which the patient was receiving oral hypoglycemic agents or insulin at the time of enrollment). Patients for whom only one treatment option was suitable were entered into a parallel, nested registry: the PCI registry for CABG-ineligible patients and the CABG registry for PCI-ineligible patients.
All diagnostic angiograms and electrocardiograms were reviewed by staff at an independent core laboratory (Cardialysis, Rotterdam, the Netherlands) who were unaware of the treatment assignments. Diagnostic angiograms were scored, according to the SYNTAX score algorithm,29 at the site and at the core laboratory. In addition, staff at an independent central chemistry laboratory (Covance, Indianapolis and Geneva) who were unaware of treatment assignments assessed selected variables.
The institutional review board at each site approved the protocol, and all patients provided written informed consent. The protocol and consent forms were consistent with the Food and Drug Administration's Guidance for Industry E6 Good Clinical Practice, the Declaration of Helsinki, the International Conference on Harmonisation, and all local regulations, as appropriate.
Revascularization and Pharmacologic Treatment
Patients were treated with the intention of achieving complete revascularization of all vessels at least 1.5 mm in diameter with stenosis of 50% or more, as identified by the local interventional cardiologist and cardiac surgeon. The surgical technique for CABG, the approaches used for stent implantation, and the postprocedure medication regimen were chosen according to local clinical practice. In patients who underwent PCI, antiplatelet medication was prescribed on the basis of the directions for use of the Taxus Express stent and local clinical practice. In most centers, thienopyridines were continued even after 6 months, with 71.1% of patients receiving them at 12 months. Aspirin was prescribed indefinitely for all patients who underwent randomization. Use of the standard of postintervention care was recommended.30 Procedural details are described in the Methods section of the Supplementary Appendix.
Primary End Point
The primary clinical end point was a composite of major adverse cardiac and cerebrovascular events (i.e., death from any cause, stroke, myocardial infarction, or repeat revascularization) throughout the 12-month period after randomization. An independent clinical events committee (including cardiologists, cardiac surgeons, and a neurologist; see the list in the Supplementary Appendix) adjudicated all primary clinical end points, staged procedures, and cases in which the sternum was reopened.
Statistical Analysis
The primary analysis was a noninferiority comparison of the two treatments for the primary end point of adverse binary cardiac or cerebrovascular events in all patients who underwent randomization (on an intention-to-treat basis). If the one-sided 95% upper confidence limit for the difference was less than the prespecified delta value (6.6%), PCI with the drug-eluting stents would be considered to be noninferior to CABG in the overall randomized cohort. The noninferiority margin was based on historical data (see the Methods section in the Supplementary Appendix). We calculated the means (±SD) for continuous variables in each of the two groups and compared them using Student's t-test. Binary variables are reported as counts and percentages, and differences between the two groups were assessed by means of the chi-square or Fisher's exact test. Cumulative event rates were estimated by means of the Kaplan–Meier method. In addition, the 12-month rates of major adverse cardiac or cerebrovascular events were analyzed on the basis of the SYNTAX score and compared with the use of a chi-square test. The SYNTAX score reflects a comprehensive anatomical assessment, with higher scores indicating more complex coronary disease; a low score was defined as ≤22, an intermediate score as 23 to 32, and a high score as ≥33 (see the Supplementary Appendix for details).
Results
Study Participants
From March 2005 through April 2007, a total of 4337 patients with previously untreated three-vessel or left main coronary artery disease (or both) were screened (Figure 1Figure 1
Enrollment and Randomization of Patients with Previously Untreated Three-Vessel or Left Main Coronary Artery Disease in the SYNTAX Trial.). After consideration by the local interventional cardiologist and cardiac surgeon and after written informed consent was obtained, 3075 patients (70.9%) were included in the study. Of these, 1800 patients were randomly assigned to undergo CABG (897 patients) or PCI with drug-eluting stents (903 patients) at sites in the United States (245 patients) and in Europe (1555 patients). The reasons for exclusion of the remaining 1262 patients are listed in Figure 1. Only one treatment option was suitable in 1275 patients (29.4%), who were enrolled in the nested registry for CABG (1077 patients) or PCI (198 patients).Patients in the two groups were well balanced with regard to most of the baseline demographic and clinical characteristics (Table 1Table 1
Baseline Characteristics of the Patients, According to Study Group.). The proportion of patients with blood pressure of 130/80 mm Hg or higher was significantly larger in the PCI group. The numbers of current smokers, patients with elevated triglyceride levels (≥150 mg per deciliter [1.7 mmol per liter]), and patients with reduced high-density lipoprotein cholesterol levels (<40 mg per deciliter [1.0 mmol per liter] for men or <50 mg per deciliter [1.3 mmol per liter] for women) were higher in the CABG group. A total of 38.8% of patients in the CABG group and 39.5% of those in the PCI group had left main coronary artery disease, with or without additional diseased vessels. Approximately 25% of patients had medically treated diabetes, of whom about one third required insulin. Moreover, nearly half the patients (45.8%) met the criteria for the metabolic syndrome.33 More than 20% of patients in both groups were considered to be at high surgical risk, on the basis of a European System for Cardiac Operative Risk Evaluation (euroSCORE)31 value of 6 or more (24.9% in the CABG group and 24.7% in the PCI group, P=0.94) and a Parsonnet score32 of 15 or more (20.2% and 20.5%, respectively; P=0.87).Overall, more than 4 clinically significant coronary lesions were treated per patient (mean, 4.4 for CABG and 4.3 for PCI); among all patients in both groups, total occlusion was identified in 23.1%, and 72.8% had a bifurcation lesion (Table 1). These results, together with other lesion characteristics, resulted in an average raw SYNTAX score of 29.1 in the CABG group and 28.4 in the PCI group (P=0.19) (Table 1).
The length of time between randomization and performance of the study procedure, the duration of the procedure, and the duration of the postprocedural hospital stay were significantly greater with CABG than with PCI (Table 1). A higher proportion of patients had complete revascularization after CABG than after PCI (63.2% vs. 56.7%, P=0.005). Medical management at discharge differed between the CABG and PCI groups: patients who underwent CABG received less pharmacologic treatment, whereas those who underwent PCI were consistently treated with antiplatelet medications (Table 2Table 2
Cardiac-Related Medications Given after the Study Procedure.). In the CABG group, off-pump surgery was performed in 15.0% of patients, one or more arterial grafts were used in 97.3% of patients, and an average of 2.8 conduits and 3.2 distal anastomoses per patient were performed. In the PCI group, 14.1% of patients underwent staged procedures, 63.1% had at least one bifurcation or trifurcation treated, more than four stents on average were implanted per patient, and a third of patients had placement of stents with a total length of more than 100 mm.A greater proportion of patients in the CABG registry had characteristics of severe lesions — including large proportions of patients with total occlusion (56.4%), bifurcation (80.8%), lesions that were more than 20 mm in length (31.5%), and heavy calcification (32.7%) — than in either randomized group or the PCI registry (Table 2 in the Supplementary Appendix). Together with other anatomical characteristics, these features resulted in an average raw SYNTAX score of 37.8±13.3 among the patients in the CABG registry (Table 2 in the Supplementary Appendix). In contrast, the prevalence of cardiac risk factors and the prevalence of coexisting conditions were increased among patients enrolled in the PCI registry. A total of 30.2% of these patients had diabetes, 40.4% had previously had a myocardial infarction, 19.3% had a diagnosis of chronic obstructive pulmonary disease, 14.1% had a history of transient ischemic attacks or stroke, and 4.7% were dependent on pacemakers — leading to average surgical scores that were higher than in the other groups of patients (euroSCORE value, 5.8±3.1; and Parsonnet score, 14.4±9.5) (Table 2 in the Supplementary Appendix).
Primary Outcome
Preprocedural rates of major adverse cardiac or cerebrovascular events were low and did not differ significantly between the two groups (0.9% in the CABG group and 0.3% in the PCI group, P=0.13) (Table 6 in the Supplementary Appendix), as was the case for in-hospital rates. The preprocedural rates of two of the individual components of the primary outcome, stroke and myocardial infarction, were similar in the two groups (Table 2 in the Supplementary Appendix). At 12 months, the incidence of major adverse cardiac or cerebrovascular events was lower in the CABG group (12.4%) than in the PCI group (17.8%, P=0.002) (Figure 2Figure 2
Rates of Outcomes among the Study Patients, According to Treatment Group. and Table 3Table 3
Clinical End Points Occurring in the Hospital or after Discharge, According to Study Group.). Thus, the absolute difference in the 12-month rate of major adverse cardiac or cerebrovascular events between the two groups was 5.5 percentage points, with an upper 95% confidence interval of 8.3 percentage points. The results of an as-treated analysis were similar: the 12-month rate of major adverse cardiac or cerebrovascular events was 12.3% with CABG and 17.6% with PCI (P=0.002).In the intention-to-treat population, 19 patients would need to be treated with CABG to avoid the primary outcome in 1 patient; the numbers needed to treat to avoid specific components of the outcome were 14 for revascularization, 119 for death, and 71 for myocardial infarction. The number needed to treat with PCI to avoid stroke in 1 patient was 60.
Secondary Outcome
The rate of repeat revascularization at 12 months was significantly higher among patients in the PCI group than among those in the CABG group (13.5% vs. 5.9%, P<0.001) (Table 3). Most patients who underwent repeat revascularization were treated with PCI rather than CABG. The rate of stroke was significantly higher with CABG than with PCI at 12 months, even though the two groups were well balanced with regard to carotid artery disease and other risk factors for stroke (Table 3). At 12 months, the two groups had similar rates of death from any cause or myocardial infarction and of the combined end point of death from any cause, stroke, or myocardial infarction (Table 3). The rate of death from cardiac causes was greater with PCI than with CABG (3.7% vs. 2.1%, P=0.05); the rate of death from noncardiac causes, although not significant, was higher with CABG (1.4% vs. 0.7%, P=0.13). The 12-month rates of symptomatic graft occlusion (in the CABG group) and stent thrombosis (in the PCI group) were similar (P=0.89) (Table 3).
Outcomes According to the SYNTAX Score
In the CABG group, the binary 12-month rates of major adverse cardiac or cerebrovascular events were similar among patients with low SYNTAX scores (0 to 22, 14.7%), those with intermediate scores (23 to 32, 12.0%), and those with high scores (≥33, 10.9%) (Figure 3Figure 3
Rates of Major Adverse Cardiac or Cerebrovascular Events among the Study Patients, According to Treatment Group and SYNTAX Score Category.). In contrast, in the PCI group, the rate of major adverse cardiac or cerebrovascular events was significantly increased among patients with high SYNTAX scores (23.4%) as compared with those with low scores (13.6%) or intermediate scores (16.7%) (P=0.002 for high vs. low scores; P=0.04 for high vs. intermediate scores) (Figure 3). There was a significant interaction between SYNTAX score and treatment group (P=0.01); patients with low or intermediate scores in the CABG group and in the PCI group had similar rates of major adverse cardiac or cerebrovascular events, whereas among patients with high scores, the event rate was significantly increased in the PCI group (Figure 3).Outcomes in Subgroups
The subgroups of patients with left main or three-vessel coronary artery disease were prespecified, and the study had a statistical power of 80% for each subgroup. However, the overarching statistical test was a noninferiority assessment of data from all patients with either left main coronary artery disease or three-vessel coronary disease (or both). Since noninferiority was not proven in this cohort, specific information for each subgroup is of an observational nature and is hypothesis generating. The 12-month rate of major adverse cardiac or cerebrovascular events among patients with left main coronary artery disease was similar in the CABG and PCI groups (13.7% and 15.8%, respectively; P=0.44). Although the rate of repeat revascularization among patients with left main coronary artery disease was significantly higher in the PCI group (11.8%, vs. 6.5% in the CABG group; P=0.02), this result was offset by a significantly higher rate of stroke in the CABG subgroup of patients with left main coronary artery disease (2.7%, vs. 0.3% in the corresponding PCI subgroup; P=0.01). A total of 36.6% of patients with left main coronary artery disease also had three-vessel disease. A post hoc analysis of the rates of major adverse cardiac or cerebrovascular events in the subgroups of patients with left main coronary artery disease revealed a higher rate among those who also had two- or three-vessel disease than among those with left main coronary artery disease alone or in combination with one-vessel disease (Fig. 6 in the Supplementary Appendix).
The 12-month rate of major adverse cardiac or cerebrovascular events among patients with three-vessel disease in the absence of left main coronary artery disease was significantly increased in the PCI group as compared with the CABG group (19.2% vs. 11.5%, P<0.001) (Fig. 6 in the Supplementary Appendix), as was the rate of repeat revascularization (14.6% vs. 5.5%, P<0.001). The rate of death from any cause, stroke, or myocardial infarction in this subgroup was similar with PCI and CABG (8.0% and 6.6%, respectively; P=0.39).
Comparisons of data for the cohort with left main coronary artery disease and the cohort with three-vessel disease showed that the cohort with three-vessel disease had higher rates of previous myocardial infarction, diabetes, poor left ventricular ejection fraction, and lesions with adverse characteristics (lesions that were totally occluded, bifurcated, or long). In addition, the cohort with three-vessel disease had increased numbers of treated vessels and lesions per patient.
Discussion
The SYNTAX trial was designed to compare current surgical and percutaneous techniques in patients with three-vessel or left main coronary artery disease (or both). For the primary end point, the 12-month rate of major adverse cardiac or cerebrovascular events, the noninferiority of PCI as compared with CABG was not demonstrated; CABG proved to be superior. Therefore, the findings with regard to components of the primary end point and subgroup analyses can only be considered as hypothesis-generating. Rates of death and myocardial infarction at 1 year were similar between patients who underwent CABG and those who underwent PCI with drug-eluting stents, whereas the rate of stroke was increased in the CABG group and the rate of repeat revascularization was increased in the PCI group.
Rates of repeat revascularization at 12 months were low in the PCI group, given the high rates of several known predictors of restenosis: lesions characterized by bifurcation or trifurcation (>80%), multivessel disease (>60%), diabetes (>25%), and lesions that were long (>20 mm in length, 20%) or totally occluded (>25%). This rate of repeat revascularization is lower than the rates reported in previous comparative trials involving patients with less-complex clinical profiles and lesions.10 The increase in the rate of repeat revascularization with PCI as compared with CABG did not appear to translate into a significant overall increase in the rate of death or myocardial infarction, although longer-term follow-up is needed. The risk of repeat revascularization after PCI needs to be balanced against the invasiveness of CABG and the risk of stroke, as previously reported in a meta-analysis of 23 studies comparing CABG and PCI, in which procedure-related strokes were found to be more common after CABG (in 1.2% of patients, vs. 0.6% of those undergoing PCI; P<0.001), without a concomitant decrease in survival.34
Recently, concern has been expressed about the possibility of an increased risk of late stent thrombosis with drug-eluting stents. In the SYNTAX trial, most cases of stent thrombosis occurred within 30 days after the procedure, and the 12-month rate of stent thrombosis in the PCI group was similar to the rate of symptomatic graft occlusion in the CABG group. However, as described in the literature, stent thrombosis often has more serious consequences for patients (rate of death, approximately 30%; rate of myocardial infarction, >60%)35,36 than does graft occlusion, which often results only in angina leading to revascularization.
The use of antiplatelet medication was high among patients in the PCI group (with 71.1% receiving a thienopyridine at 12 months). There was an imbalance between the two groups with regard to general medical management apart from thienopyridine use. Thienopyridine therapy was not mandated beyond 6 months in the PCI group, since the study was designed to compare current CABG and PCI practices, including medication regimens. The low rate of stroke among patients who underwent PCI may have resulted from the use of highly effective dual-antiplatelet therapy, which prevents thromboembolic events; additional treatment with antiplatelet drugs might therefore benefit patients undergoing CABG. In addition, more patients in the CABG group than in the PCI group declined to participate after providing consent; in general, this imbalance was due to the greater invasiveness of CABG.
The SYNTAX score was designed to predict outcomes related to anatomical characteristics and, to a lesser extent, the functional risk of occlusion for any segment of the coronary-artery bed (as reflected by the Leaman score37). In our study, the raw SYNTAX score was predictive of outcomes in patients who underwent PCI. In particular, among patients in the PCI group with high SYNTAX scores, not only was the overall rate of major adverse cardiac or cerebrovascular events significantly increased, but also the rate of the composite components of death, stroke, and myocardial infarction was slightly raised (11.9%, vs. 7.6% in the CABG group; P=0.08). This finding suggests that a percutaneous approach should be avoided in patients with high SYNTAX scores. Similar results were reported after the stratification of patients with three-vessel disease in the ARTS II registry.38 Retrospective analysis of the ability of the SYNTAX score to predict outcome is currently being performed and is anticipated to be used to evaluate the relative weight of the individual score components. Additional validation of the score in other populations of patients is also needed. Outcomes in the surgical group of our randomized cohort were not influenced by the SYNTAX score.
The completeness of revascularization (i.e., whether all identified lesions were treated) was determined after the procedure by the investigator. The rate of complete revascularization was lower in both treatment groups in our study than in previous studies.14,15,21,23,39 This result is most likely due to a different definition of completeness of treatment used in the earlier trials and the more complex anatomical characteristics of the patients in our trial.
Although our study provides important information about current treatment of coronary artery disease, there are limitations. First, the 12-month follow-up period may not be sufficient to reflect the true long-term effect of CABG as compared with PCI with drug-eluting stents on cardiac-related health. However, our early results in terms of major adverse cardiac or cerebrovascular events are similar to those of a meta-analysis34 of trials comparing CABG and PCI with predominantly bare-metal stents. The meta-analysis showed that the rate of major adverse cardiac or cerebrovascular events was lower with CABG than with PCI and that patients who underwent CABG had fewer repeat revascularization procedures than patients who underwent PCI. After 5 years of follow-up, the meta-analysis did not show any significant differences in rates of survival between the CABG and PCI groups,34 although other studies have shown differences in mortality.10-12
Second, the use of medication differed between the groups in our study, reflecting variations in standard care of patients between the two treatment groups. Third, more patients withdrew, after randomization, from the CABG group than from the PCI group. Fourth, although randomization was conducted in a blinded manner, with clinicians and participants unaware of future treatment assignments, it was not possible to blind the performance of the treatment. Finally, the definition of myocardial infarction was based on a surgical definition (the finding of a new Q-wave on electrocardiography, in association with a value for the creatine kinase MB fraction that was five times the upper limit of the normal range), which may have resulted in less severe cases of myocardial infarction being overlooked.
In conclusion, the results of our trial show that CABG, as compared with PCI, is associated with a lower rate of major adverse cardiac or cerebrovascular events at 1 year among patients with three-vessel or left main coronary artery disease (or both) and should therefore remain the standard of care for such patients.
Supported by Boston Scientific.
Dr. Kappetein reports receiving consulting and lecture fees from Boston Scientific; and Dr. Feldman, consulting and lecture fees and grant support from Boston Scientific and consulting fees from Abbott. Mr. Bass and Mr. Van Dyck and Drs. Leadley and Dawkins report being full-time employees of, and owning equity in, Boston Scientific. No other potential conflict of interest relevant to this article was reported.
We thank the clinical events committee (V.L. Babikian, D. Birnbaum, T.P. Carrel, M. Gorman, C. Hanet, O.M. Hess, E.W.L. Jansen, L.J. Kappelle, P.G. Steg) and the data and safety monitoring committee (J.-P. Bassand, T. Clayton, D.P. Faxon, B.J. Gersh, J.L. Monro, S. Pocock, M.I. Turina) of the SYNTAX trial, Kristine Roy of Boston Scientific for her help in preparing the manuscript, and Peggy Pereda of Boston Scientific for her help with data analysis.
Source Information
From Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands (P.W.S., A.P.K., M.B.); Institut Cardiovasculaire Paris Sud, Massy, France (M.-C.M.); San Raffaele Scientific Institute, Milan (A.C.); Mayo Clinic, Rochester, MN (D.R.H.); Medical City Hospital, Dallas (M.J.M.); University Hospital Uppsala, Uppsala, Sweden (E.S.); Evanston Hospital, Evanston, IL (T.E.F.); Boston Scientific, Marlborough, MA (E.J.B., N.V.D., K.L., K.D.D.); and Herzzentrum Universität Leipzig, Leipzig, Germany (F.W.M.).
Address reprint requests to Dr. Serruys at the Erasmus University Medical Center, Rotterdam, Gravendijkwal 230, 3015 CE Rotterdam, the Netherlands, or at p.w.j.c.serruys@erasmusmc.nl.
The other Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) investigators are listed in the Supplementary Appendix, available with the full text of this article at NEJM.org.
- References
References
1
Favaloro RG . Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg 1968;5:334-339
CrossRef | Medline2
Buxton BF ,Komeda M ,Fuller JA ,Gordon I . Bilateral internal thoracic artery grafting may improve outcome of coronary artery surgery: risk-adjusted survival. Circulation 1998;98:Suppl:II-13
Flynn M ,Reddy S ,Shepherd W , et al. Fast-tracking revisited: routine cardiac surgical patients need minimal intensive care. Eur J Cardiothorac Surg 2004;25:116-122
CrossRef | Web of Science | Medline4
Janssen DP ,Noyez L ,Wouters C ,Brouwer RM . Preoperative prediction of prolonged stay in the intensive care unit for coronary bypass surgery. Eur J Cardiothorac Surg 2004;25:203-207
CrossRef | Web of Science | Medline5
Tavilla G ,Kappetein AP ,Braun J ,Gopie J ,Tjien AT ,Dion RA . Long-term follow-up of coronary artery bypass grafting in three-vessel disease using exclusively pedicled bilateral internal thoracic and right gastroepiploic arteries. Ann Thorac Surg 2004;77:794-799
CrossRef | Web of Science | Medline6
Barner HB . Operative treatment of coronary atherosclerosis. Ann Thorac Surg 2008;85:1473-1482
CrossRef | Web of Science | Medline7
Gruntzig A . Transluminal dilatation of coronary-artery stenosis. Lancet 1978;1:263-263
CrossRef | Web of Science | Medline8
Bittl JA . Advances in coronary angioplasty. N Engl J Med 1996;335:1290-1302[Erratum, N Engl J Med 1997;336:670.]
Full Text | Web of Science | Medline9
Serruys PW ,Kutryk MJB ,Ong ATL . Coronary-artery stents. N Engl J Med 2006;354:483-495
Full Text | Web of Science | Medline10
Booth J ,Clayton T ,Pepper J , et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 2008;118:381-388
CrossRef | Web of Science | Medline11
Daemen J ,Boersma E ,Flather M , et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008;118:1146-1154
CrossRef | Web of Science | Medline12
Hannan EL ,Wu C ,Walford G , et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008;358:331-341
Full Text | Web of Science | Medline13
Brener SJ ,Galla JM ,Bryant R III ,Sabik JF III ,Ellis SG . Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. Am J Cardiol 2008;101:169-172
CrossRef | Web of Science | Medline14
Briguori C ,Condorelli G ,Airoldi F , et al. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol 2007;99:779-784
CrossRef | Web of Science | Medline15
Buszman PE ,Kiesz SR ,Bochenek A , et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol 2008;51:538-545
CrossRef | Web of Science | Medline16
Chieffo A ,Morici N ,Maisano F , et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 2006;113:2542-2547
CrossRef | Web of Science | Medline17
Herz I ,Moshkovitz Y ,Loberman D , et al. Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease. Ann Thorac Surg 2005;80:2086-2090
CrossRef | Web of Science | Medline18
Javaid A ,Steinberg DH ,Buch AN , et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007;116:Suppl:I-200
CrossRef | Web of Science19
Lee MS ,Jamal F ,Kedia G , et al. Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. Int J Cardiol 2007;123:34-42
CrossRef | Web of Science | Medline20
Lee MS ,Kapoor N ,Jamal F , et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006;47:864-870
CrossRef | Web of Science | Medline21
Palmerini T ,Barlocco F ,Santarelli A , et al. A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years). Eur Heart J 2007;28:2714-2719
CrossRef | Web of Science | Medline22
Sanmartin M ,Baz JA ,Claro R , et al. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. Am J Cardiol 2007;100:970-973
CrossRef | Web of Science | Medline23
Yang ZK ,Shen WF ,Zhang RY , et al. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease. J Interv Cardiol 2007;20:10-16
CrossRef | Medline24
Serruys PW ,Daemen J ,Morice M-C , et al. Three-year follow-up of the ARTS-II-sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. EuroIntervention 2007;3:450-459
CrossRef25
Stettler C ,Wandel S ,Allemann S , et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937-948
CrossRef | Web of Science | Medline26
Smith SC Jr ,Feldman TE ,Hirshfeld JW Jr , et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:e1-e121
CrossRef | Medline27
Kappetein AP ,Dawkins KD ,Mohr FW , et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease: insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg 2006;29:486-491
CrossRef | Web of Science | Medline28
Ong AT ,Serruys PW ,Mohr FW , et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006;151:1194-1204
CrossRef | Web of Science | Medline29
Sianos G ,Morel MA ,Kappetein AP , et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1:219-22730
King SB III ,Smith SC Jr ,Hirshfeld JW Jr , et al. 2007 Focused update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 2008;117:261-295[Erratum, Circulation 2008;117(6):e161.]
CrossRef | Web of Science | Medline31
Nashef SA ,Roques F ,Michel P ,Gauducheau E ,Lemeshow S ,Salamon R . European System for Cardiac Operative Risk Evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13
CrossRef | Web of Science | Medline32
Parsonnet V ,Dean D ,Bernstein AD . A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989;79:I-3[Erratum, Circulation 1990;82:1078.]33
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
CrossRef | Web of Science34
Bravata DM ,Gienger AL ,McDonald KM , et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007;147:703-716
Web of Science | Medline35
Daemen J ,Wenaweser P ,Tsuchida K , et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-678
CrossRef | Web of Science | Medline36
Mauri L ,Hsieh WH ,Massaro JM ,Ho KK ,D'Agostino R ,Cutlip DE . Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029
Full Text | Web of Science | Medline37
Leaman DM ,Brower RW ,Meester GT ,Serruys P ,van den Brand M . Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 1981;63:285-299
CrossRef | Web of Science | Medline38
Valgimigli M ,Serruys PW ,Tsuchida K , et al. Cyphering the complexity of coronary artery disease using the Syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 2007;99:1072-1081
CrossRef | Web of Science | Medline39
van den Brand MJBM ,Rensing BJWM ,Morel MM , et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 2002;39:559-564
CrossRef | Web of Science | Medline
- Citing Articles (605)
Citing Articles
1
2013. A. , 3-141.
CrossRef2
Yong-Giun Kim, Duk-Woo Park, Woo Seok Lee, Gyung-Min Park, Byung Joo Sun, Chang Hoon Lee, Ki Won Hwang, Sung Won Cho, Yoo Ri Kim, Hae Geun Song, Jung-Min Ahn, Won-Jang Kim, Jong-Young Lee, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seungbong Han, Sung-Ho Jung, Suk Jung Choo, Cheol Hyun Chung, Jae-Won Lee, Seung-Jung Park. (2012) Influence of Diabetes Mellitus on Long-Term (Five-Year) Outcomes of Drug-Eluting Stents and Coronary Artery Bypass Grafting for Multivessel Coronary Revascularization. The American Journal of Cardiology 109:11, 1548-1557
CrossRef3
Deepak Thomas, Robert P. Giugliano. (2012) Management of Non–ST-Segment Elevation Acute Coronary Syndrome. Critical Pathways in Cardiology 11:2, 62-73
CrossRef4
Yoshinobu Onuma, Takashi Muramatsu, Alexander Kharlamov, Patrick W. Serruys. (2012) Freeing the vessel from metallic cage: what can we achieve with bioresorbable vascular scaffolds?. Cardiovascular Intervention and Therapeutics
CrossRef5
O. Alfieri. (2012) The beauty of the differences. European Journal of Cardio-Thoracic Surgery
CrossRef6
S. J. Head, S. Kaul, A. J. J. C. Bogers, A. P. Kappetein. (2012) Non-inferiority study design: lessons to be learned from cardiovascular trials. European Heart Journal
CrossRef7
Siamak Mohammadi, Dimitri Kalavrouziotis, Francois Dagenais, Pierre Voisine, Eric Charbonneau. (2012) Completeness of Revascularization and Survival Among Octogenarians With Triple-Vessel Disease. The Annals of Thoracic Surgery 93:5, 1432-1437
CrossRef8
Ralf Lehmann, Joachim R. Ehrlich, Salvatore De Rosa, Ioakim Spyridopoulos, Rafael Laskowski, Janine Kremer, Eva Herrmann, Andreas M. Zeiher, Volker Schächinger, Stephan Fichtlscherer. (2012) Impact of Interventional Strategy for Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention on Long-term Survival. Canadian Journal of Cardiology
CrossRef9
Mariam Samim, Pierfrancesco Agostoni, Michiel Voskuil, Anouar Belkacemi, Pieter A. Doevendans, Pieter R. Stella. (2012) Optical coherence tomography assessment of early stent strut coverage in patients treated with a thin-strut bare cobalt-chromium stent coated with silicon carbide. International Journal of Cardiology 157:2, 291-292
CrossRef10
Martin Mates, Petr Kala, Karel Kopřiva, Ondřej Aschermann. (2012) The Concept of Functional Revascularization. Cor et Vasa
CrossRef11
Mauri, Laura, . (2012) Why We Still Need Randomized Trials to Compare Effectiveness. New England Journal of Medicine 366:16, 1538-1540
Full Text12
Weintraub, William S., Grau-Sepulveda, Maria V., Weiss, Jocelyn M., O'Brien, Sean M., Peterson, Eric D., Kolm, Paul, Zhang, Zugui, Klein, Lloyd W., Shaw, Richard E., McKay, Charles, Ritzenthaler, Laura L., Popma, Jeffrey J., Messenger, John C., Shahian, David M., Grover, Frederick L., Mayer, John E., Shewan, Cynthia M., Garratt, Kirk N., Moussa, Issam D., Dangas, George D., Edwards, Fred H., . (2012) Comparative Effectiveness of Revascularization Strategies. New England Journal of Medicine 366:16, 1467-1476
Full Text13
M. P. B. d. O. Sa, A. M. M. N. Soares, P. C. Lustosa, W. N. Martins, F. Browne, P. E. Ferraz, F. P. Vasconcelos, R. C. Lima. (2012) Meta-analysis of 5674 patients treated with percutaneous coronary intervention and drug-eluting stents or coronary artery bypass graft surgery for unprotected left main coronary artery stenosis. European Journal of Cardio-Thoracic Surgery
CrossRef14
Oliver J Liakopoulos, Elmar W Kuhn, Ingo Slottosch, Gernot Wassmer, Thorsten Wahlers, Oliver J Liakopoulos. 2012. Preoperative statin therapy for patients undergoing cardiac surgery. .
CrossRef15
Seung-Jung Park, Cheol Whan Lee. (2012) Coronary artery disease: Risk models for revascularization—the search continues. Nature Reviews Cardiology
CrossRef16
M. Y. Emmert, S. P. Salzberg, H. R. Cetina Biefer, S. H. Sundermann, B. Seifert, J. Grunenfelder, S. Jacobs, V. Falk. (2012) Total arterial off-pump surgery provides excellent outcomes and does not compromise complete revascularization. European Journal of Cardio-Thoracic Surgery 41:4, e25-e31
CrossRef17
Maksymilian P. Opolski, Cezary Kepka, Stephan Achenbach, Zbigniew Juraszynski, Jerzy Pregowski, Mariusz Kruk, Marcin Niewada, Michal Jakubczyk, Anna Teresinska, Lidia Chojnowska, Zofia T. Bilinska, Zofia Dzielinska, Marcin Demkow, Witold Ruzyllo, Zbigniew Chmielak, Adam Witkowski. (2012) Coronary Computed Tomographic Angiography for Prediction of Procedural and Intermediate Outcome of Bypass Grafting to Left Anterior Descending Artery Occlusion With Failed Visualization on Conventional Angiography. The American Journal of Cardiology
CrossRef18
Philippe Généreux, Tullio Palmerini, Adriano Caixeta, Gregg Rosner, Philip Green, Ovidiu Dressler, Ke Xu, Helen Parise, Roxana Mehran, Patrick W. Serruys, Gregg W. Stone. (2012) Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention. Journal of the American College of Cardiology
CrossRef19
Clemens von Birgelen, Mounir W.Z. Basalus, Kenneth Tandjung, K. Gert van Houwelingen, Martin G. Stoel, J.(Hans) W. Louwerenburg, Gerard C.M. Linssen, Salah A.M. Saïd, Miep A.W.J. Kleijne, Hanim Sen, Marije M. Löwik, Job van der Palen, Patrick M.J. Verhorst, Frits H.A.F. de Man. (2012) A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients. Journal of the American College of Cardiology 59:15, 1350-1361
CrossRef20
Valentina Coluccia, Francesco Burzotta, Enrico Romagnoli, Carlo Trani, Maura Giammarinaro, Giovanni Paolo Talarico, Giuseppe Vincenzo Jannelli, Giampaolo Niccoli, Italo Porto, Antonio Maria Leone, Antonella Tommasino, Giovanni Schiavoni, Filippo Crea. (2012) EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions. International Journal of Cardiology
CrossRef21
Sachie Terazawa, Kazuyoshi Tajima, Yoshiyuki Takami, Keisuke Tanaka, Noritaka Okada, Akihiko Usui, Yuichi Ueda. (2012) Early and Late Outcomes of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention with Drug-Eluting Stents for Dialysis Patients. Journal of Cardiac Surgeryno-no
CrossRef22
Elvin Kedhi, Marc Gomes, Kaiyum Joesoef, Jochem Wassing, Dick Goedhart, Eugene McFadden, Pieter C. Smits. (2012) Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial. EuroIntervention 7:12, 1376-1385
CrossRef23
Peter W. Radke, Hans.-H. Sievers, Heribert Schunkert. (2012) Brücke zwischen Kardiologie und Herzchirurgie. CardioVasc 12:2, 38-41
CrossRef24
Marzia Leacche, John G. Byrne, Natalia S. Solenkova, Brendan Reagan, Tahir I. Mohamed, Joseph L. Fredi, David X. Zhao. (2012) Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE. The Journal of Thoracic and Cardiovascular Surgery
CrossRef25
G. Souteyrand, P. Motreff, N. Durel, J.-R. Lusson, B. Citron. (2012) La revascularisation myocardique et son suivi. Archives des Maladies Professionnelles et de l'Environnement
CrossRef26
Jason C. Kovacic, Jose M. Castellano, Valentin Fuster. (2012) The links between complex coronary disease, cerebrovascular disease, and degenerative brain disease. Annals of the New York Academy of Sciences 1254:1, 99-105
CrossRef27
Marco Novara, Fabrizio D’Ascenzo, Anna Gonella, Mario Bollati, Giuseppe Biondi-Zoccai, Claudio Moretti, Pierluigi Omedè, Filippo Sciuto, Imad Sheiban, Fiorenzo Gaita. (2012) Changing of SYNTAX score performing fractional flow reserve in multivessel coronary artery disease. Journal of Cardiovascular Medicine1
CrossRef28
Niels Ramsing, Michael Maeng, Jens Flensted Lassen, Leif Thuesen. 2012. The Nordic Experience. , 21-33.
CrossRef29
R. Dörr, J. Stumpf, S.G. Spitzer, B. Krosse, D. Tschöpe, T. Lohmann, O. Schnell. (2012) Prävalenz unentdeckter Glukosestoffwechselstörungen in der invasiven und interventionellen Kardiologie. Herz
CrossRef30
Salvatore Brugaletta, Hector M Garcia-Garcia, Yoshinobu Onuma, Patrick W Serruys. (2012) Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives. Expert Review of Medical Devices1-12
CrossRef31
A. B. A. Vonk. (2012) Non-ST elevation myocardial infarction? Intervene!. European Journal of Cardio-Thoracic Surgery
CrossRef32
S. Desch, E. Boudriot, A. Rastan, P.E. Buszman, A. Bochenek, F.W. Mohr, G. Schuler, H. Thiele. (2012) Bypass surgery versus percutaneous coronary intervention for the treatment of unprotected left main disease. Herz
CrossRef33
H. Rittger, M. Arnold, M. Schmid, S. Zimmermann, W.G. Daniel. (2012) Koronarintervention. Herz
CrossRef34
Ziad Sergie, Roxana Mehran. (2012) Survival benefit with PCI for chronic total occlusions: The Jury is still out. Catheterization and Cardiovascular Interventions 79:4, 613-614
CrossRef35
Christopher Cao, Con Manganas, Paul Bannon, Michael Vallely, Tristan D. Yan. (2012) Drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease: A meta-analysis of early outcomes from randomized and nonrandomized studies. The Journal of Thoracic and Cardiovascular Surgery
CrossRef36
Ziad Dahdouh, Vincent Roule, Rémi Sabatier, Thérèse Lognoné, Alain Manrique, Mathieu Bignon, Guillaume Malcor, Massimo Massetti, Gilles Grollier. (2012) Left main coronary stenting in a non surgical octogenarian population: a possible approach. Cardiovascular Revascularization Medicine 13:2, 119-124
CrossRef37
Nico H.J. Pijls, Jan-Willem E.M. Sels. (2012) Functional Measurement of Coronary Stenosis. Journal of the American College of Cardiology 59:12, 1045-1057
CrossRef38
Robert A. Henderson, Adam D. Timmis. (2012) Almanac 2011: Stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology. The Egyptian Heart Journal
CrossRef39
E. L. Senanayake, N. J. Howell, J. Evans, D. Ray, J. Mascaro, T. R. Graham, S. J. Rooney, D. Pagano. (2012) Contemporary outcomes of urgent coronary artery bypass graft surgery following non-ST elevation myocardial infarction: urgent coronary artery bypass graft surgery consistently outperforms Global Registry of Acute Coronary Events predicted survival. European Journal of Cardio-Thoracic Surgery
CrossRef40
2012. References. , 348-358.
CrossRef41
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting, Alice K. Jacobs, Jeffrey L. Anderson, Nancy Albert, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Jonathan L. Halperin, Judith S. Hochman, Frederick G. Kushner, E. Magnus Ohman, William Stevenson, Clyde W. Yancy. (2012) 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary. Catheterization and Cardiovascular Interventions 79:3, 453-495
CrossRef42
Vinay Prasad, Adam Cifu. (2012) A medical burden of proof: Towards a new ethic. BioSocieties
CrossRef43
Stuart J. Head, M. Mostafa Mokhles, A. Pieter Kappetein. (2012) Invited Commentary. The Annals of Thoracic Surgery 93:2, 530
CrossRef44
Gabriel L. Sardi, Michael A. Gaglia, Gabriel Maluenda, Rebecca Torguson, Ana Laynez-Carnicero, Itsik Ben-Dor, Camille Hauville, Zhenyi Xue, William O. Suddath, Kenneth M. Kent, Lowell F. Satler, Augusto D. Pichard, Joseph Lindsay, Ron Waksman. (2012) Outcome of Percutaneous Coronary Intervention Utilizing Drug-Eluting Stents in Patients With Reduced Left Ventricular Ejection Fraction. The American Journal of Cardiology 109:3, 344-351
CrossRef45
Gabriele Pesarini, Francesco Santini, Giulia Geremia, Carlo Zivelonghi, Flavio Ribichini. (2012) Risk Stratification in Acute Coronary Syndromes. Journal of Cardiovascular Translational Research 5:1, 1-10
CrossRef46
Kyriakos Anastasiadis, Polychronis Antonitsis, Anna-Bettina Haidich, Helena Argiriadou, Apostolos Deliopoulos, Christos Papakonstantinou. (2012) Use of minimal extracorporeal circulation improves outcome after heart surgery; a systematic review and meta-analysis of randomized controlled trials. International Journal of Cardiology
CrossRef47
Sisira Siribaddana. (2012) Cardiac dysfunction in the CABG patient. Current Opinion in Pharmacology
CrossRef48
Eric J. Velazquez, Judson B. Williams, Eric Yow, Linda K. Shaw, Kerry L. Lee, Harry R. Phillips, Christopher M. O'Connor, Peter K. Smith, Robert H. Jones. (2012) Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy. The Annals of Thoracic Surgery 93:2, 523-530
CrossRef49
Andrew W. ElBardissi, Sary F. Aranki, Shubin Sheng, Sean M. O’Brien, Caprice C. Greenberg, James S. Gammie. (2012) Trends in isolated coronary artery bypass grafting: An analysis of the Society of Thoracic Surgeons adult cardiac surgery database. The Journal of Thoracic and Cardiovascular Surgery 143:2, 273-281
CrossRef50
Ryan Kelly, Karen J. Buth, Jean-Francois Légaré. (2012) Bilateral internal thoracic artery grafting is superior to other forms of multiple arterial grafting in providing survival benefit after coronary bypass surgery. The Journal of Thoracic and Cardiovascular Surgery
CrossRef51
Stefano Mastrobuoni, Nada Gawad, Joel Price, Vincent Chan, Marc Ruel, Thierry G. Mesana, Fraser D. Rubens. (2012) Use of bilateral internal thoracic artery during coronary artery bypass graft surgery in Canada: The bilateral internal thoracic artery survey. The Journal of Thoracic and Cardiovascular Surgery
CrossRef52
Maik JD Grundeken, Joanna J Wykrzykowska. (2012) Biolimus-eluting stent with biodegradable polymer: one step forward in the fight against stent thrombosis vulnerability?. Interventional Cardiology 4:1, 11-25
CrossRef53
Ronen Jaffe, David A. Halon, Ariel Roguin, Ronen Rubinshtein, Basil S. Lewis. (2012) A Poiseuille-based coronary angiographic index for prediction of fractional flow reserve. International Journal of Cardiology
CrossRef54
Shizuyuki Dohi, Kan Kajimoto, Katsumi Miyauchi, Taira Yamamoto, Keiichi Tambara, Hirotaka Inaba, Kenji Kuwaki, Hiroshi Tamura, Takahiko Kojima, Ken Yokoyama, Takeshi Kurata, Hiroyuki Daida, Atsushi Amano. (2012) Comparing outcomes after off-pump coronary artery bypass versus drug-eluting stent in diabetic patients. Journal of Cardiology
CrossRef55
Christian W. Hamm, Jean-Pierre Bassand, Stefan Agewall, Jeroen Bax, Eric Boersma, Hector Bueno, Pio Caso, Dariusz Dudek, Stephan Gielen, Kurt Huber, Magnus Ohman, Mark C. Petrie, Frank Sonntag, Miguel Sousa Uva, Robert F. Storey, William Wijns, Doron Zahger. (2012) Guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST. Revista Española de Cardiología 65:2, 173.e1-173.e55
CrossRef56
Kan Kajimoto, Katsumi Miyauchi, Taira Yamamoto, Hiroyuki Daida, Atsushi Amano. (2012) Meta-analysis of Randomized Controlled Trials on the Treatment of Unprotected Left Main Coronary Artery Disease: One-Year Outcomes with Coronary Artery Bypass Grafting Versus Percutaneous Coronary Artery Intervention with Drug-Eluting Stent. Journal of Cardiac Surgeryno-no
CrossRef57
Joanne Shannon, Antonio Colombo. (2012) Revascularization in multivessel CAD: a functional approach. Nature Reviews Cardiology
CrossRef58
Marco Roffi, Flavio Ribichini, Fausto Castriota, Alberto Cremonesi. (2012) Management of Combined Severe Carotid and Coronary Artery Disease. Current Cardiology Reports
CrossRef59
D. P. Taggart. (2012) Incomplete revascularization: appropriate and inappropriate. European Journal of Cardio-Thoracic Surgery
CrossRef60
Seung-Whan Lee, Sung-Hwan Kim, Seon-Ok Kim, Seungbong Han, Young-Hak Kim, Duk-Woo Park, Soo-Jin Kang, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park. (2012) Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef61
J. Fajadet, A. Chieffo. (2012) Current management of left main coronary artery disease. European Heart Journal 33:1, 36-50
CrossRef62
N. Ikeda, N. Kogame, R. Iijima, M. Nakamura, K. Sugi. (2012) Carotid artery intima-media thickness and plaque score can predict the SYNTAX score. European Heart Journal 33:1, 113-119
CrossRef63
L. David Hillis, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, Verdi J. DiSesa, Loren F. Hiratzka, Adolph M. Hutter, Michael E. Jessen, Ellen C. Keeley, Stephen J. Lahey, Richard A. Lange, Martin J. London, Michael J. Mack, Manesh R. Patel, John D. Puskas, Joseph F. Sabik, Ola Selnes, David M. Shahian, Jeffrey C. Trost, Michael D. Winniford, Alice K. Jacobs, Jeffrey L. Anderson, Nancy Albert, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Jonathan L. Halperin, Judith S. Hochman, Frederick G. Kushner, E. Magnus Ohman, William Stevenson, Clyde W. Yancy. (2012) 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary. The Journal of Thoracic and Cardiovascular Surgery 143:1, 4-34
CrossRef64
Tatsiana Suvorava, Vu Thao-Vi Dao, Murat Bas, Georg Kojda. (2012) Nitric oxide and the CABG patient. Current Opinion in Pharmacology
CrossRef65
R. J. Nuis, A. E. Dager, R. M. Boon, M. C. Jaimes, B. Caicedo, J. Fonseca, N. M. Mieghem, L. M. Benitez, J. P. Umana, W. W. O’Neill, E. Marchena, P. P. Jaegere. (2012) Patients with aortic stenosis referred for TAVI: treatment decision, in-hospital outcome and determinants of survival. Netherlands Heart Journal 20:1, 16-23
CrossRef66
David Adlam, Nicholas Evans, Aneal Malhotra, Disha Midha, Felicity Rowley, David Hutchings, Mirae Shin, Guy Mole, Alexander Stockenhuber, Mark Lumb, Jonathan Wordsworth, Sophie Frantal, J. Colin Forfar. (2012) Repeat percutaneous coronary revascularization: Indications and outcomes in a “Real World” cohort. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef67
Damian Kawecki, Beata Morawiec, Marcin Fudal, Wojciech Milejski, Wojciech Jacheć, Ewa Nowalany-Kozielska. (2012) Comparison of Coronary Artery Bypass Grafting with Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease. Yonsei Medical Journal 53:1, 58
CrossRef68
Kyung Woo Park, Si-Hyuck Kang, Hyo-Soo Kim. (2012) Response to "Sirolimus or paclitaxel drug eluting stent in left main disease: The winner is…". International Journal of Cardiology 154:2, 192-193
CrossRef69
Yu-Lan Jou, Tse-Min Lu, Ying-Hwa Chen, Shih-Hsien Sung, Kang-Ling Wang, Shao-Sung Huang, Wan-Ting Lin, Wan-Leong Chan, Shing-Jong Lin. (2012) Comparison of the predictive value of EuroSCORE, SYNTAX score, and clinical SYNTAX score for outcomes of patients undergoing percutaneous coronary intervention for unprotected left main coronary artery disease. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef70
Daniel Suissa, Paul Brassard, Brielan Smiechowski, Samy Suissa. (2012) Number needed to treat is incorrect without proper time-related considerations. Journal of Clinical Epidemiology 65:1, 42-46
CrossRef71
J. M. Blazeby. (2012) Recruiting patients into randomized clinical trials in surgery. British Journal of Surgeryn/a-n/a
CrossRef72
Suguru Okubo, Hiroaki Miyata, Ai Tomotaki, Tadashi Iwanaka. (2012) A Review of Propriety of Clinical Database for Quality Improvement Initiative. Iryo To Shakai 21:4, 435-450
CrossRef73
Jie Chen, John A. Rizzo. (2012) The Economics of Cardiovascular Disease in the United States. Critical Care Clinics 28:1, 77-88
CrossRef74
Ramesh S. Kutty, Sukumaran K. Nair. (2012) Surgery for coronary artery disease. Surgery (Oxford) 30:1, 32-38
CrossRef75
Hui-Li Gan, Jian-Qun Zhang, Wei Xiao, Shuang Zhao, Fang-jong Huang, Cheng-xiong Gu, Chun-shang Lu, Pi-Shan Wang. (2012) Ostial left main coronary artery stenosis as an additional risk factor in off-pump coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery 143:1, 103-110
CrossRef76
Stuart J Head, Ad JJC Bogers, A Pieter Kappetein. (2012) Drug-eluting stent implantation for coronary artery disease: current stents and a comparison with bypass surgery. Current Opinion in Pharmacology
CrossRef77
Giuseppe Sangiorgi, Giuseppe Biondi-Zoccai, Maria Grazia Modena. (2012) Repetita iuvant (repeating helps): why another paper on a new stent is important. EuroIntervention 7:9, 1014-1017
CrossRef78
ANTONIO PARMA, ROSARIO FIORILLI, FRANCESCO DE FELICE, FRANCESCO CHINI, PAOLO GIORGI ROSSI, PIERO BORGIA, MARCO STEFANO NAZZARO, CARMINE MUSTO, GABRIELLA GUASTICCHI, ROBERTO VIOLINI. (2012) Early and Mid-Term Clinical Outcome of Emergency PCI in Patients with STEMI due to Unprotected Left Main Coronary Artery Disease. Journal of Interventional Cardiologyno-no
CrossRef79
Felix Mahfoud, Michael Böhm, Magnus Baumhäkel. (2012) Inadequate Reporting of Concomitant Drug Treatment in Cardiovascular Interventional Head-to-Head Trials. Clinical Cardiologyn/a-n/a
CrossRef80
Jennifer Conroy, Usman Baber, Roxana Mehran. (2012) Future Perspectives on Percutaneous Coronary Interventions in Women. Interventional Cardiology Clinics 1:2, 251
CrossRef81
Michael Ried, Reinhard Kobuch, Leopold Rupprecht, Andreas Keyser, Michael Hilker, Christof Schmid, Claudius Diez. (2012) Reduced 30-day mortality in men after elective coronary artery bypass surgery with minimized extracorporeal circulation - a propensity score analysis. BMC Cardiovascular Disorders 12:1, 17
CrossRef82
Elliott M. Antman. 2012. Design and Conduct of Clinical Trials. , 49-55.
CrossRef83
David A. Morrow, William E. Boden. 2012. Stable Ischemic Heart Disease. , 1210-1269.
CrossRef84
Franz-Josef Neumann, Heinz Joachim Büttner. 2012. Evidence-Based Interventional Practice. , 16-29.
CrossRef85
Gregg W. Stone, Ajay J. Kirtane. 2012. Bare Metal and Drug-Eluting Coronary Stents. , 171-196.
CrossRef86
Jeffrey J. Popma, Deepak L. Bhatt. 2012. Percutaneous Coronary Intervention. , 1270-1300.
CrossRef87
Arashk Motiei, David R. Holmes. 2012. Complex and Multi-vessel Percutaneous Coronary Intervention. , 303-311.
CrossRef88
Daniel Mark. 2012. Medical Economics in Interventional Cardiology. , 861-876.
CrossRef89
Gregory W. Barsness, David E. Kandzari. 2012. Elective Intervention for Stable Angina or Silent Ischemia. , 209-222.
CrossRef90
Srihari S. Naidu, Howard C. Herrmann. 2012. Support Devices for High-Risk Percutaneous Coronary Interventions. , 455-466.
CrossRef91
Jeffrey Popma, Alexandra Almonacid, David Burke. 2012. Qualitative and Quantitative Coronary Angiography. , 757-775.
CrossRef92
Masakiyo Nobuyoshi, Hiroyoshi Yokoi, Shinichi Shirai. 2012. Small Vessel and Diffuse Disease. , 288-293.
CrossRef93
Seung-Jung Park, Young-Hak Kim. 2012. Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Stenosis. , 294-302.
CrossRef94
Scot Garg, Patrick W. Serruys. 2012. Individualized Assessment for Percutaneous or Surgical Revascularization. , 3-15.
CrossRef95
Troels Thim, Michael Maeng, Jens Flensted Lassen, Anne Kaltoft, Lisette Okkels Jensen, Jan Ravkilde, Per Thayssen, Soren Galatius, Evald Hoj Christiansen, Thomas Engstrom, Morten Madsen, Leif Thuesen, Hans Henrik Tilsted. (2012) Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (A SORT OUT III substudy). BMC Cardiovascular Disorders 12:1, 18
CrossRef96
Tullio Palmerini, Laura Alessi, Nicole Rizzo, George Dangas. (2012) Percutaneous revascularization of left main. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef97
Tullio Palmerini, Laura Alessi, George Dangas. (2012) Revascularization of unprotected left main coronary artery disease: Strategy selection and systematic risk assessment. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef98
Kyriakos Anastasiadis, Stavros Hadjimiltiades, Polychronis Antonitsis. (2012) Successful high-risk percutaneous coronary intervention with the use of minimal extracorporeal circulation system. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef99
Philippe Garot, Muriel Tafflet, Sundar Kumar, Neus Salvatella, Olivier Darremont, Xavier Jouven, Didier Carrié, Thierry Lefèvre, Varvara Russu, Marie-Claude Morice. (2012) Reproducibility and factors influencing the assessment of the SYNTAX score in the left main xience study. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef100
Daniel Burkhoff, Srihari S. Naidu. (2012) The science behind percutaneous hemodynamic support: A review and comparison of support strategies. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef101
David R. Holmes, Michael J. Mack, Sanjay Kaul, Arvind Agnihotri, A. Pieter Kappetein, Karen P. Alexander, Jane A. Linderbaum, Steven R. Bailey, Chirojit Mukherjee, John H. Calhoon, Debabrata Mukherjee, Blase A. Carabello, Catherine M. Otto, Milind Y. Desai, Carlos E. Ruiz, Fred H. Edwards, Ralph L. Sacco, Gary S. Francis, Donnette Smith, Timothy J. Gardner, James D. Thomas, Robert A. Harrington, Deepak L. Bhatt, Victor A. Ferrari, Adrian F. Hernandez, John D. Fisher, Alice K. Jacobs, Mario J. Garcia, Sanjay Kaul, Timothy J. Gardner, Jane A. Linderbaum, Federico Gentile, David J. Moliterno, Michael F. Gilson, Howard H. Weitz. (2012) 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef102
Pravien Khanna, Erik Stilp, Steven Pfau. (2012) Recovery of left ventricular function after percutaneous revascularization of a left main chronic total occlusion. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef103
Sameer Bansilal, Deepak L. Bhatt. (2012) Declining Coronary Artery Bypass-Related Mortality: More Than Meets the Eye?. Clinical Cardiologyn/a-n/a
CrossRef104
William E. Boden, Aloke V. Finn, Dharmesh Patel, W. Frank Peacock, Udho Thadani, Franklin H. Zimmerman. (2012) Nitrates as an Integral Part of Optimal Medical Therapy and Cardiac Rehabilitation for Stable Angina: Review of Current Concepts and Therapeutics. Clinical Cardiologyn/a-n/a
CrossRef105
William E. Boden. 2012. Angina Pectoris and Stable Ischemic Heart Disease. , 412-425.
CrossRef106
Paul S. Teirstein, Bruce W. Lytle. 2012. Interventional and Surgical Treatment of Coronary Artery Disease. , 448-453.
CrossRef107
Sanjeeb Roy, Ajeet Bana, Rajeev Gupta, Rakesh Chittora, Sameer Sharma, Navneet Mehta. (2012) Left main coronary artery bifurcation angioplasty and stenting after aortic valve replacement: a case report. Indian Heart Journal 64:1, 80-83
CrossRef108
B.J. Gersh. (2012) Functional SYNTAX Score for Risk Assessment in Multivessel Coronary Artery Disease. Yearbook of Cardiology 2012, 210-212
CrossRef109
B.J. Gersh. (2012) Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Yearbook of Cardiology 2012, 221-223
CrossRef110
Yasunari Sakamoto, Toshiya Muramatsu, Reiko Tsukahara, Yoshiaki Ito, Hiroshi Ishimori, Keisuke Hirano, Masatsugu Nakano. (2011) A case achieved successful revascularization to severe ischemic coronary artery disease after endovascular recanalization with infrarenal aortic occlusion. Cardiovascular Intervention and Therapeutics
CrossRef111
H. B. Bittner, S. Lehmann, A. Rastan, F. W. Mohr. (2011) Impact of clopidogrel on bleeding complications and survival in off-pump coronary artery bypass grafting. Interactive CardioVascular and Thoracic Surgery
CrossRef112
S. J. Head, M. J. Mack, D. R. Holmes, F. W. Mohr, M.-C. Morice, P. W. Serruys, A. P. Kappetein. (2011) Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. European Journal of Cardio-Thoracic Surgery
CrossRef113
, Derek J. Hausenloy, Luciano Candilio, Chris Laing, Gudrun Kunst, John Pepper, Shyam Kolvekar, Richard Evans, Steve Robertson, Rosemary Knight, Cono Ariti, Tim Clayton, Derek M. Yellon. (2011) Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. Clinical Research in Cardiology
CrossRef114
C. Girasis, S. Garg, L. Raber, G. Sarno, M.-A. Morel, H. M. Garcia-Garcia, T. F. Luscher, P. W. Serruys, S. Windecker. (2011) SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. European Heart Journal 32:24, 3115-3127
CrossRef115
, C. W. Hamm, J.-P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, D. Dudek, S. Gielen, K. Huber, M. Ohman, M. C. Petrie, F. Sonntag, M. S. Uva, R. F. Storey, W. Wijns, D. Zahger, , J. J. Bax, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, A. Torbicki, A. Vahanian, S. Windecker, , S. Windecker, S. Achenbach, L. Badimon, M. Bertrand, H. E. Botker, J.-P. Collet, F. Crea, N. Danchin, E. Falk, J. Goudevenos, D. Gulba, R. Hambrecht, J. Herrmann, A. Kastrati, K. Kjeldsen, S. D. Kristensen, P. Lancellotti, J. Mehilli, B. Merkely, G. Montalescot, F.-J. Neumann, L. Neyses, J. Perk, M. Roffi, F. Romeo, M. Ruda, E. Swahn, M. Valgimigli, C. J. Vrints, P. Widimsky. (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal 32:23, 2999-3054
CrossRef116
Damian Kawecki, Grzegorz Kubiak, Katarzyna Orszulik, Aleksandra Kusińska, Katarzyna Mitręga, Magdalena Pałka, Zofia Trzepaczyńska, Ewa Nowalany-Kozielska. (2011) Quality of life in patients with severe left ventricle dysfunction due to coronary artery disease. Central European Journal of Medicine 6:6, 807-812
CrossRef117
Chang-Wook Nam, William F Fearon. (2011) Role of the functional SYNTAX score in evaluating multivessel coronary artery disease. Interventional Cardiology 3:6, 695-704
CrossRef118
A. Kapur, A. C. Qureshi, S. Gallagher, M. Finlay, I. S. Malik, J. Mayet, M. Roughton, K. J. Beatt, R. J. Hall, P. Nihoyannopoulos. (2011) Myocardial function may improve equally in diabetic patients following both multivessel percutaneous coronary intervention and coronary artery bypass grafting: results from a CARDia trial substudy. European Journal of Echocardiography 12:12, 904-909
CrossRef119
Michael J. Mack, Adrian P. Banning, Patrick W. Serruys, Marie-Claude Morice, Yves Taeymans, Guido Van Nooten, Gianfederico Possati, Filippo Crea, Kristin L. Hood, Katrin Leadley, Keith D. Dawkins, A. Pieter Kappetein. (2011) Bypass Versus Drug-Eluting Stents at Three Years in SYNTAX Patients With Diabetes Mellitus or Metabolic Syndrome. The Annals of Thoracic Surgery 92:6, 2140-2146
CrossRef120
Fausto Biancari, Mikko Myllylä, Pekka Porela, Timo Laitio, Kari Kuttila, Jari Satta, Martti Lepojärvi, Tatu Juvonen, Juhani K. E. Airaksinen. (2011) Postoperative stroke in patients on oral anticoagulation undergoing coronary artery bypass surgery. Scandinavian Cardiovascular Journal 45:6, 360-368
CrossRef121
Maximilian Y. Emmert, Burkhardt Seifert, Markus Wilhelm, Jürg Grünenfelder, Volkmar Falk, Sacha P. Salzberg. (2011) Aortic no-touch technique makes the difference in off-pump coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery 142:6, 1499-1506
CrossRef122
A. Thiem, T. Attmann, J. Cremer. (2011) Moderne Koronarchirurgie in Zusammenhang mit der SYNTAX-Studie und aktuellen Leitlinien. Herz 36:8, 669-676
CrossRef123
Chuntao Wu, Songyang Zhao, Andrew S. Wechsler, Stephen Lahey, Gary Walford, Alfred T. Culliford, Jeffrey P. Gold, Craig R. Smith, David R. Holmes, Spencer B. King, Robert S.D. Higgins, Desmond Jordan, Edward L. Hannan. (2011) Long-Term Mortality of Coronary Artery Bypass Grafting and Bare-Metal Stenting. The Annals of Thoracic Surgery 92:6, 2132-2138
CrossRef124
Gerhard Wimmer-Greinecker, Olivier Bouchot, Jean P. Verhoye, Louis P. Perrault, Jochen Börgermann, Anno Diegeler, Leen Van Garsse, Ardawan J. Rastan. (2011) Randomized Clinical Trial Comparing a Thermosensitive Polymer (LeGoo) With Conventional Vessel Loops for Temporary Coronary Artery Occlusion During Off-Pump Coronary Artery Bypass Surgery. The Annals of Thoracic Surgery 92:6, 2177-2183
CrossRef125
George Hahalis, George Dangas, Periklis Davlouros, Dimitrios Alexopoulos. (2011) Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: From BARI to SYNTAX. International Journal of Cardiology 153:2, 126-134
CrossRef126
Juan-Carlos Kaski, Antonio Arrebola-Moreno, Jason Dungu. (2011) Treatment strategies for chronic stable angina. Expert Opinion on Pharmacotherapy 12:18, 2833-2844
CrossRef127
, B. Scheller, B. Levenson, M. Joner, R. Zahn, V. Klauss, C. Naber, V. Schächinger, A. Elsässer. (2011) Medikamente freisetzende Koronarstents und mit Medikamenten beschichtete Ballonkatheter. Der Kardiologe 5:6, 411-435
CrossRef128
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting. (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary. Journal of the American College of Cardiology 58:24, 2550-2583
CrossRef129
L. David Hillis, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, Verdi J. DiSesa, Loren F. Hiratzka, Adolph M. Hutter, Michael E. Jessen, Ellen C. Keeley, Stephen J. Lahey, Richard A. Lange, Martin J. London, Michael J. Mack, Manesh R. Patel, John D. Puskas, Joseph F. Sabik, Ola Selnes, David M. Shahian, Jeffrey C. Trost, Michael D. Winniford. (2011) 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. Journal of the American College of Cardiology 58:24, e123-e210
CrossRef130
L. David Hillis, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, Verdi J. DiSesa, Loren F. Hiratzka, Adolph M. Hutter, Michael E. Jessen, Ellen C. Keeley, Stephen J. Lahey, Richard A. Lange, Martin J. London, Michael J. Mack, Manesh R. Patel, John D. Puskas, Joseph F. Sabik, Ola Selnes, David M. Shahian, Jeffrey C. Trost, Michael D. Winniford. (2011) 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary. Journal of the American College of Cardiology 58:24, 2584-2614
CrossRef131
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting. (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. Journal of the American College of Cardiology 58:24, e44-e122
CrossRef132
Gijong Yi, Young-Nam Youn, Soonchang Hong, Suk-Won Song, Kyung-Jong Yoo. (2011) Comparison of Long-Term Outcome of Off-Pump Coronary Artery Bypass Grafting Versus Drug-Eluting Stents in Triple-Vessel Coronary Artery Disease. The American Journal of Cardiology
CrossRef133
T. Rassaf, M. Kelm, S. Nitschmann. (2011) Lebensqualität nach Koronarintervention oder Bypasschirurgie. Der Internist
CrossRef134
Timm Bauer, Helge Möllmann, Uwe Zeymer, Matthias Hochadel, Holger Nef, Franz Weidinger, Ralf Zahn, Christian W. Hamm, Jean Marco, Anselm K. Gitt. (2011) Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry. Heart and Vessels
CrossRef135
Chuanyan Zhao, Xin Wang, Xiaoyan Wu, Lianqun Cui. (2011) Early and Long-Term Outcomes After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Disease With Drug-Eluting Stents in Patients With Non-ST–Elevation Acute Coronary Syndrome. Canadian Journal of Cardiology 27:6, 743-748
CrossRef136
Mehmet Salih Bilal, Onur Gurer, Nusen Tanrikulu, Ahmet Kirbas. (2011) Repair of Left Main Coronary Ostial Stenosis Using Autologous Aortic Tissue. Journal of Cardiac Surgery 26:6, 586-590
CrossRef137
Sridhar Venkatachalam, Mehdi H. Shishehbor. (2011) Management of carotid disease in patients undergoing coronary artery bypass surgery. Current Opinion in Cardiology 26:6, 480-487
CrossRef138
Fleur R. Graaf, Joëlla E. Velzen, Agnieszka J. Witkowska, Joanne D. Schuijf, Noortje Bijl, Lucia J. Kroft, Albert Roos, Johan H. C. Reiber, Jeroen J. Bax, Greetje J. Grooth, J. Wouter Jukema, Ernst E. Wall. (2011) Diagnostic performance of 320-slice multidetector computed tomography coronary angiography in patients after coronary artery bypass grafting. European Radiology 21:11, 2285-2296
CrossRef139
David P. Taggart. (2011) Lessons learned from the SYNTAX trial for multivessel and left main stem coronary artery disease. Current Opinion in Cardiology 26:6, 502-507
CrossRef140
Wijnand K. den Dekker, Jaco H. Houtgraaf, Yoshinobu Onuma, Edouard Benit, Robbert J. de Winter, William Wijns, Manfred Grisold, Stephan Verheye, Sigmund Silber, Emmanuel Teiger, Stephen M. Rowland, Erik Ligtenberg, Jonathan Hill, Marcus Wiemer, Peter den Heijer, Benno J. Rensing, Keith M. Channon, Patrick W.J.C. Serruys, Henricus J. Duckers. (2011) Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. Atherosclerosis 219:1, 245-252
CrossRef141
R. Doerr, U. Hoffmann, W. Otter, L. Heinemann, W. Hunger-Battefeld, B. Kulzer, A. Klinge, V. Lodwig, I. Amann-Zalan, D. Sturm, D. Tschoepe, S. G. Spitzer, J. Stumpf, T. Lohmann, O. Schnell. (2011) Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study. Diabetologia 54:11, 2923-2930
CrossRef142
Bradley G. Leshnower, Robert A. Guyton, John D. Puskas. (2011) Why randomized clinical trials are important to cardiac surgeons. Current Opinion in Cardiology 26:6, 536-540
CrossRef143
Robert A. Henderson, Adam D. Timmis. (2011) Almanac 2011: stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology. Revista Portuguesa de Cardiologia 30:11, 869-878
CrossRef144
K.E. Juhani Airaksinen, Fausto Biancari, Pasi Karjalainen, Reija Mikkola, Kari Kuttila, Pekka Porela, Timo Laitio, Gregory Y.H. Lip. (2011) Safety of coronary artery bypass surgery during therapeutic oral anticoagulation. Thrombosis Research 128:5, 435-439
CrossRef145
Michael E. Halkos, Thomas A. Vassiliades, John S. Douglas, Douglas C. Morris, S. Tanveer Rab, Henry A. Liberman, Habib Samady, Patrick D. Kilgo, Robert A. Guyton, John D. Puskas. (2011) Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting for the Treatment of Multivessel Coronary Artery Disease. The Annals of Thoracic Surgery 92:5, 1695-1702
CrossRef146
Colm Hanratty, Simon Walsh. (2011) Longitudinal compression: a “new” complication with modern coronary stent platforms – time to think beyond deliverability?. EuroIntervention 7:7, 872-877
CrossRef147
Li-qiu Yan, Li-jun Guo, Fu-chun Zhang, Wei Gao. (2011) The Relationship Between Kidney Function and Angiographically-Derived SYNTAX Score. Canadian Journal of Cardiology 27:6, 768-772
CrossRef148
Joshua M. Stolker, David J. Cohen, Jason B. Lindsey, Kevin F. Kennedy, Neal S. Kleiman, Steven P. Marso. (2011) Mode of death after contemporary percutaneous coronary intervention: A report from the Evaluation of Drug Eluting Stents and Ischemic Events registry. American Heart Journal 162:5, 914-921
CrossRef149
Vincent E. Friedewald, William E. Boden, Gregg W. Stone, Clyde W. Yancy, William C. Roberts. (2011) The Editor's Roundtable: Role of Percutaneous Coronary Intervention and Drug-Eluting Stents in Patients With Stable Coronary Heart Disease. The American Journal of Cardiology 108:10, 1417-1425
CrossRef150
Alexander Kulik, Marc Ruel. (2011) Lipid-lowering therapy and coronary artery bypass graft surgery. Current Opinion in Cardiology 26:6, 508-517
CrossRef151
Robert A. Henderson, Adam D. Timmis. (2011) Almanac 2011: Stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology. Revista Portuguesa de Cardiologia (English Edition) 30:11, 869-878
CrossRef152
James Tatoulis, Brian F. Buxton, John A. Fuller. (2011) The right internal thoracic artery. Current Opinion in Cardiology 26:6, 528-535
CrossRef153
Davide Capodanno, Corrado Tamburino. (2011) Unraveling the EXCEL: Promises and challenges of the next trial of left main percutaneous coronary intervention. International Journal of Cardiology
CrossRef154
Muhammed Akhtar, Alain Waked, Hilal Bhat, Mariam Khalid, Sumaya Teli, Faisal B Saiful, James Lafferty, Tariq Bhat. (2011) Drug-eluting stent thrombosis after 2029 days of placement: longest ever reported interval between drug-eluting stent placement and very late thrombosis. Future Cardiology 7:6, 745-748
CrossRef155
Inder M. Singh, David R. Holmes. (2011) Myocardial Revascularization by Percutaneous Coronary Intervention: Past, Present, and the Future. Current Problems in Cardiology 36:10, 375-401
CrossRef156
Giuseppe Ferrante, Patrizia Presbitero, Marco Valgimigli, Marie-Claude Morice, Paolo Pagnotta, Guido Belli, Elena Corrada, Yoshinobu Onuma, Peter Barlis, Didier Locca, Eric Eeckhout, Carlo Di Mario, Patrick Serruys. (2011) Percutaneous coronary intervention versus bypass surgery for left main coronary artery disease: a meta-analysis of randomised trials. EuroIntervention 7:6, 738-746
CrossRef157
Joanne Shannon, Antonio Colombo. (2011) Additional data supporting the safety and effectiveness of unprotected left main interventions. EuroIntervention 7:6, 653-657
CrossRef158
Carlos Sánchez-González, José F. Díaz-Fernández, Manuel Jiménez-Navarro, Juan C. Fernández-Guerrero, Juan H. Alonso Briales, Antonio Gómez Menchero, Manuel F. Guzmán Herrera, Rosa M. Cardenal-Piris, José M. Hernández García. (2011) Pronóstico a medio plazo del intervencionismo percutáneo electivo sobre el tronco común de la coronaria izquierda. Experiencia multicéntrica. Cardiocore 46:4, 143-149
CrossRef159
Vasim Farooq, Salvatore Brugaletta, Patrick W. Serruys. (2011) Utilizing Risk Scores in Determining the Optimal Revascularization Strategy for Complex Coronary Artery Disease. Current Cardiology Reports 13:5, 415-423
CrossRef160
J C Kovacic, V Fuster. (2011) From Treating Complex Coronary Artery Disease to Promoting Cardiovascular Health: Therapeutic Transitions and Challenges, 2010–2020. Clinical Pharmacology & Therapeutics 90:4, 509-518
CrossRef161
F Mangiacapra, B De Bruyne, W Wijns, J Bartunek. (2011) Optimizing Revascularization Strategies in Coronary Artery Disease for Optimal Benefit to Patients. Clinical Pharmacology & Therapeutics 90:4, 630-633
CrossRef162
Serban Puricel, Patrick Adorjan, Markus Oberhänsli, Jean-Christophe Stauffer, Aris Moschovitis, Rolf Vogel, Jean-Jacques Goy, Olivier Müller, Eric Eeckhout, Mario Togni, Peter Wenaweser, Bernhard Meier, Stephan Windecker, Stéphane Cook. (2011) Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study. EuroIntervention 7:6, 697-704
CrossRef163
Vasim Farooq, Jung Ho Heo, Lorenz Räber, Salvatore Brugaletta, Maria Radu, Bill Gogas, Roberto Diletti, Yoshinobu Onuma, Hector Garcia-Garcia, Patrick Serruys. (2011) Tools & Techniques: Risk stratification and diagnostic tools in left main stem intervention. EuroIntervention 7:6, 747-753
CrossRef164
James B. McClurken, Raphael Rosenhek, T. Sloane Guy, Daniel E. Forman. (2011) Risk Stratification in Elderly Coronary Artery Disease Patients: Can We Predict Which Seniors Benefit Most from Revascularization Options?. Current Cardiovascular Risk Reports 5:5, 422-431
CrossRef165
Didier Carrié, Hélène Eltchaninoff, Thierry Lefèvre, Marc Silvestri, Philippe Brunel, Jean Fajadet, Anouska Moynagh, Martine Gilard, René Koning, Alain Dibie, Olivier Darremont, Jean Marc Lablanche, Didier Blanchard. (2011) Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre registry for stenting of unprotected LMCA stenosis) registry. EuroIntervention 7:6, 680-688
CrossRef166
Alexander Kulik, Pierre Voisine, Patrick Mathieu, Roy G. Masters, Thierry G. Mesana, Michel R. Le May, Marc Ruel. (2011) Statin Therapy and Saphenous Vein Graft Disease After Coronary Bypass Surgery: Analysis From the CASCADE Randomized Trial. The Annals of Thoracic Surgery 92:4, 1284-1291
CrossRef167
David E. Kandzari, John A. Ormiston. (2011) Revascularization for Unprotected Left Main Coronary Artery Disease: An Evolution in Clinical Decision Making. Current Cardiology Reports 13:5, 424-431
CrossRef168
Marie-Claude Morice, Ted E. Feldman, Michael Mack, Elisabeth Ståhle, David Holmes, Antonio Colombo, Marie-Angèle Morel, Marcel van den Brand, Patrick Serruys, Friedrich Mohr, Didier Carrié, Gérard Fournial, Stefan James, Katrin Leadley, Keith Dawkins, A. Pieter Kappetein. (2011) Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS). EuroIntervention 7:6, 670-679
CrossRef169
Seung-Jung Park, Young-Hak Kim. (2011) Does it pay to be indecisive when considering revascularization during percutaneous coronary intervention?. Interventional Cardiology 3:5, 523-525
CrossRef170
Nikhil P Jaik, Ramanan Umakanthan, Marzia Leacche, Natalia Solenkova, Jorge M Balaguer, Steven J Hoff, Stephen K Ball, David X Zhao, John G Byrne. (2011) Current status of hybrid coronary revascularization. Expert Review of Cardiovascular Therapy 9:10, 1331-1337
CrossRef171
Gregg W. Stone, Jeffrey W. Moses. (2011) Interventional cardiology: How should the appropriateness of PCI be judged?. Nature Reviews Cardiology 8:10, 544-546
CrossRef172
Chang-Wook Nam, Fabio Mangiacapra, Robert Entjes, In-Sung Chung, Jan-Willem Sels, Pim A.L. Tonino, Bernard De Bruyne, Nico H.J. Pijls, William F. Fearon. (2011) Functional SYNTAX Score for Risk Assessment in Multivessel Coronary Artery Disease. Journal of the American College of Cardiology 58:12, 1211-1218
CrossRef173
Davide Capodanno, Gregg W. Stone, Marie C. Morice, Theodore A. Bass, Corrado Tamburino. (2011) Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease. Journal of the American College of Cardiology 58:14, 1426-1432
CrossRef174
Joanna Wykrzykowska, Scot Garg, Yoshinobu Onuma, Ton de Vries, Marie-Angele Morel, Gerrit-Anne van Es, Pawel Buszman, Axel Linke, Thomas Ischinger, Volker Klauss, Roberto Corti, Franz Eberli, William Wijns, Marie-Claude Morice, Carlo Di Mario, Robert-Jan van Geuns, Peter Juni, Stephan Windecker, Patrick Serruys. (2011) Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "Call-comers" LEADERS trial. EuroIntervention 7:5, 605-613
CrossRef175
Neal S. Kleiman. (2011) Bringing It All Together. Journal of the American College of Cardiology 58:12, 1219-1221
CrossRef176
Kevin L. Greason, Hartzell V. Schaff. (2011) Myocardial Revascularization by Coronary Arterial Bypass Graft: Past, Present, and Future. Current Problems in Cardiology 36:9, 325-368
CrossRef177
A. P. Kappetein, T. E. Feldman, M. J. Mack, M.-C. Morice, D. R. Holmes, E. Stahle, K. D. Dawkins, F. W. Mohr, P. W. Serruys, A. Colombo. (2011) Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. European Heart Journal 32:17, 2125-2134
CrossRef178
D. Carrié. (2011) L’insuffisance coronaire. Archives des Maladies du Coeur et des Vaisseaux - Pratique 2011:200, 24-27
CrossRef179
Davide Capodanno, Valeria Calvi, Corrado Tamburino. (2011) A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention. International Journal of Cardiology
CrossRef180
Bernardo Cortese, Alessandra Bertoletti. (2011) Paclitaxel coated balloons for coronary artery interventions: A comprehensive review of preclinical and clinical data. International Journal of Cardiology
CrossRef181
Martin Misfeld, R. John L. Brereton, Elizabeth A. Sweetman, Gordon S. Doig. (2011) Neurologic complications after off-pump coronary artery bypass grafting with and without aortic manipulation: Meta-analysis of 11,398 cases from 8 studies. The Journal of Thoracic and Cardiovascular Surgery 142:2, e11-e17
CrossRef182
M. Lindstaedt, A. Mügge. (2011) Myocardial fractional flow reserve. Herz 36:5, 410-416
CrossRef183
EMMANOUIL S. BRILAKIS, JOHN M. LASALA, DAVID A. COX, THOMAS S. BOWMAN, RUTH M. STARZYK, KEITH D. DAWKINS. (2011) Two-Year Outcomes after Utilization of the TAXUS Paclitaxel-Eluting Stent in Bifurcations and Multivessel Stenting in the ARRIVE Registries. Journal of Interventional Cardiology 24:4, 342-350
CrossRef184
Patrick A. Calvert, Daniel R. Obaid, Michael O'Sullivan, Leonard M. Shapiro, Duncan McNab, Cameron G. Densem, Peter M. Schofield, Denise Braganza, Sarah C. Clarke, Kausik K. Ray, Nick E.J. West, Martin R. Bennett. (2011) Association Between IVUS Findings and Adverse Outcomes in Patients With Coronary Artery Disease. JACC: Cardiovascular Imaging 4:8, 894-901
CrossRef185
J. Bonatti, E. J. Lehr, M. Vesely, G. Friedrich, T. Schachner, N. Bonaros, B. Griffith, D. Zimrin. (2011) Hybrid coronary revascularization – techniques and outcome. European Surgery 43:4, 198-204
CrossRef186
Hisato Takagi, Takuya Umemoto. (2011) A meta-analysis of randomized trials and adjusted observational studies of drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery disease. International Journal of Cardiology 150:3, 341-343
CrossRef187
Jason Hockenberry, Xin Lu, Mary S. Vaughan-Sarrazin, Stephen Snyder, Eric Peterson, Peter Cram. (2011) Shifts in Surgical Revascularization and Valve Procedures Among Medicare Beneficiaries. Medical Care 49:8, 686-692
CrossRef188
Andreas Boening, Bernd Niemann, Alexander Wiedemann, Peter Roth, Rolf-Hasso Bödeker, Christine Scheibelhut, Markus Schönburg. (2011) Coronary stenting before coronary artery bypass graft surgery in diabetic patients does not increase the perioperative risk of surgery. The Journal of Thoracic and Cardiovascular Surgery 142:2, e53-e57
CrossRef189
James A. Goldstein, Sean P. Madden, Stephen T. Sum, Simon R. Dixon, Ryan D. Madder, James E. Muller. (2011) Assessment of Plaque Composition with Near-Infrared Spectroscopy. Current Cardiovascular Imaging Reports 4:4, 298-308
CrossRef190
Corrado Tamburino, Davide Capodanno, Maria Elena Di Salvo, Anna Caggegi, Davide Tomasello, Glauco Cincotta, Marco Miano, Anna Petralia, Egidio Varone, Martina Patanè, Claudia Tamburino, Salvatore Tolaro, Leonardo Patanè, Antonio Maria Calafiore. (2011) Routine versus selective coronary artery bypass for left main coronary artery revascularization: The appraise a customized strategy for left main revascularization (CUSTOMIZE) study. International Journal of Cardiology 150:3, 307-314
CrossRef191
IBRAHIM H. TANBOGA, MEHMET EKINCI, TURGAY ISIK, MUSTAFA KURT, AHMET KAYA, SERDAR SEVIMLI. (2011) Reproducibility of Syntax Score: From Core Lab to Real World. Journal of Interventional Cardiology 24:4, 302-306
CrossRef192
Fabio Mangiacapra, Emanuele Barbato. (2011) From SYNTAX to FAME, a paradigm shift in revascularization strategies. Journal of Cardiovascular Medicine 12:8, 538-542
CrossRef193
Kyung Woo Park, Si-Hyuck Kang, Keun-Ho Park, Dong-Hyun Choi, Hae-Young Lee, Hyun-Jae Kang, Young-Seok Cho, Tae-Jin Yeon, Woo-Young Chung, Bon-Kwon Koo, In-Ho Chae, Dong-Ju Choi, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim. (2011) Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: Complete 2-year follow-up of a two-center registry. International Journal of Cardiology 151:1, 89-95
CrossRef194
Anjan Kumar Das. (2011) Randomised Clinical Trials in Surgery: A Look at the Ethical and Practical Issues. Indian Journal of Surgery 73:4, 245-250
CrossRef195
Kwok M. Ho, Jen Aik Tan. (2011) Benefits and Risks of Maintaining Normothermia during Cardiopulmonary Bypass in Adult Cardiac Surgery: A Systematic Review. Cardiovascular Therapeutics 29:4, 260-279
CrossRef196
Shailesh Nandish, Jamison Wyatt, Oscar Bailon, Mike Smith, Rene Oliveros, Robert Chilton. (2011) Implementing Cardiovascular Risk Reduction in Patients with Cardiovascular Disease and Diabetes Mellitus. The American Journal of Cardiology 108:3, 42B-51B
CrossRef197
Young Bin Song, Sang-Yeub Lee, Joo-Yong Hahn, Seung-Hyuk Choi, Jin-Ho Choi, Sang Hoon Lee, Kyung Pyo Hong, Jeong Euy Park, Hyeon-Cheol Gwon. (2011) Complete versus incomplete revascularization for treatment of multivessel coronary artery disease in the drug-eluting stent era. Heart and Vessels
CrossRef198
Ming-Sum Lee, David P. Faxon. (2011) Revascularization of Left Main Coronary Artery Disease. Cardiology in Review 19:4, 177-183
CrossRef199
J. James B. Edelman, Tristan D. Yan, Michael P. Vallely, Paul G. Bannon. (2011) Reply to the Editor. The Journal of Thoracic and Cardiovascular Surgery 142:1, 242-243
CrossRef200
Maximilian Y. Emmert, Sacha P. Salzberg, Burkhardt Seifert, Hector Rodriguez, Andre Plass, Simon P. Hoerstrup, Jürg Grünenfelder, Volkmar Falk. (2011) Is off-pump superior to conventional coronary artery bypass grafting in diabetic patients with multivessel disease?. European Journal of Cardio-Thoracic Surgery 40:1, 233-239
CrossRef201
Hisato Takagi, Hideaki Manabe, Takuya Umemoto. (2011) The Gordian knot of revascularization for multivessel coronary artery disease. The Journal of Thoracic and Cardiovascular Surgery 142:1, 241-242
CrossRef202
David R. Holmes, Michael J. Mack. (2011) Transcatheter Valve Therapy: A Professional Society Overview from the American College of Cardiology Foundation and The Society of Thoracic Surgeons. The Annals of Thoracic Surgery 92:1, 380-389
CrossRef203
Angela Migliorini, Renato Valenti, Guido Parodi, Piergiovanni Buonamici, Giampaolo Cerisano, Nazario Carrabba, Ruben Vergara, David Antoniucci. (2011) The Impact of Right Coronary Artery Chronic Total Occlusion on Clinical Outcome of Patients Undergoing Percutaneous Coronary Intervention for Unprotected Left Main Disease. Journal of the American College of Cardiology 58:2, 125-130
CrossRef204
Robert T. Gerber, Alfonso Ielasi, Rasha Al-Lamee, Azeem Latib, Flavio Airoldi, Massimo Ferraro, Luca Ferri, Giorgio Bassanelli, Cosmo Godino, Andrew S.P. Sharp, Alaide Chieffo, Mauro Carlino, Matteo Montorfano, Giuseppe M. Sangiorgi, Antonio Colombo. (2011) Long-term follow-up of multivessel percutaneous coronary intervention with drug-eluting stents for de novo lesions with correlation to the SYNTAX score. Cardiovascular Revascularization Medicine 12:4, 220-227
CrossRef205
David R. Holmes, Michael J. Mack. (2011) Transcatheter Valve Therapy. Journal of the American College of Cardiology 58:4, 445-455
CrossRef206
Matthias Siepe, Thomas Pfeiffer, Andreas Gieringer, Silke Zemann, Christoph Benk, Christian Schlensak, Friedhelm Beyersdorf. (2011) Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. European Journal of Cardio-Thoracic Surgery 40:1, 200-207
CrossRef207
V. Kunadian, A. Zaman, W. Qiu. (2011) Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies. European Journal of Heart Failure 13:7, 773-784
CrossRef208
Clemens von Birgelen, Marc Hartmann. (2011) Beyond the lumen border: on the use of intravascular ultrasound in the left main coronary artery. EuroIntervention 7:3, 300-302
CrossRef209
Mark WI Webster. (2011) Clinical practice and implications of recent diabetes trials. Current Opinion in Cardiology 26:4, 288-293
CrossRef210
Florian Dick, Ana Hristic, Eva Roost-Krähenbühl, Thierry Aymard, Alberto Weber, Hendrik T. Tevaearai, Thierry P. Carrel. (2011) Persistent sensitivity disorders at the radial artery and saphenous vein graft harvest sites: a neglected side effect of coronary artery bypass grafting procedures. European Journal of Cardio-Thoracic Surgery 40:1, 221-226
CrossRef211
Cezary Kepka, Maksymilian P. Opolski, Zbigniew Juraszynski, Mariusz Kruk, Jerzy Pregowski, Radoslaw Pracon, Wojciech Dyk, Marcin Demkow, Adam Witkowski, Witold Ruzyllo. (2011) Computed Tomography to Predict Surgical Revascularization of a Left Anterior Descending Artery Occlusion Incompletely Visualized by Conventional Angiography. Journal of Thoracic Imaging1
CrossRef212
Shikhar Agarwal, Tarique Zaman, E. Murat Tuzcu, Mehdi Shishehbor, A. Michael Lincoff, Patrick L. Whitlow, Christopher Bajzer, Irving Franco, Ravi Nair, Russell Raymond, Stephen G. Ellis, Samir R. Kapadia. (2011) Comparison of Outcomes of Unprotected Left Main Versus Multivessel Coronary Artery Interventions. The American Journal of Cardiology 108:1, 15-20
CrossRef213
Joshua Lehrer, William F. Fearon. 2011. Stable Angina. , 33-42.
CrossRef214
Yue Li, Ravinay Bhindi, Levon M. Khachigian. (2011) Recent developments in drug-eluting stents. Journal of Molecular Medicine 89:6, 545-553
CrossRef215
Christopher Rao, Vanash Patel, Michael Ibrahim, Kamran Ahmed, Kathie A. Wong, Ara Darzi, Ludwig K. von Segesser, Thanos Athanasiou. (2011) Leadership in cardiac surgery. European Journal of Cardio-Thoracic Surgery 39:6, 905-911
CrossRef216
Vasim Farooq, Salvatore Brugaletta, Patrick W. Serruys. (2011) The SYNTAX Score and SYNTAX-Based Clinical Risk Scores. Seminars in Thoracic and Cardiovascular Surgery 23:2, 99-105
CrossRef217
María Riera, Jaime Herrero, Jordi Ibáñez, Carlos Campillo, Rocío Amézaga, José I. Sáez de Ibarra, Miguel Fiol, Oriol Bonnín. (2011) Mid-Term Survival of Patients Undergoing Major Cardiac Surgery. Revista Española de Cardiología (English Edition) 64:6, 463-469
CrossRef218
Giovanni B. Pedrazzini, Dragana Radovanovic, Giuseppe Vassalli, Daniel Sürder, Tiziano Moccetti, Franz Eberli, Philip Urban, Stephan Windecker, Hans Rickli, Paul Erne. (2011) Primary Percutaneous Coronary Intervention for Unprotected Left Main Disease in Patients With Acute ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions 4:6, 627-633
CrossRef219
Tullio Palmerini, Philippe Genereux, Adriano Caixeta, Ecaterina Cristea, Alexandra Lansky, Roxana Mehran, George Dangas, Dana Lazar, Raquel Sanchez, Martin Fahy, Ke Xu, Gregg W. Stone. (2011) Prognostic Value of the SYNTAX Score in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology 57:24, 2389-2397
CrossRef220
Myriam Moret, Philippe Moulin. (2011) Dépistage de l’ischémie myocardique silencieuse des patients diabétiques : modalités et enjeux. La Presse Médicale 40:6, 625-633
CrossRef221
Akira Marui, Takeshi Kimura, Shiro Tanaka, Yutaka Furukawa, Toru Kita, Ryuzo Sakata. (2011) Significance of off-pump coronary artery bypass grafting compared with percutaneous coronary intervention: a propensity score analysis. European Journal of Cardio-Thoracic Surgery
CrossRef222
Davide Capodanno, Anna Caggegi, Piera Capranzano, Glauco Cincotta, Marco Miano, Gionbattista Barrano, Sergio Monaco, Francesco Calvo, Corrado Tamburino. (2011) Validating the EXCEL hypothesis: A propensity score matched 3-year comparison of percutaneous coronary intervention versus coronary artery bypass graft in left main patients with SYNTAX score ≤32. Catheterization and Cardiovascular Interventions 77:7, 936-943
CrossRef223
Scot Garg, Giovanna Sarno, Chrysafios Girasis, Pascal Vranckx, Ton de Vries, Michael Swart, Marco Bressers, Hector M. Garcia-Garcia, Gerrit-Anne van Es, Lorenz Räber, Gianluca Campo, Marco Valgimigli, Keith D. Dawkins, Stephan Windecker, Patrick W. Serruys. (2011) A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials. JACC: Cardiovascular Interventions 4:6, 645-653
CrossRef224
Rolf Ekroth, Elisabeth Ståhle. (2011) Randomized controlled studies: Scientific evidence or disinformation?. Scandinavian Cardiovascular Journal 45:3, 131-132
CrossRef225
R. A. Veasey, J. A. J. Hyde, M. E. Lewis, U. H. Trivedi, A. C. Cohen, G. W. Lloyd, S. S. Furniss, N. R. Patel, A. N. Sulke. (2011) It’s good to talk! Changes in coronary revascularisation practice in PCI centres without onsite surgical cover and the impact of an angiography video conferencing system. International Journal of Clinical Practice 65:6, 658-663
CrossRef226
Gerald S Werner. (2011) Outcomes following successful recanalization of chronic total coronary occlusions. Interventional Cardiology 3:3, 391-405
CrossRef227
Robert D. Safian. (2011) Left main and high-risk PCI: What, exactly, is it high risk for?. Catheterization and Cardiovascular Interventions 77:7, 952-953
CrossRef228
María Riera, Jaime Herrero, Jordi Ibáñez, Carlos Campillo, Rocío Amézaga, José I. Sáez de Ibarra, Miguel Fiol, Oriol Bonnín. (2011) Supervivencia a medio plazo de los pacientes operados en cirugía cardiaca mayor. Revista Española de Cardiología 64:6, 463-469
CrossRef229
Sean OZ Bello, Edward WK Peng, Pradip K Sarkar. (2011) Conduits for coronary artery bypass surgery: the quest for second best. Journal of Cardiovascular Medicine 12:6, 411-421
CrossRef230
Stuart J. Head, Ad J.J.C. Bogers, A. Pieter Kappetein. (2011) Nonrandomized Data on Drug-Eluting Stents Compared With Coronary Bypass Surgery. Journal of the American College of Cardiology 57:24, 2457-2458
CrossRef231
Michael S. Lee, Tae Yang, Giuseppe Biondi-Zoccai, Dario Sillano, Enrico Cerrato, Giuseppe Tarantini, Jola Xhaxho, Joseph Aragon, Imad Sheiban. (2011) Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function. Catheterization and Cardiovascular Interventions 77:7, 945-951
CrossRef232
A. P. Slootweg, J. W. Louwerenburg, G. Mecozzi, L. J. Wagenaar, P. M. J. Verhorst. (2011) Obstructive intramyocardial haematoma after percutaneous coronary intervention. Netherlands Heart Journal
CrossRef233
Park, Seung-Jung, Kim, Young-Hak, Park, Duk-Woo, Yun, Sung-Cheol, Ahn, Jung-Min, Song, Hae Geun, Lee, Jong-Young, Kim, Won-Jang, Kang, Soo-Jin, Lee, Seung-Whan, Lee, Cheol Whan, Park, Seong-Wook, Chung, Cheol-Hyun, Lee, Jae-Won, Lim, Do-Sun, Rha, Seung-Woon, Lee, Sang-Gon, Gwon, Hyeon-Cheol, Kim, Hyo-Soo, Chae, In-Ho, Jang, Yangsoo, Jeong, Myung-Ho, Tahk, Seung-Jea, Seung, Ki Bae, . (2011) Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease. New England Journal of Medicine 364:18, 1718-1727
Full Text234
Naoki Masuda, Yoshihiro Morino, Toshiharu Fujii, Eri Toda, Gaku Nakazawa, Takashi Matsukage, Nobuhiko Ogata, Yuji Ikari. (2011) A simple method preventing tangling of the guidewires during percutaneous coronary intervention for bifurcation lesions. Cardiovascular Intervention and Therapeutics 26:2, 117-123
CrossRef235
H. Rittger, J. Rieber, K. Kögler, A. Sinha, M. Schmidt, O.-A. Breithardt, P. Biggar, F. Einsle, A. Diegeler, J. Brachmann. (2011) Clinical outcome and quality of life after interventional treatment of left main disease with drug-eluting-stents in comparison to CABG in elderly and younger patients. Clinical Research in Cardiology 100:5, 439-446
CrossRef236
Lenard Conradi, Hermann Reichenspurner. (2011) 3 Jahre nach SYNTAX – Stent oder Skalpell?. Clinical Research in Cardiology Supplements 6:S1, 43-48
CrossRef237
Giuseppe Biondi-Zoccai, Imad Sheiban, Claudio Moretti, Tullio Palmerini, Antonio Marzocchi, Davide Capodanno, Corrado Tamburino, Massimo Margheri, Giuseppe Vecchi, Giuseppe Sangiorgi, Andrea Santarelli, Antonio l. Bartorelli, Carlo Briguori, Luigi Vignali, Francesco di Pede, Angelo Ramondo, Massimo Medda, Marco Carlo, Giovanni Falsini, Alberto Benassi, Cataldo Palmieri, Vincenzo Filippone, Diego Sangiorgi, Fabio Barlocco, Stefano Servi. (2011) Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. Clinical Research in Cardiology 100:5, 403-411
CrossRef238
Won-Jang Kim, Young-Hak Kim, Duk-Woo Park, Sung-Cheol Yun, Jong-Young Lee, Soo-Jin Kang, Seung-Whan Lee, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park. (2011) Comparison of single- versus two-stent techniques in treatment of unprotected left main coronary bifurcation disease. Catheterization and Cardiovascular Interventions 77:6, 775-782
CrossRef239
Duk-Woo Park, Young-Hak Kim, Sung-Cheol Yun, Hae Geun Song, Jung-Min Ahn, Jun-Hyok Oh, Won-Jang Kim, Jong-Young Lee, Soo-Jin Kang, Seung-Whan Lee, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park. (2011) Complexity of Atherosclerotic Coronary Artery Disease and Long-Term Outcomes in Patients With Unprotected Left Main Disease Treated With Drug-Eluting Stents or Coronary Artery Bypass Grafting. Journal of the American College of Cardiology 57:21, 2152-2159
CrossRef240
E. Boudriot, H. Thiele, G. Schuler. (2011) Hauptstamminterventionen. Herz 36:3, 214-221
CrossRef241
Fabrizio Tomai, Gabriele Pesarini, Fausto Castriota, Bernhard Reimers, Leonardo De Luca, Giovanni De Persio, Daniela Spartà, Cristina Aurigemma, Andrea Pacchioni, Barbara Spagnolo, Alberto Cremonesi, Flavio Ribichini. (2011) Early and Long-Term Outcomes After Combined Percutaneous Revascularization in Patients With Carotid and Coronary Artery Stenoses. JACC: Cardiovascular Interventions 4:5, 560-568
CrossRef242
Flavio Ribichini, David Taggart. (2011) Implications of new ESC/EACTS guidelines on myocardial revascularisation for patients with multi-vessel coronary artery disease. European Journal of Cardio-Thoracic Surgery 39:5, 619-622
CrossRef243
W. Motz, W. Kerner. (2011) Kardiale Endorganschäden bei Diabetes. Der Internist 52:5, 505-517
CrossRef244
(2011) Deutsch-österreichische S3-Leitlinie „Infarktbedingter kardiogener Schock – Diagnose, Monitoring und Therapie“. Intensivmedizin und Notfallmedizin 48:4, 291-344
CrossRef245
Seshasayee Narasimhan, Vankeepuram S. Srinivas, Joseph John DeRose. (2011) Hybrid Coronary Revascularization. Cardiology in Review 19:3, 101-107
CrossRef246
Ioannis Velissaris, Dimitrios Kiskinis, Kyriakos Anastasiadis. (2011) Synchronous carotid artery stenting and open heart surgery. Journal of Vascular Surgery 53:5, 1237-1241
CrossRef247
Stuart J Head, Ad JJC Bogers, Patrick W Serruys, Johanna JM Takkenberg, A Pieter Kappetein. (2011) A crucial factor in shared decision making: the team approach. The Lancet 377:9780, 1836
CrossRef248
Giulio G. Stefanini, Patrick W. Serruys, Sigmund Silber, Ahmed A. Khattab, Robert J. van Geuns, Gert Richardt, Pawel E. Buszman, Henning Kelbæk, Adrianus J. van Boven, Sjoerd H. Hofma, Axel Linke, Volker Klauss, William Wijns, Carlos Macaya, Philippe Garot, Carlo Di Mario, Ganesh Manoharan, Ran Kornowski, Thomas Ischinger, Antonio L. Bartorelli, Pierre Gobbens, Stephan Windecker. (2011) The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents. Journal of the American College of Cardiology 57:22, 2221-2232
CrossRef249
Hiroaki Miyata, Noboru Motomura, Hiroyuki Tsukihara, Shinichi Takamoto. (2011) Risk models including high-risk cardiovascular procedures: clinical predictors of mortality and morbidity. European Journal of Cardio-Thoracic Surgery 39:5, 667-674
CrossRef250
Dean Kereiakes, Pieter C. Smits, Elvin Kedhi, Helen Parise, Martin Fahy, Patrick W. Serruys, Gregg W. Stone. (2011) Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials. EuroIntervention 7:1, 74-83
CrossRef251
Tristan D. Yan, Ratnasari Padang, Chin Poh, Christopher Cao, Michael K. Wilson, Paul G. Bannon, Michael P. Vallely. (2011) Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized studies. The Journal of Thoracic and Cardiovascular Surgery 141:5, 1134-1144
CrossRef252
Alan D. Bell, André Roussin, Raymond Cartier, Wee Shian Chan, James D. Douketis, Anil Gupta, Maria E. Kraw, Thomas F. Lindsay, Michael P. Love, Neesh Pannu, Rémi Rabasa-Lhoret, Ashfaq Shuaib, Philip Teal, Pierre Théroux, Alexander G.G. Turpie, Robert C. Welsh, Jean-François Tanguay. (2011) The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines. Canadian Journal of Cardiology 27:3, S1-S59
CrossRef253
G.S. Werner. (2011) Therapie des chronischen Koronararterienverschlusses. Herz 36:3, 222-231
CrossRef254
J. James Edelman, Tristan D. Yan, Paul G. Bannon, Michael K. Wilson, Michael P. Vallely. (2011) Coronary Artery Bypass Grafting With and Without Manipulation of the Ascending Aorta – A Meta-Analysis. Heart, Lung and Circulation 20:5, 318-324
CrossRef255
Bryan P. Yan, Andrew E. Ajani, David J. Clark. 2011. Approach to Multivessel Coronary Artery Disease. , 312-321.
CrossRef256
Abhiram Prasad, Bernard J. Gersh. 2011. Stable Angina. , 213-231.
CrossRef257
Alaide Chieffo, Valeria Magni, Antonio Colombo. 2011. Percutaneous Coronary Intervention in Unprotected Left Main. , 280-297.
CrossRef258
R. Hachamovitch, A. Rozanski, L. J. Shaw, G. W. Stone, L. E. J. Thomson, J. D. Friedman, S. W. Hayes, I. Cohen, G. Germano, D. S. Berman. (2011) Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. European Heart Journal 32:8, 1012-1024
CrossRef259
Philippe Kolh, William Wijns. (2011) Joint ESC/EACTS guidelines on myocardial revascularization. Journal of Cardiovascular Medicine 12:4, 264-267
CrossRef260
Thomas D Stuckey, Bruce R Brodie. (2011) Outcomes with drug-eluting stents in diabetic patients. Interventional Cardiology 3:2, 235-245
CrossRef261
Sigmund Silber, Stephan Windecker, Pascal Vranckx, Patrick W Serruys. (2011) Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial. The Lancet 377:9773, 1241-1247
CrossRef262
Scot Garg, Giovanna Sarno, Juan-Luis Gutiérrez-Chico, Hector Garcia-Garcia, Josep Gomez-Lara, Patrick Serruys. (2011) Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study. EuroIntervention 6:9, 1060-1067
CrossRef263
Scot Garg, Patrick W. Serruys, Sigmund Silber, Joanna Wykrzykowska, Robert Jan van Geuns, Gert Richardt, Pawel E. Buszman, Henning Kelbæk, Adrianus Johannes van Boven, Sjoerd H. Hofma, Axel Linke, Volker Klauss, William Wijns, Carlos Macaya, Philippe Garot, Carlo DiMario, Ganesh Manoharan, Ran Kornowski, Thomas Ischinger, Antonio Bartorelli, Eric Van Remortel, Jacintha Ronden, Stephan Windecker. (2011) The Prognostic Utility of the SYNTAX Score on 1-Year Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents. JACC: Cardiovascular Interventions 4:4, 432-441
CrossRef264
M. Chan, B. Fu, P. Singh, H. Dent, D. Mitchell. (2011) Re: Improving ENT trainees’ training opportunity in percutaneous tracheostomy: how we do it. Clinical Otolaryngology 36:2, 180-181
CrossRef265
J.J.B. Edelman, T.D. Yan, R. Padang, P.G. Bannon, M.P. Vallely. (2011) Coronary Artery Bypass Grafting with and without Manipulation of the Aorta—A Meta-analysis. Heart, Lung and Circulation 20:4, 256
CrossRef266
Kamran Muhammad, Thomas Helton, Gus Theodos, Samir Kapadia, E Murat Tuzcu. (2011) Hybrid cardiovascular therapy: interventional (and surgical) procedures in high-risk patients. Interventional Cardiology 3:2, 171-189
CrossRef267
Robert S.D. Higgins. (2011) Presidential address: a bench by the road. The American Journal of Surgery 201:4, 421-428
CrossRef268
Michio Kawasuji. (2011) Debate over patient-centered care: Percutaneous coronary intervention or coronary artery bypass grafting?. Surgery Today 41:4, 459-462
CrossRef269
Cathy Johnman, Keith G Oldroyd, Jill P Pell. (2011) Elective percutaneous coronary intervention in the elderly patient. Aging Health 7:2, 271-281
CrossRef270
Scott J. Hoffman, David R. Holmes, Alejandro A. Rabinstein, Charanjit S. Rihal, Bernard J. Gersh, Ryan J. Lennon, Riyaz Bashir, Rajiv Gulati. (2011) Trends, Predictors, and Outcomes of Cerebrovascular Events Related to Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions 4:4, 415-422
CrossRef271
Stephen H. Mckellar, Morgan L. Brown, Robert L. Frye. 2011. Is there an Optimal Revascularization Strategy in Diabetic Patients with Ischemic Heart Disease?. , 145-152.
CrossRef272
Cohen, David J., Van Hout, Ben, Serruys, Patrick W., Mohr, Friedrich W., Macaya, Carlos, den Heijer, Peter, Vrakking, M.M., Wang, Kaijun, Mahoney, Elizabeth M., Audi, Salma, Leadley, Katrin, Dawkins, Keith D., Kappetein, A. Pieter, . (2011) Quality of Life after PCI with Drug-Eluting Stents or Coronary-Artery Bypass Surgery. New England Journal of Medicine 364:11, 1016-1026
Full Text273
Robert J. Applegate. (2011) Toward Better Stratification of Patients With Left Main Disease. JACC: Cardiovascular Interventions 4:3, 298-299
CrossRef274
Thomas Schachner, Nikolaos Bonaros, Dominik Wiedemann, Eric J. Lehr, Felix Weidinger, Gudrun Feuchtner, David Zimrin, Johannes Bonatti. (2011) Predictors, Causes, and Consequences of Conversions in Robotically Enhanced Totally Endoscopic Coronary Artery Bypass Graft Surgery. The Annals of Thoracic Surgery 91:3, 647-653
CrossRef275
David M. Martin, Fergal J. Boyle. (2011) Drug-eluting stents for coronary artery disease: A review. Medical Engineering & Physics 33:2, 148-163
CrossRef276
Yaron Barac, Gil Bolotin. (2011) The 2010 European Revascularisation Guidelines implementation: the Israeli cardiac surgeons’ perspective. EuroIntervention 6:8, 918-919
CrossRef277
David Taggart. (2011) Time for Coronary Artery Bypass Grafting to Make a Comeback?. Seminars in Thoracic and Cardiovascular Surgery 23:1, 5-7
CrossRef278
Yoshinobu Onuma, Joanna J. Wykrzykowska, Scot Garg, Pascal Vranckx, Patrick W. Serruys. (2011) 5-Year Follow-Up of Coronary Revascularization in Diabetic Patients With Multivessel Coronary Artery Disease. JACC: Cardiovascular Interventions 4:3, 317-323
CrossRef279
Fausto Biancari, Sanna Yli-Pyky. (2011) Meta-analysis on the use of the Heartstring anastomotic device to prevent stroke in patients undergoing off-pump coronary artery bypass grafting. European Journal of Cardio-Thoracic Surgery
CrossRef280
Luca Testa, Francesco Bedogni. (2011) How should I treat a coronary “traffic jam”? A triple kissing balloon in distal left main trifurcation. EuroIntervention 6:8, 1011-1016
CrossRef281
Jerome Federspiel, Sally Stearns, Ron van Domburg, Brett Sheridan, Jennifer Lund, Patrick Serruys. (2011) Risk-benefit trade-offs in revascularisation choices. EuroIntervention 6:8, 936-941
CrossRef282
Davide Capodanno, Corrado Tamburino. (2011) Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: Use, pitfalls, and new directions. American Heart Journal 161:3, 462-470
CrossRef283
Justin Schaffer, Steve K. Singh. (2011) Invited Commentary. The Annals of Thoracic Surgery 91:3, 660
CrossRef284
David H. Adams, Joanna Chikwe, Farzan Filsoufi, Anelechi C. Anyanwu. (2011) The Year in Cardiovascular Surgery. Journal of the American College of Cardiology 57:13, 1425-1444
CrossRef285
Vasim Farooq, Salvatore Brugaletta, Pascal Vranckx, Patrick Serruys. (2011) A guide to interpreting and assessing the performance of prediction models. EuroIntervention 6:8, 909-912
CrossRef286
Arie Steinvil, Ben Sadeh, Yaron Arbel, Dan Justo, Anca Belei, Natan Borenstein, Shmuel Banai, Amir Halkin. (2011) Prevalence and Predictors of Concomitant Carotid and Coronary Artery Atherosclerotic Disease. Journal of the American College of Cardiology 57:7, 779-783
CrossRef287
Onur Sokullu, Numan Ali Aydemir, Erol Kurc, Batuhan Ozay, Fuat Bilgen, Murat Demirtas, Serap Aykut Aka. (2011) Emergency Management for Critical Left Main Coronary Artery Stenosis. The Heart Surgery Forum 14:1, E12-E17
CrossRef288
Stephen P Hoole, Jaap N Hamburger. (2011) Calculators of revascularization risk: peering into the crystal ball. Interventional Cardiology 3:1, 49-53
CrossRef289
Ricardo A. Costa, Johan H. C. Reiber. (2011) QCA editorial. The International Journal of Cardiovascular Imaging 27:2, 155-156
CrossRef290
A.J. Rastan, F.W. Mohr. (2011) 3-Jahres-Ergebnisse der SYNTAX-Studie. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie 25:1, 38-44
CrossRef291
Salvatore Davide Tomasello, Luca Costanzo, Alfredo Rugero Galassi. (2011) Coronary revascularization strategies in patients with chronic heart failure. Interventional Cardiology 3:1, 91-100
CrossRef292
Shigeru Saito. (2011) Treatment Option Approaches to the Management of Chronic Total Occlusions. Current Treatment Options in Cardiovascular Medicine 13:1, 4-15
CrossRef293
Robert K. Riezebos, Jan G.P. Tijssen, Freek W.A. Verheugt, Gerrit J. Laarman. (2011) Percutaneous Coronary Intervention for Non ST-Elevation Acute Coronary Syndromes: Which, When and How?. The American Journal of Cardiology 107:4, 509-515
CrossRef294
Tarun Chakravarty, Mamta H. Buch, Hursh Naik, Anthony J. White, Niraj Doctor, Jay Schapira, James M. Mirocha, Gregory Fontana, James S. Forrester, Raj Makkar. (2011) Predictive Accuracy of SYNTAX Score for Predicting Long-Term Outcomes of Unprotected Left Main Coronary Artery Revascularization. The American Journal of Cardiology 107:3, 360-366
CrossRef295
(2011) CardioPulse Articles * Clinical trials on transcatheter aortic valve implantation cannot be compared because of inconsistent endpoints * The outcome of patients referred to a transcatheter aortic valve implantation multidisciplinary team * The time has come for a SYNTAX-like trial for transcatheter aortic valve implantation * Design for the future in cardiovascular medicine * Book Review * Fast Facts: Vascular and Endovascular Surgery Highlights 2009-10. European Heart Journal 32:2, 125-132
CrossRef296
Xiaoxiao Zhao, Yujie Zhou, Hui Song, Like Guan, Guanbin Zheng, Zhehu Jin, Dongmei Shi, Yuzi Li, Yonghe Guo, Guo-Ping Shi, Xian Wu Cheng. (2011) Comparison of Bypass Surgery with Drug-Eluting Stents in Diabetic Patients with Left Main Coronary Stenosis. Yonsei Medical Journal 52:6, 923
CrossRef297
Nahush A. Mokadam, Ryland E. Melford Jr., Charles Maynard, John R. Goss, Douglas Stewart, Mark Reisman, Gabriel S. Aldea. (2011) Prevalence and Procedural Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in Patients with Diabetes and Multivessel Coronary Artery Disease. Journal of Cardiac Surgery 26:1, 1-8
CrossRef298
Shuai Zheng, Zhe Zheng, Jianfeng Hou, Shengshou Hu. (2011) Comparison between Drug-Eluting Stents and Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: A Meta-Analysis of Two Randomized Trials and Thirteen Observational Studies. Cardiology 118:1, 22-32
CrossRef299
Jun Chen, Zhen-Yu Jia, Yuan-Yuan Wang, Gao-Jun Teng. (2011) In Vivo Serial MR Imaging Evaluates Neointimal Hyperplasia Inhibited by Intravenously Transfused Endothelial Progenitor Cells in Carotid Artery Injured Mice. Journal of Neuroimaging 21:1, 49-55
CrossRef300
S. Tanveer Rab, John S. Douglas, Ellen Lyons, John D. Puskas, Darpan Bansal, Michael E. Halkos, Robert A. Guyton, Thomas A. Vassiliades. (2011) Hybrid coronary revascularization for the treatment of left main coronary stenosis: A feasibility study. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef301
Gerald S Werner. (2011) The BridgePoint devices to facilitate recanalization of chronic total coronary occlusions through controlled subintimal reentry. Expert Review of Medical Devices 8:1, 23-29
CrossRef302
William van Gaal, Jayanth Arnold, Luca Testa, Theo Karamitsos, Chris Lim, Francis Ponnuthurai, Steffen Petersen, Jane Francis, Joseph Selvanayagam, Rana Sayeed, Nicholas West, Steve Westaby, Stefan Neubauer, Adrian Banning. (2011) Myocardial Injury following Coronary Artery Surgery versus Angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging. EuroIntervention 6:6, 703-710
CrossRef303
Alfredo R. Galassi, Francesco Marzá, Salvatore Azzarelli, Salvatore D. Tomasello. (2011) Role of Stress Myocardial Scintigraphy in the Evaluation of Incompletely Revascularized Post-PCI Patients. International Journal of Molecular Imaging 2011, 1-7
CrossRef304
Masato Murakami. (2011) Coronary artery disease and revascularization procedure : Percutaneous coronary intervention and coronary artery bypass graft surgery. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 123:1, 57-58
CrossRef305
Enrico Ammirati, Ornella E. Rimoldi, Paolo G. Camici. (2011) Is There Evidence Supporting Coronary Revascularization in Patients With Left Ventricular Systolic Dysfunction?. Circulation Journal 75:1, 3-10
CrossRef306
Aram Mardian. 2011. Medical Acupuncture. , 139-154.
CrossRef307
S. BREITER. 2011. Membranes for oxygenators and plasma filters. , 3-33.
CrossRef308
Hiroshi Ito. (2011) Optimal treatment for coronary artery disease in patients with diabetes: percutaneous coronary intervention, coronary artery bypass graft, and medications. General Thoracic and Cardiovascular Surgery 59:1, 6-13
CrossRef309
Nico H.J. Pijls, Pim A.L. Tonino. (2011) Reply. Journal of the American College of Cardiology 57:1, 116
CrossRef310
Takashi Akasaka. (2011) What Can We Expect in PCI in Patients With Chronic Coronary Artery Disease. Circulation Journal 75:1, 211-217
CrossRef311
Friedrich W. Mohr, Ardawan J. Rastan, Patrick W. Serruys, A. Pieter Kappetein, David R. Holmes, Jose L. Pomar, Stephen Westaby, Katrin Leadley, Keith D. Dawkins, Michael J. Mack. (2011) Complex coronary anatomy in coronary artery bypass graft surgery: Impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. The Journal of Thoracic and Cardiovascular Surgery 141:1, 130-140
CrossRef312
Munetaka Masuda. (2011) Which is the Best Technique for CABG; OPCAB, On-pump Arrest CABG or On-pump Beating CABG?. Annals of Thoracic and Cardiovascular Surgery 17:3, 218-220
CrossRef313
Susanne Lison, Wulf Dietrich, Siegmund Braun, Johannes Boehm, Tibor Schuster, Anna Englhard, Anna Perchuc, Michael Spannagl, Raimund Busley. (2011) Enhanced Thrombin Generation After Cardiopulmonary Bypass Surgery. Anesthesia & Analgesia 112:1, 37-45
CrossRef314
Masato Nakamura. (2011) Angiography Is the Gold Standard and Objective Evidence of Myocardial Ischemia Is Mandatory If Lesion Severity Is Questionable. Circulation Journal 75:1, 204-210
CrossRef315
David J. Cohen, Tara A. Lavelle, Ben Van Hout, Haiyan Li, Yang Lei, Katherine Robertus, Duane Pinto, Elizabeth A. Magnuson, Thomas F. Mcgarry, Scott K. Lucas, Phillip A. Horwitz, Carl A. Henry, Patrick W. Serruys, Friedrich W. Mohr, A. Pieter Kappetein. (2011) Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: One-year results from the SYNTAX trial. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef316
S. Garg, M. Magro, P.W. Serruys. 2011. Drug-Eluting Stents. , 427-448.
CrossRef317
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting, Alice K. Jacobs, Jeffrey L. Anderson, Nancy Albert, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Jonathan L. Halperin, Judith S. Hochman, Frederick G. Kushner, E. Magnus Ohman, William Stevenson, Clyde W. Yancy. (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef318
Hiroki Shiomi, Toshihiro Tamura, Shunichiro Niki, Tomohisa Tada, Junichi Tazaki, Masanao Toma, Koh Ono, Tetsuo Shioi, Takeshi Morimoto, Masaharu Akao, Yutaka Furukawa, Yoshihisa Nakagawa, Takeshi Kimura. (2011) Inter- and Intra-Observer Variability for Assessment of the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Score and Association of the SYNTAX Score With Clinical Outcome in Patients Undergoing Unprotected Left Main Stenting in the Real World. Circulation Journal 75:5, 1130-1137
CrossRef319
Duk-Woo Park, Young-Hak Kim, Hae-Geun Song, Jung-Min Ahn, Junhyok Oh, Won-Jang Kim, Jong-Young Lee, Soo-Jin Kang, Seung-Whan Lee, Cheol-Whan Lee, Seong-Wook Park, Sung-Cheol Yun, Sung Ho Jung, Suk-Jung Choo, Cheol-Hyun Chung, Jae-Won Lee, Seung-Jung Park. (2011) Long-Term Comparison of Drug-Eluting Stents and Coronary Artery Bypass Grafting for Multivessel Coronary Revascularization. Journal of the American College of Cardiology 57:2, 128-137
CrossRef320
Khurshid Ahmed, Myung Ho Jeong, Rabin Chakraborty, Young Joon Hong, Doo Sun Sim, Seung Hwan Hwang, Min Goo Lee, Keun Ho Park, Ju Han Kim, Youngkeun Ahn, Myeong Chan Cho, Chong Jin Kim, Young Jo Kim, Jong Chun Park, Jung Chaee Kang, Korea Acute Myocardial Infarction R. (2011) Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation vs. Coronary Artery Bypass Grafting for Multivessel Coronary Artery Disease in Metabolic Syndrome Patients With Acute Myocardial Infarction. Circulation Journal
CrossRef321
Pedro A. Lemos. (2011) Neo-lumen creation in total chronic occlusions. Catheterization and Cardiovascular Interventions 79:1, 49-49
CrossRef322
Ronen Rubinshtein, Amir Lerman, Daniel B. Spoon, Charanjit S. Rihal. (2011) Anatomic features of the left main coronary artery and factors associated with its bifurcation angle: A 3-dimensional quantitative coronary angiographic study. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef323
Juan Garcia-Lara, Eduardo Pinar, Raul Valdesuso, Javier Lacunza, Juan R. Gimeno, José A. Hurtado, Mariano Valdés-Chávarri. (2011) Percutaneous coronary intervention with rotational atherectomy for severely calcified unprotected left main : Immediate and two years follow-up results. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef324
John M. Murkin. 2011. Central Nervous System Dysfunction after Cardiopulmonary Bypass. , 1061-1085.
CrossRef325
Mark Kozak, Charles E. Chambers. 2011. Cardiac Catheterization Laboratory. , 33-73.
CrossRef326
Andrea Gagnor, Francesco Tomassini, Enrico Romagnoli, Vincenzo Infantino, Maria Cristina Rosa Brusin, Cristina Maria, Rosario Tripodi, Giuseppe Sangiorgi, Ferdinando Varbella. (2011) Percutaneous left main coronary disease treatment without on-site surgery back-up in patients with acute coronary syndromes. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef327
Frédéric Vanden Eynden, Jacques P. Goldstein. 2011. Cardiac Surgery. , 671-676.
CrossRef328
Michael Ragosta. 2011. Multivessel Coronary Artery Disease. , 189-194.
CrossRef329
Michael Ragosta. 2011. Unprotected Left Main Coronary Intervention. , 47-54.
CrossRef330
Stéphane Manzo-Silberman, Olivier Varenne. 2011. Invasive Cardiac Procedures. , 559-564.
CrossRef331
Brijeshwar Maini, Srihari S. Naidu, Suresh Mulukutla, Neal Kleiman, Theodore Schreiber, David Wohns, Simon Dixon, Charanjit Rihal, Rajesh Dave, William O'Neill. (2011) Real-world use of the impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: The uspella registry. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef332
David C.M. Corteville, David F. Armstrong, Daniel G. Montgomery, Eva Kline-Rogers, Zachary D. Goldberger, James B. Froehlich, Hitinder S. Gurm, Kim A. Eagle. (2011) Treatment and Outcomes of First Troponin-Negative Non–ST-Segment Elevation Myocardial Infarction. The American Journal of Cardiology 107:1, 24-29
CrossRef333
N. Ghosh, O. E. Rimoldi, R. S. B. Beanlands, P. G. Camici. (2010) Assessment of myocardial ischaemia and viability: role of positron emission tomography. European Heart Journal 31:24, 2984-2995
CrossRef334
STEPHEN P. HOOLE, PATRICK M. HECK, ANDREW C. EPSTEIN, SARAH C. CLARKE, NICK E. J. WEST, DAVID P. DUTKA. (2010) Elective Coronary Stenting Increases Fractional Flow Reserve in Other Arteries due to an Increase in Microvascular Resistance: Clinical Implications for Assessment of Multivessel Disease. Journal of Interventional Cardiology 23:6, 520-527
CrossRef335
Vittorio Mantovani, Vincenzo Lepore, Antonietta Mira, Eva Berglin. (2010) Non-inferiority randomized trials, an issue between science and ethics: The case of the SYNTAX study. Scandinavian Cardiovascular Journal 44:6, 321-324
CrossRef336
Jack C.J. Sun, Kevin H.T. Teoh, Andre Lamy, Tej Sheth, Mary Lou Ellins, Hyejung Jung, Salim Yusuf, Sonia Anand, Stuart Connolly, Richard P. Whitlock, John W. Eikelboom. (2010) Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study. American Heart Journal 160:6, 1178-1184
CrossRef337
Ahmed Abdel-Latif, Debabrata Mukherjee, Paymon Mesgarzadeh, Khaled M. Ziada. (2010) Drug-eluting stents in patients with end-stage renal disease: Meta-analysis and systematic review of the literature. Catheterization and Cardiovascular Interventions 76:7, 942-948
CrossRef338
Dahud Qarawani, Nahir Menachem, Diab Ganem, Yonathan Hasin. (2010) Unprotected left main stenting, short- and long-term outcomes. Acute Cardiac Care 12:4, 124-129
CrossRef339
R. Bekeredjian, T. Schilling, H.A. Katus, A. Haverich. (2010) Schwindende Fachgrenzen zwischen Kardiologie und Kardiochirurgie: Status quo. Der Chirurg 81:12, 1058-1065
CrossRef340
Lanfroi Graziani. (2010) Au sujet de l’article : Impact des lésions tibiales isolées sur les résultats dans la population en ischémie critique de membre. Ann Vasc Surg 2010 ; 24 : 349-359. Annales de Chirurgie Vasculaire 24:8, 1250-1251
CrossRef341
Dean J. Kereiakes, Krishnankutty Sudhir, James B. Hermiller, Paul C. Gordon, Joanne Ferguson, Manejeh Yaqub, Poornima Sood, Xiaolu Su, Steven Yakubov, Alexandra J. Lansky, Gregg W. Stone. (2010) Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention. JACC: Cardiovascular Interventions 3:12, 1229-1239
CrossRef342
C. Klopsch, D. Furlani, R. Gäbel, E. Pittermann, C. Yerebakan, A. Kaminski, N. Ma, A. Liebold, G. Steinhoff. (2010) Kardiale Protektion und Regeneration. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie 24:6, 369-375
CrossRef343
Giuseppe Biondi-Zoccai, Marzia Lotrionte, Imad Sheiban. (2010) Management of multivessel coronary disease after ST-elevation myocardial infarction treated by primary coronary angioplasty. American Heart Journal 160:6, S28-S35
CrossRef344
Elizabeth M. Holper, Tayo Addo. (2010) Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention. Coronary Artery Disease 21:7, 397-401
CrossRef345
Giuseppe Tarantini, Davide Lanzellotti. (2010) Three-vessel coronary disease in diabetics: personalized versus evidence-based revascularization strategy. Future Cardiology 6:6, 797-809
CrossRef346
Federico J Benetti. (2010) MINI-off-pump coronary artery bypass graft: long-term results. Future Cardiology 6:6, 791-795
CrossRef347
Giovanna Sarno, Scot Garg, Yoshinobu Onuma, Juan-Luis Gutiérrez-Chico, Marcel J.B.M. van den Brand, Benno J.W.M. Rensing, Marie-angele Morel, Patrick W. Serruys. (2010) Impact of Completeness of Revascularization on the Five-Year Outcome in Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Patients (from the ARTS-II Study). The American Journal of Cardiology 106:10, 1369-1375
CrossRef348
, , W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M. F. Piepoli, C. Pirlet, J. L. Pomar, N. Reifart, F. L. Ribichini, M. J. Schalij, P. Sergeant, P. W. Serruys, S. Silber, M. Sousa Uva, D. Taggart, , A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. E. Vardas, P. Widimsky, , P. Kolh, O. Alfieri, J. Dunning, S. Elia, P. Kappetein, U. Lockowandt, G. Sarris, P. Vouhe, , P. Kearney, L. von Segesser, S. Agewall, A. Aladashvili, D. Alexopoulos, M. J. Antunes, E. Atalar, A. Brutel de la Riviere, A. Doganov, J. Eha, J. Fajadet, R. Ferreira, J. Garot, J. Halcox, Y. Hasin, S. Janssens, K. Kervinen, G. Laufer, V. Legrand, S. A. M. Nashef, F.-J. Neumann, K. Niemela, P. Nihoyannopoulos, M. Noc, J. J. Piek, J. Pirk, Y. Rozenman, M. Sabate, R. Starc, M. Thielmann, D. J. Wheatley, S. Windecker, M. Zembala. (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 31:20, 2501-2555
CrossRef349
D. P. Taggart, D. G. Altman, A. M. Gray, B. Lees, F. Nugara, L.-M. Yu, H. Campbell, M. Flather, . (2010) Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). European Heart Journal 31:20, 2470-2481
CrossRef350
Upendra Kaul, Aijaz H Mansoor. (2010) SPIRIT clinical trial program. Interventional Cardiology 2:5, 635-644
CrossRef351
Michael S. Lee, Tae Yang, William F. Fearon, Michael Ho, Giuseppe Tarantini, Jola Xhaxho, Gino Gerosa, Mark Weston, Ashkan Ehdaie, LeRoy Rabbani, Ajay J. Kirtane. (2010) Long-Term Outcomes After Percutaneous Coronary Intervention of Left Main Coronary Artery for Treatment of Cardiac Allograft Vasculopathy After Orthotopic Heart Transplantation. The American Journal of Cardiology 106:8, 1086-1089
CrossRef352
Duk-Woo Park, Young-Hak Kim, Sung-Cheol Yun, Jong-Young Lee, Won-Jang Kim, Soo-Jin Kang, Seung-Whan Lee, Cheol-Whan Lee, Jae-Joong Kim, Suk-Jung Choo, Cheol-Hyun Chung, Jae-Won Lee, Seong-Wook Park, Seung-Jung Park. (2010) Long-Term Outcomes After Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease. Journal of the American College of Cardiology 56:17, 1366-1375
CrossRef353
Bimmer E Claessen, Adriano Caixeta, José PS Henriques, Jan J Piek. (2010) Current status of the Xience V ® everolimus-eluting coronary stent system. Expert Review of Cardiovascular Therapy 8:10, 1363-1374
CrossRef354
Stefan Toggweiler, Nadja Urbanek, Andreas W. Schoenenberger, Paul Erne. (2010) Analysis of coronary bifurcations by intravascular ultrasound and virtual histology. Atherosclerosis 212:2, 524-527
CrossRef355
Yanai Ben-Gal, Jeffrey W. Moses, Roxana Mehran, Alexandra J. Lansky, Giora Weisz, Eugenia Nikolsky, Michael Argenziano, Matthew R. Williams, Antonio Colombo, Philip E. Aylward, Gregg W. Stone. (2010) Surgical Versus Percutaneous Revascularization for Multivessel Disease in Patients With Acute Coronary Syndromes. JACC: Cardiovascular Interventions 3:10, 1059-1067
CrossRef356
J. James Edelman, Tristan D. Yan, Ratnasari Padang, Paul G. Bannon, Michael P. Vallely. (2010) Off-Pump Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention: A Meta-Analysis of Randomized and Nonrandomized Studies. The Annals of Thoracic Surgery 90:4, 1384-1390
CrossRef357
Hisato Takagi, Hideaki Manabe, Takuya Umemoto. (2010) Percutaneous Stenting Versus Bypass Surgery for Unprotected Left Main Coronary Artery Disease. The American Journal of Cardiology 106:7, 1059
CrossRef358
G. Morton, A. Schuster, D. Perera, E. Nagel. (2010) Cardiac magnetic resonance imaging to guide complex revascularization in stable coronary artery disease. European Heart Journal 31:18, 2209-2215
CrossRef359
Usman Baber, Annapoorna S. Kini, Samin K. Sharma. (2010) Stenting of complex lesions: an overview. Nature Reviews Cardiology 7:9, 485-496
CrossRef360
H. Reichenspurner, L. Conradi, J. Cremer, F. W. Mohr. (2010) Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated!. Clinical Research in Cardiology 99:9, 541-544
CrossRef361
Michael P. Vallely, Tristan D. Yan, J. James B. Edelman, Mark Hayman, R. John L. Brereton, Donald E. Ross. (2010) Anaortic, Total-arterial, Off-pump Coronary Artery Bypass Surgery: How To Do It. Heart, Lung and Circulation 19:9, 555-560
CrossRef362
Elvin Kedhi, Gregg W Stone. (2010) Everolimus-eluting stents: insights from the SPIRIT IV and COMPARE trials. Expert Review of Cardiovascular Therapy 8:9, 1207-1210
CrossRef363
Davide Capodanno, Maria-Elena Di Salvo, Corrado Tamburino. (2010) Impact of right coronary artery disease on mortality in patients undergoing percutaneous coronary intervention of unprotected left main coronary artery disease. EuroIntervention 6:4, 454-460
CrossRef364
Scot Garg, Gregg W. Stone, Arie-Peter Kappetein, Joseph F. Sabik, Charles Simonton, Patrick W. Serruys. (2010) Clinical and Angiographic Risk Assessment in Patients With Left Main Stem Lesions. JACC: Cardiovascular Interventions 3:9, 891-901
CrossRef365
Annemarie E Engström, Jan J Piek, José PS Henriques. (2010) Percutaneous left ventricular assist devices for high-risk percutaneous coronary intervention. Expert Review of Cardiovascular Therapy 8:9, 1247-1255
CrossRef366
Satoshi Hida, Taishiro Chikamori, Hirokazu Tanaka, Yuko Igarashi, Chie Shiba, Tsuguhisa Hatano, Yasuhiro Usui, Akira Yamashina. (2010) Sex-specific approach to gated SPECT volumetric analysis after stress and at rest to detect high-risk coronary artery disease. Nuclear Medicine Communications 31:9, 800-806
CrossRef367
Volker Schächinger, Christian Herdeg, Bruno Scheller. (2010) Best way to revascularize patients with main stem and three vessel lesions: patients should undergo PCI!. Clinical Research in Cardiology 99:9, 531-539
CrossRef368
Robert Applegate, James Hermiller, Mark Sanz, Julie Doostzadeh, Wesley Pierson, Xiaolu Su, Alexandra Lansky, Krishnankutty Sudhir, Gregg Stone. (2010) Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial. EuroIntervention 6:4, 437-446
CrossRef369
Deepak Thomas, Robert P. Giugliano. (2010) Perspectives on the 2009 Focused Updates on the Management of ST-Segment Elevation Myocardial Infarction and Percutaneous Intervention. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 9:3, 126-133
CrossRef370
Anastasia Damelou, Periklis Davlouros, Vasileios Karantalis, Dimitrios Alexopoulos. (2010) Double-barrel stenting of distal left main stenosis in a patient with acute coronary syndrome: Intravascular ultrasound and optical coherence tomography follow-up at six months. Canadian Journal of Cardiology 26:7, e282-e285
CrossRef371
YOSHINOBU MURASATO, YUTAKA HIKICHI, SUNAO NAKAMURA, FUMIHIKO KAJIYA, KIYOTAKA IWASAKI, YOSHIHISA KINOSHITA, MASAHIRO YAMAWAKI, TOSHIRO SHINKE, SHNICHIRO YAMADA, TAKEHIRO YAMASHITA, GIM-HOOI CHOO, CHANG-WOOK NAM, YOUNG-HAK KIM, NIGEL JEPSON, MIROSLAW FERENC. (2010) Recent Perspective on Coronary Bifurcation Intervention: Statement of the “Bifurcation Club in KOKURA”. Journal of Interventional Cardiology 23:4, 295-304
CrossRef372
Scot Garg, Patrick W. Serruys. (2010) Coronary Stents. Journal of the American College of Cardiology 56:10, S1-S42
CrossRef373
Tamer Elghobary, Jean-Francois Légaré. (2010) What has happened to multiple arterial grafting in coronary artery bypass grafting surgery?. Expert Review of Cardiovascular Therapy 8:8, 1099-1105
CrossRef374
SHAO-LIANG CHEN, FEY YE, JUN-JIE ZHANG, ZUO-YING HU, NAI-LIANG TIAN, JUN-XIA ZHANG, TAK W. KWAN. (2010) Prediction of Clinical Outcomes in Patients with Unprotected Left Main Trifurcation Lesions Treated by Drug-Eluting Stents: Importance of 2-Stent Technique and SYNTAX Score. Journal of Interventional Cardiology 23:4, 352-357
CrossRef375
Michael S. Lee, Pooya Bokhoor, Seung-Jung Park, Young-Hak Kim, Gregg W. Stone, Imad Sheiban, Giuseppe Biondi-Zoccai, Dario Sillano, Jonathan Tobis, David E. Kandzari. (2010) Unprotected Left Main Coronary Disease and ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions 3:8, 791-795
CrossRef376
M. Stramba-Badiale. (2010) Women and research on cardiovascular diseases in Europe: a report from the European Heart Health Strategy (EuroHeart) project. European Heart Journal 31:14, 1677-1681
CrossRef377
G. Robert Myers, William S. Weintraub. (2010) Coronary artery disease: Revascularization strategies for patients with CAD and diabetes. Nature Reviews Cardiology 7:7, 364-366
CrossRef378
Joanna J. Wykrzykowska, Scot Garg, Chrysafios Girasis, Ton de Vries, Marie-Angele Morel, Gerrit-Anne van Es, Pawel Buszman, Axel Linke, Thomas Ischinger, Volker Klauss, Roberto Corti, Franz Eberli, William Wijns, Marie-Claude Morice, Carlo di Mario, Robert Jan van Geuns, Peter Juni, Stephan Windecker, Patrick W. Serruys. (2010) Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial. Journal of the American College of Cardiology 56:4, 272-277
CrossRef379
Cathy Jeon, Susana C. Candia, John C. Wang, Elizabeth M. Holper, Michelle Ammerer, Richard E. Kuntz, Laura Mauri. (2010) Relative spatial distributions of coronary artery bypass graft insertion and acute thrombosis: A model for protection from acute myocardial infarction. American Heart Journal 160:1, 195-201
CrossRef380
Nico H.J. Pijls, William F. Fearon, Pim A.L. Tonino, Uwe Siebert, Fumiaki Ikeno, Bernhard Bornschein, Marcel van't Veer, Volker Klauss, Ganesh Manoharan, Thomas Engstrøm, Keith G. Oldroyd, Peter N. Ver Lee, Philip A. MacCarthy, Bernard De Bruyne. (2010) Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease. Journal of the American College of Cardiology 56:3, 177-184
CrossRef381
Hui-Chun Huang, Hsien-Li Kao, Xue-Ming Wu, Sheoi-Shen Wang, Ron-Bin Hsu, Yi-Lwun Ho, Ming-Fong Chen. (2010) Long-term prognosis in ethnic Chinese patients with unprotected left main coronary artery disease. Clinical Research in Cardiology 99:7, 437-443
CrossRef382
Dean J. Kereiakes, Louis A. Cannon, Robert L. Feldman, Jeffrey J. Popma, Raymond Magorien, Robert Whitbourn, Ira M. Dauber, Abram C. Rabinowitz, Michael W. Ball, Barry Bertolet, Ameer Kabour, Michael C. Foster, John C. Wang, Paul Underwood, Keith D. Dawkins. (2010) Clinical and Angiographic Outcomes After Treatment of De Novo Coronary Stenoses With a Novel Platinum Chromium Thin-Strut Stent. Journal of the American College of Cardiology 56:4, 264-271
CrossRef383
Colin Berry, Stéphane Noble, Reda Ibrahim, Jean Grégoire, Sylvie Levesque, Philippe L. L'Allier, Jean-Claude Tardif. (2010) Remodeling is a more important determinant of lumen size than atheroma burden in left main coronary artery disease. American Heart Journal 160:1, 188-194.e1
CrossRef384
Duk-Woo Park, Ki Bae Seung, Young-Hak Kim, Jong-Young Lee, Won-Jang Kim, Soo-Jin Kang, Seung-Whan Lee, Cheol Whan Lee, Seong-Wook Park, Sung-Cheol Yun, Hyeon-Cheol Gwon, Myung-Ho Jeong, Yang-Soo Jang, Hyo-Soo Kim, Pum Joon Kim, In-Whan Seong, Hun Sik Park, Taehoon Ahn, In-Ho Chae, Seung-Jea Tahk, Wook-Sung Chung, Seung-Jung Park. (2010) Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease. Journal of the American College of Cardiology 56:2, 117-124
CrossRef385
Hiromi Muta, Masahiro Ishii. (2010) Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Stenotic Lesions after Kawasaki Disease. The Journal of Pediatrics 157:1, 120-126
CrossRef386
Kirk N. Garratt, David R. Holmes. (2010) Benefit With Impella?. Journal of the American College of Cardiology 55:23, 2608
CrossRef387
Timm Bauer, Uwe Zeymer. (2010) Impact of age on outcomes of percutaneous coronary intervention in acute coronary syndromes patients. Interventional Cardiology 2:3, 319-325
CrossRef388
Sanjay B. Pandya, Young-Hak Kim, Sheridan N. Meyers, Charles J. Davidson, James D. Flaherty, Duk-Woo Park, Anuj Mediratta, Karen Pieper, Eric Reyes, Robert O. Bonow, Seung-Jung Park, Nirat Beohar. (2010) Drug-Eluting Versus Bare-Metal Stents in Unprotected Left Main Coronary Artery Stenosis. JACC: Cardiovascular Interventions 3:6, 602-611
CrossRef389
Barry F. Uretsky. (2010) IIb or Not IIb? Toward a Rational Application of Left Main Stenting
Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 55:23, 2553-2555
CrossRef390
Stephen G. Ellis. (2010) Percutaneous Left Main Invention. JACC: Cardiovascular Interventions 3:6, 642-647
CrossRef391
Brett C. Sheridan, Sally C. Stearns, Joseph S. Rossi, Laura P. D'Arcy, Jerome J. Federspiel, Timothy S. Carey. (2010) Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients. The Annals of Thoracic Surgery 89:6, 1889-1895
CrossRef392
Finn Gustafsson, Dan Atar, Bertram Pitt, Faiez Zannad, Marc A. Pfeffer. (2010) Maximizing scientific knowledge from randomized clinical trials. American Heart Journal 159:6, 937-943
CrossRef393
Anders Ahlsson, Espen Fengsrud, Lennart Bodin, Anders Englund. (2010) Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality. European Journal of Cardio-Thoracic Surgery 37:6, 1353-1359
CrossRef394
Aaron From, Firas Al Badarin, Stephen Cha, Charanjit Rihal. (2010) Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis of data from the ARTS II, CARDia, ERACI III, and SYNTAX studies and systematic review of observational data. EuroIntervention 6:2, 269-276
CrossRef395
RALF LEHMANN, STEPHAN FICHTLSCHERER, VOLKER SCHÄCHINGER, LAURA HELD, CAROLA HOBLER, GREGOR BAIER, ANDREAS M. ZEIHER, IOAKIM SPYRIDOPOULOS. (2010) Complete Revascularization in Patients Undergoing Multivessel PCI is an Independent Predictor of Improved Long-term Survival. Journal of Interventional Cardiology 23:3, 256-263
CrossRef396
Corrado Tamburino, Piera Capranzano, Davide Capodanno, Francesco Tagliareni, Giuseppe Biondi-Zoccai, Alessandra Sanfilippo, Anna Caggegi, Giombattista Barrano, Sergio Monaco, Salvatore D. Tomasello, Alessio La Manna, Marilena Di Salvo, Imad Sheiban. (2010) Plaque Distribution Patterns in Distal Left Main Coronary Artery to Predict Outcomes After Stent Implantation. JACC: Cardiovascular Interventions 3:6, 624-631
CrossRef397
Pim A.L. Tonino, William F. Fearon, Bernard De Bruyne, Keith G. Oldroyd, Massoud A. Leesar, Peter N. Ver Lee, Philip A. MacCarthy, Marcel van't Veer, Nico H.J. Pijls. (2010) Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study. Journal of the American College of Cardiology 55:25, 2816-2821
CrossRef398
Mohammad Reza Movahed, Mehrtash Hashemzadeh, Ali Khoynezhad, M. Mazen Jamal, Radhakrishnan Ramaraj. (2010) Sex- and ethnic group–specific nationwide trends in the use of coronary artery bypass grafting in the United States. The Journal of Thoracic and Cardiovascular Surgery 139:6, 1545-1547
CrossRef399
Alaide Chieffo, Valeria Magni, Azeem Latib, Francesco Maisano, Alfonso Ielasi, Matteo Montorfano, Mauro Carlino, Cosmo Godino, Massimo Ferraro, Giliola Calori, Ottavio Alfieri, Antonio Colombo. (2010) 5-Year Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Versus Coronary Artery Bypass Graft for Unprotected Left Main Coronary Artery Lesions. JACC: Cardiovascular Interventions 3:6, 595-601
CrossRef400
David M. Holzhey, Martin M. Luduena, Ardawan Rastan, Stephan Jacobs, Thomas Walther, Friedrich W. Mohr, Volkmar Falk. (2010) Is the SYNTAX Score a Predictor of Long-term Outcome after Coronary Artery Bypass Surgery?. The Heart Surgery Forum 13:3, E143-E148
CrossRef401
Enrico Orsini, Giovanni Battista Zito. (2010) Matching pathophysiology and evidence-based medicine for optimal management of ischemic heart disease. Journal of Cardiovascular Medicine 11:6, 469-476
CrossRef402
Christian H. Møller, Mario J. Perko, Jens T. Lund, Lars W. Andersen, Henning Kelbæk, Jan K. Madsen, Christian Gluud, Daniel A. Steinbrüchel. (2010) Graft patency after off-pump versus on-pump coronary artery surgery in high-risk patients. Scandinavian Cardiovascular Journal 44:3, 161-167
CrossRef403
Krischan D. Sjauw, Annemarie E. Engström, Jose P.S. Henriques. (2010) Reply. Journal of the American College of Cardiology 55:23, 2608-2609
CrossRef404
Young-Hak Kim, Duk-Woo Park, Won-Jang Kim, Jong-Young Lee, Sung-Cheol Yun, Soo-Jin Kang, Seung-Whan Lee, Cheol Whan Lee, Myeong-Ki Hong, Seong-Wook Park, Seung-Jung Park. (2010) Impact of the Extent of Coronary Artery Disease on Outcomes After Revascularization for Unprotected Left Main Coronary Artery Stenosis. Journal of the American College of Cardiology 55:23, 2544-2552
CrossRef405
Young-Hak Kim, Duk-Woo Park, Won-Jang Kim, Jong-Young Lee, Sung-Cheol Yun, Soo-Jin Kang, Seung-Whan Lee, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park. (2010) Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) Score for Prediction of Outcomes After Unprotected Left Main Coronary Revascularization. JACC: Cardiovascular Interventions 3:6, 612-623
CrossRef406
B.K. Goyal. (2010) Percutaneous UPLM revascularisation: The time has come. Catheterization and Cardiovascular Interventions 75:7, 1050-1050
CrossRef407
Yoshinobu Onuma, Chrysafios Girasis, Nicolo Piazza, Hector M. Garcia-Garcia, Neville Kukreja, Scot Garg, Jannet Eindhoven, Jin-Ming Cheng, Marco Valgimigli, Ron van Domburg, Patrick W. Serruys. (2010) Long-Term Clinical Results Following Stenting of the Left Main Stem. JACC: Cardiovascular Interventions 3:6, 584-594
CrossRef408
XiaoFan Wu, YunDai Chen, Hong Liu, Paul S. Teirstein, Ajay J. Kirtane, ChangJiang Ge, XianTao Song, Xin Chen, ChengXiong Gu, FangJiong Huang, ShuZheng Lv. (2010) Comparison of Long-Term (4-Year) Outcomes of Patients With Unprotected Left Main Coronary Artery Narrowing Treated With Drug-Eluting Stents Versus Coronary-Artery Bypass Grafting. The American Journal of Cardiology 105:12, 1728-1734
CrossRef409
Michael S. Lee, Tae Yang, Jashdeep Dhoot, Zahid Iqbal, Hsini Liao. (2010) Meta-Analysis of Studies Comparing Coronary Artery Bypass Grafting With Drug-Eluting Stenting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease. The American Journal of Cardiology 105:11, 1540-1544
CrossRef410
Burton E. Sobel. (2010) A perspective on the development of coronary revascularization. Coronary Artery Disease 21:3, 199-203
CrossRef411
Dean J. Kereiakes. (2010) Cultivating Prognosis Following Percutaneous Coronary Intervention. Journal of the American College of Cardiology 55:18, 1933-1935
CrossRef412
Somjot S Brar, Gregg W Stone. (2010) Decision-making: stenting in acute myocardial infarction. Future Cardiology 6:3, 301-314
CrossRef413
Mike Seddon, Nick Curzen. (2010) CORONARY REVASCULARISATION IN CHRONIC KIDNEY DISEASE PART 1: STABLE CORONARY ARTERY DISEASE. Journal of Renal Care 36, 106-117
CrossRef414
Iñigo Lozano, Pablo Avanzas, Juan Rondan. (2010) SYNTAX score and left main stenting: Do we need clinical variables to predict outcomes?. American Heart Journal 159:5, e25
CrossRef415
Jon C. George, David J. Moliterno, George D. Dangas. (2010) American College of Cardiology Annual Scientific Session 2010. JACC: Cardiovascular Interventions 3:5, 562-564
CrossRef416
Hisato Takagi, Masafumi Matsui, Takuya Umemoto. (2010) Increased late mortality with percutaneous stenting for unprotected left main coronary artery stenosis relative to coronary artery bypass grafting: A meta-analysis of observational studies. The Journal of Thoracic and Cardiovascular Surgery 139:5, 1351-1353
CrossRef417
Douglass A. Morrison. (2010) How much delta does your kappa make to my patients? Putting the SYNTAX score into clinical context. Catheterization and Cardiovascular Interventions 75:6, 953-956
CrossRef418
Mounir Basalus, K. van Houwelingen, Marc Ankone, Jan Feijen, Clemens von Birgelen. (2010) Micro-computed tomographic assessment following extremely oversized partial postdilatation of drug-eluting stents. EuroIntervention 6:1, 141-148
CrossRef419
Guido Parodi, Akiko Maehara, Gabriele Giuliani, Takashi Kubo, Gary Mintz, Angela Migliorini, Renato Valenti, Nazario Carrabba, David Antoniucci. (2010) Optical coherence tomography in unprotected left main coronary artery stenting. EuroIntervention 6:1, 94-99
CrossRef420
Scot Garg, Carl Schultz, Giovanna Sarno, Patrick Serruys. (2010) How should I treat a tortuous calcified right coronary artery?. EuroIntervention 6:1, 161-167
CrossRef421
Simon R. Dixon, Cindy L. Grines, William W. O'Neill. (2010) The Year in Interventional Cardiology. Journal of the American College of Cardiology 55:20, 2272-2286
CrossRef422
Rolf Dörr. (2010) Bypasschirurgie versus perkutane koronare Intervention bei Patienten mit Diabetes mellitus. Herz 35:3, 182-190
CrossRef423
Burton E. Sobel. (2010) Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial. Coronary Artery Disease 21:3, 189-198
CrossRef424
Augusto Gallino, Francesco Siclari. (2010) Síndrome coronario agudo en pacientes con bypass arterial coronario previo. Revista Española de Cardiología 63:5, 516-517
CrossRef425
Oliver J Liakopoulos, Elmar W Kuhn, Ingo Slottosch, Gernot Wassmer, Thorsten Wahlers, Oliver J Liakopoulos. 2010. Preoperative statin therapy for patients undergoing cardiac surgery. .
CrossRef426
Giuseppe G. L. Biondi-Zoccai, Elena Giraudi, Claudio Moretti, Filippo Sciuto, Pierluigi Omedè, Dario Sillano, Paolo Garrone, Gian Paolo Trevi, Imad Sheiban. (2010) Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry. Clinical Research in Cardiology 99:4, 235-242
CrossRef427
Pablo Maureira, Fabrice Vanhuyse, Malik Lekehal, Nguyen Tran, Jean-Pierre Carteaux, Jean-Pierre Villemot. (2010) Left Main Coronary Disease Treated by Direct Surgical Angioplasty: Long-Term Results. The Annals of Thoracic Surgery 89:4, 1151-1157
CrossRef428
Flavio Ribichini, Gerardo Ansalone, Antonio Bartorelli, Federico Beqaraj, Andrea Berni, Salvatore Colangelo, Maurizio DʼAmico, Francesco Della Rovere, Antonio Fiscella, Gabriele Gabrielli, Ciro Indolfi, Luigi La Vecchia, Paolo Loschiavo, Giampietro Marinoni, Antonio Marzocchi, Diego Milazzo, Michele Romano, Pietro Sangiorgio, Imad Sheiban, Corrado Tamburino, Bernardino Tuccillo, Rosvaldo Villani, Barbara Cappi, Maria Josè Lopera Quijada, Corrado Vassanelli. (2010) A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial. Journal of Cardiovascular Medicine 11:4, 299-309
CrossRef429
Javier Sanz, Pedro R. Moreno, Valentin Fuster. (2010) The Year in Atherothrombosis. Journal of the American College of Cardiology 55:14, 1487-1498
CrossRef430
Hans-Joachim Trappe. (2010) The SYNTAX study. Clinical Research in Cardiology Supplements 5:S1, 70-74
CrossRef431
Elvin Kedhi, Eugene McFadden, Pieter C Smits. (2010) Everolimus-eluting versus paclitaxel-eluting stents – Authors' reply. The Lancet 375:9721, 1161-1162
CrossRef432
Shailja V. Parikh, James A. de Lemos, Michael E. Jessen, Emmanouil S. Brilakis, E. Magnus Ohman, Anita Y. Chen, Tracy Y. Wang, Eric D. Peterson, Matthew T. Roe, Elizabeth M. Holper. (2010) Timing of In-Hospital Coronary Artery Bypass Graft Surgery for Non–ST-Segment Elevation Myocardial Infarction Patients. JACC: Cardiovascular Interventions 3:4, 419-427
CrossRef433
Rainer Wessely. (2010) New drug-eluting stent concepts. Nature Reviews Cardiology 7:4, 194-203
CrossRef434
Anna Norhammar, Bo Lagerqvist, Nawsad Saleh. (2010) Long-term mortality after PCI in patients with diabetes mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry. EuroIntervention 5:8, 891-897
CrossRef435
Asmir I. Syed, Amit Karkar, Rebecca Torguson, Yanlin Li, Itsik Ben-Dor, Sara D. Collins, Gilles Lemesle, Gabriel Maluenda, Zhenyi Xue, Mickey Scheinowitz, Kimberly Kaneshige, Lowell F. Satler, Kenneth M. Kent, William O. Suddath, Augusto D. Pichard, Joseph Lindsay, Ron Waksman. (2010) Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?. Cardiovascular Revascularization Medicine 11:2, 91-97
CrossRef436
Maria M. Wanitschek, Otmar Pachinger, Hannes F. Alber. (2010) Ein „gefährliches Duo“. Wiener klinisches Magazin 13:2, 32-43
CrossRef437
P. Tuppin, A. Neumann, D. Simon, A. Weill, C. de Peretti, N. Danchin, P. Ricordeau, H. Allemand. (2010) Characteristics and management of diabetic patients hospitalized for myocardial infarction in France. Diabetes & Metabolism 36:2, 129-136
CrossRef438
Elisabetta Varani, Paolo Guastaroba, Gian Di Tanna, Francesco Saia, Marco Balducelli, Gianluca Campo, Luigi Vignali, Rosario Rossi, Antonio Manari, Giancarlo Piovaccari, Rossana De Palma, Antonio Marzocchi. (2010) Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation. EuroIntervention 5:8, 953-961
CrossRef439
Michael A. Kutcher. (2010) Cardiac Magnetic Resonance Imaging to Assess and Predict Improvement of Myocardial Function After Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions 3:4, 401-402
CrossRef440
Fausto Biancari, Mikko Myllylä, Samuli Lepojärvi, Kari Kuttila, Pekka Porela, Timo Laitio, Antti Ylitalo, Vesa Jokinen, Antti Luokkala, K.E. Juhani Airaksinen. (2010) Preoperative Warfarin Treatment and Outcome of Coronary Artery Bypass Graft Surgery. The Annals of Thoracic Surgery 89:4, 1139-1145
CrossRef441
Mariann Gyöngyösi, Irene M Lang, Thomas Neunteufl, Susanne Winkler, Lisa Krenn, Elisabeth Enzenhofer, Georg Delle-Karth, Gerald Maurer, Dietmar Glogar. (2010) The Austrian Multivessel Taxus™ Stent (AUTAX) registry. Interventional Cardiology 2:2, 113-120
CrossRef442
Cosmo Godino, Guido Parodi, Shinichi Furuichi, Azeem Latib, Rossella Barbagallo, Omer Goktekin, Michela Cera, Ralf Mueller, Corrado Tamburino, Eberhard Grube, Carlo Di Mario, Bernard Reimers, Alaide Chieffo, David Antoniucci, Antonio Colombo, Giuseppe Sangiorgi. (2010) Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry). EuroIntervention 5:8, 906-916
CrossRef443
Sharon W. Kirschbaum, Tirza Springeling, Eric Boersma, Adriaan Moelker, Wim J. van der Giessen, Patrick W. Serruys, Pim J. de Feyter, Robert-Jan M. van Geuns. (2010) Complete Percutaneous Revascularization for Multivessel Disease in Patients With Impaired Left Ventricular Function. JACC: Cardiovascular Interventions 3:4, 392-400
CrossRef444
Jawahar L. Mehta, Zoran Bursac, Paulette Mehta, Darpan Bansal, Louis Fink, James Marsh, Rishi Sukhija, Rajesh Sachdeva. (2010) Racial Disparities in Prescriptions for Cardioprotective Drugs and Cardiac Outcomes in Veterans Affairs Hospitals. The American Journal of Cardiology 105:7, 1019-1023
CrossRef445
Carlos Oviedo, Akiko Maehara, Gary S. Mintz, Kenichi Tsujita, Takashi Kubo, Hiroshi Doi, Celia Castellanos, Alexandra J. Lansky, Roxana Mehran, George Dangas, Martin B. Leon, Gregg W. Stone, Barry Templin, Hiroshi Araki, Masahiko Ochiai, Jeffrey W. Moses. (2010) Is Accurate Intravascular Ultrasound Evaluation of the Left Circumflex Ostium from a Left Anterior Descending to Left Main Pullback Possible?. The American Journal of Cardiology 105:7, 948-954
CrossRef446
Michael S. Lee, Tae Yang, Jashdeep Dhoot, Hsini Liao. (2010) Meta-Analysis of Clinical Studies Comparing Coronary Artery Bypass Grafting With Percutaneous Coronary Intervention and Drug-Eluting Stents in Patients With Unprotected Left Main Coronary Artery Narrowings. The American Journal of Cardiology 105:8, 1070-1075
CrossRef447
Ardawan Julian Rastan, Holger Thiele, Gerhard Schuler, Friedrich Wilhelm Mohr. (2010) Stellenwert der koronaren Bypass operation in der Therapie der akuten Koronarsyndrome. Herz 35:2, 70-78
CrossRef448
Barry F. Uretsky. (2010) Time for left main stenting in patients with LV dysfunction? Proceed with Caution!. Catheterization and Cardiovascular Interventions 75:4, 594-595
CrossRef449
C. Richard Conti. (2010) Grading Chronic Angina Pectoris (Myocardial Ischemia). Clinical Cardiology 33:3, 124-125
CrossRef450
Kate Leslie, Paul S. Myles, Andrew Forbes, Matthew T. V. Chan. (2010) The Effect of Bispectral Index Monitoring on Long-Term Survival in the B-Aware Trial. Anesthesia & Analgesia 110:3, 816-822
CrossRef451
W. Anne, R. Tavernier, M. Duytschaever. (2010) Four types of complications in paroxysmal atrial fibrillation ablation. Europace 12:3, 303-304
CrossRef452
M. L. Simoons, S. Windecker. (2010) Chronic stable coronary artery disease: drugs vs. revascularization. European Heart Journal 31:5, 530-541
CrossRef453
Scot Garg, Patrick Serruys. (2010) Benefits of and safety concerns associated with drug-eluting coronary stents. Expert Review of Cardiovascular Therapy 8:3, 449-470
CrossRef454
Jeffrey J. Popma, Senthil Nathan, Robert C. Hagberg, Kamal R. Khabbaz. (2010) Hybrid myocardial revascularization: An integrated approach to coronary revascularization. Catheterization and Cardiovascular Interventions 75:S1, S28-S34
CrossRef455
Harold L. Dauerman. (2010) Percutaneous Coronary Intervention, Diabetes Mellitus, and Death
CrossRef456
Adrian P. Banning, Stephen Westaby, Marie-Claude Morice, A. Pieter Kappetein, Friedrich W. Mohr, Sergio Berti, Mattia Glauber, Mirle A. Kellett, Robert S. Kramer, Katrin Leadley, Keith D. Dawkins, Patrick W. Serruys. (2010) Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease. Journal of the American College of Cardiology 55:11, 1067-1075
CrossRef457
Patrick W. Serruys, Yoshinobu Onuma, Scot Garg, Pascal Vranckx, Bernard De Bruyne, Marie-Claude Morice, Antonio Colombo, Carlos Macaya, Gert Richardt, Jean Fajadet, Christian Hamm, Monique Schuijer, Tessa Rademaker, Kristel Wittebols, Hans Peter Stoll. (2010) 5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions. Journal of the American College of Cardiology 55:11, 1093-1101
CrossRef458
Alexandre Hertig, Taduri Gangadhar, Raghu Kalluri. (2010) Renal studies provide an insight into cardiac extracellular matrix remodeling during health and disease. Journal of Molecular and Cellular Cardiology 48:3, 497-503
CrossRef459
Shinichi Shirai, Takeshi Kimura, Masakiyo Nobuyoshi, Takeshi Morimoto, Kenji Ando, Yoshimitsu Soga, Kyohei Yamaji, Katsuhiro Kondo, Koyu Sakai, Takeshi Arita, Masahiko Goya, Masashi Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Kazuaki Mitsudo. (2010) Impact of Multiple and Long Sirolimus-Eluting Stent Implantation on 3-Year Clinical Outcomes in the j-Cypher Registry. JACC: Cardiovascular Interventions 3:2, 180-188
CrossRef460
Alaide Chieffo, Angela Hoye, Fina Mauri, Ghada W. Mikhail, Michelle Ammerer, Cindy Grines, Liliana Grinfeld, Mina Madan, Patrizia Presbitero, Kimberly A. Skelding, Bonnie H. Weiner, Roxana Mehran, . (2010) Gender-based issues in interventional cardiology: A consensus statement from the Women in Innovations (WIN) Initiative. Catheterization and Cardiovascular Interventions 75:2, 145-152
CrossRef461
Sanjay Kaul, George A. Diamond. (2010) Trial and Error. Journal of the American College of Cardiology 55:5, 415-427
CrossRef462
Imad Sheiban, Carlo La Spina, Erika Cavallero, Giuseppe Biondi-Zoccai, Francesco Colombo, Tullio Palmerini, Antonio Marzocchi, Corrado Tamburino, Massimo Margheri, Giuseppe Vecchi, Giuseppe Sangiorgi, Andrea Santarelli, Antonio Bartorelli, Carlo Briguori, Luigi Vignali, Francesco di Pede, Angelo Ramondo, Cecilia Fantoni, Marco de Carlo, Giovanni Falsini, Alberto Benassi, Cataldo Palmieri, Vincenzo Filippone, Diego Sangiorgi, Stefano de Servi. (2010) Sex-related differences in patients undergoing percutaneous unprotected left main stenting. EuroIntervention 5:7, 795-800
CrossRef463
Brian J. Page, Dmitriy Kireyev, William E. Boden. (2010) The Role of Revascularization Versus Medical Therapy in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease. Current Diabetes Reports 10:1, 10-15
CrossRef464
F.W. Mohr, A.J. Rastan, J. Cremer, H. Reichenspurner. (2010) Die Bedeutung der SYNTAX-Studie für die moderne Koronarchirurgie. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie 24:1, 49-57
CrossRef465
Özcan Birim, Ad Bogers, A. Pieter Kappetein. (2010) Cost effectiveness of coronary revascularisation. EuroIntervention 5:7, 763-767
CrossRef466
Alaide Chieffo, Angela Hoye, Fina Mauri, Ghada Mikhail, Michelle Ammerer, Cindy Grines, Liliana Grinfeld, Mina Madan, Patrizia Presbitero, Kimberly A. Skelding, Bonnie H. Weiner, Roxana Mehran. (2010) Cuestiones relativas al sexo en cardiología intervencionista: declaración de consenso de la iniciativa Women in Innovations (WIN). Revista Española de Cardiología 63:2, 200-208
CrossRef467
William F. Fearon. (2010) Impact of Drug-Eluting Stent Length on Outcomes. JACC: Cardiovascular Interventions 3:2, 189-190
CrossRef468
Dario Sillano, Vincenzo Infantino, Giuseppe Biondi-Zoccai, Imad Sheiban. (2010) Management of restenosis after drug-eluting stent placement for unprotected left main disease. Interventional Cardiology 2:1, 77-84
CrossRef469
Don Poldermans, Jeroen J Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav FM Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen. (2010) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. European Journal of Anaesthesiology 27:2, 92-137
CrossRef470
Roberta Rossini, Giuseppe Musumeci, Alessandro Aprile, Orazio Valsecchi. (2010) Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents. Expert Review of Pharmacoeconomics & Outcomes Research 10:1, 49-61
CrossRef471
Akhil Kapur, Roger J. Hall, Iqbal S. Malik, Ayesha C. Qureshi, Jeremy Butts, Mark de Belder, Andreas Baumbach, Gianni Angelini, Adam de Belder, Keith G. Oldroyd, Marcus Flather, Michael Roughton, Petros Nihoyannopoulos, Jens Peder Bagger, Kenneth Morgan, Kevin J. Beatt. (2010) Randomized Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Diabetic Patients. Journal of the American College of Cardiology 55:5, 432-440
CrossRef472
Spencer B. King, John Jeffrey Marshall, Pradyumna E. Tummala. (2010) Revascularization for Coronary Artery Disease: Stents Versus Bypass Surgery. Annual Review of Medicine 61:1, 199-213
CrossRef473
V. Falk. (2010) Stay off-pump and do not touch the aorta!. European Heart Journal 31:3, 278-280
CrossRef474
Alaide Chieffo, Angela Hoye, Fina Mauri, Ghada Mikhail, Michelle Ammerer, Cindy Grines, Liliana Grinfeld, Mina Madan, Patrizia Presbitero, Kimberly Skelding, Bonnie Weiner, Roxana Mehran. (2010) Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative. EuroIntervention 5:7, 773-779
CrossRef475
Jon C. George, George D. Dangas. (2010) 2009 Focused Updates to Guidelines in ST-Elevation Myocardial Infarction and Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions 3:2, 256-258
CrossRef476
Ronald P Caputo. (2010) Current considerations regarding the percutaneous revascularization of chronic total coronary occlusions. Interventional Cardiology 2:1, 37-43
CrossRef477
Si-Hyuck Kang, Kay-Hyun Park, Dong-Ju Choi, Kyung Woo Park, Woo-Young Chung, Cheong Lim, Ki-Bong Kim, Hyo-Soo Kim. (2010) Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Left Main Coronary Artery Disease (from a Two-Center Registry). The American Journal of Cardiology 105:3, 343-351
CrossRef478
2010. Synopsis of Adult Cardiac Surgical Disease. , 1-83.
CrossRef479
S. B. King. (2010) Which stent for diabetic patients: the glass half-full or half-empty?. European Heart Journal 31:2, 143-145
CrossRef480
Chrysafios Girasis, Patrick W. Serruys, Yoshinobu Onuma, Antonio Colombo, David R. Holmes, Ted E. Feldman, Eric J. Bass, Katrin Leadley, Keith D. Dawkins, Marie-Claude Morice. (2010) 3-Dimensional Bifurcation Angle Analysis in Patients With Left Main Disease. JACC: Cardiovascular Interventions 3:1, 41-48
CrossRef481
Ken-ichirou Yamagata, Yu Kataoka, Nobuaki Kokubu, Yoichiro Kasahara, Mitsuru Abe, Hiroyuki Nakajima, Junjiro Kobayashi, Yoritaka Otsuka. (2010) A 3-Year Clinical Outcome After Percutaneous Coronary Intervention Using Sirolimus-Eluting Stent and Off-Pump Coronary Artery Bypass Grafting for the Treatment of Diabetic Patients With Multivessel Disease. Circulation Journal 74:4, 671-678
CrossRef482
Joan F. Hilton. (2010) Noninferiority trial designs for odds ratios and risk differences. Statistics in Medicinen/a-n/a
CrossRef483
Tadateru Takayama, Takafumi Hiro, Atsushi Hirayama. (2010) Is Angioplasty Able to Become the Gold Standard of Treatment Beyond Bypass Surgery for Patients With Multivessel Coronary Artery Disease?. Circulation Journal 74:12, 2744-2749
CrossRef484
Hisato Takagi, Takuya Umemoto. (2010) Drug-Eluting Stents vs Bypass Surgery for Unprotected Left Main Disease. Circulation Journal 74:10, 2244
CrossRef485
Shichiro Abe, Teruo Inoue, Isao Taguchi. (2010) The Entire Coronary Arterial System Rather Than Just the Culprit Lesion Should be Evaluated in Patients With Acute Coronary Syndrome. Circulation Journal 74:3, 430-431
CrossRef486
Hisato Takagi, Takuya Umemoto. (2010) Drug-Eluting Stents vs Bypass Surgery for Multivessel Disease. Circulation Journal 74:9, 2021-2022
CrossRef487
Kazuhiro SASE. (2010) Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 41:4, 133-139
CrossRef488
Antonio Linde-Estrella, Antonio Domínguez-Franco, Antonio J. Muñoz-García, Manuel F. Jiménez-Navarro. (2010) Eficacia y efectividad en la revascularización coronaria multivaso de pacientes diabéticos. Revista Española de Cardiología 63:1, 115-116
CrossRef489
Alan K. Berger, Charles A. Herzog. (2010) Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in CKD. American Journal of Kidney Diseases 55:1, 15-20
CrossRef490
Hagen Gorki, Nirav C. Patel, Georgia Panagopoulos, Joan Jennings, Lognathen Balacumaraswami, Konstadinos Plestis, Valavanur A. Subramanian. (2010) Off-pump Coronary Bypass Surgery in Patients With Low Ejection Fraction. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 5:1, 33-41
CrossRef491
Agustín Albarrán, Josepa Mauri, Eduardo Pinar, José Antonio Baz. (2010) Actualización en cardiología intervencionista. Revista Española de Cardiología 63, 86-100
CrossRef492
Valentín Fuster. (2010) De la enfermedad multivaso compleja a la salud cardiovascular. Revista Española de Cardiología 63, 3-11
CrossRef493
Davide Capodanno, Marco Miano, Glauco Cincotta, Anna Caggegi, Cettina Ruperto, Rita Bucalo, Alessandra Sanfilippo, Piera Capranzano, Corrado Tamburino. (2010) EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. American Heart Journal 159:1, 103-109
CrossRef494
Scot Garg, Chrysafios Girasis, Giovanna Sarno, Dick Goedhart, Marie-Angèle Morel, Hector M. Garcia-Garcia, Marco Bressers, Gerrit-Anne van Es, Patrick W. Serruys, . (2010) The SYNTAX score revisited: A reassessment of the SYNTAX score reproducibility. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef495
Marco V. Wainstein, Jorge P. Ribeiro. (2010) Long-term complication after LM bifurcation treatment. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef496
Akhil Kapur, Davide Bartolini, Malcolm C Finlay, Ayesha C Qureshi, Marcus Flather, Julian W Strange, Roger J Hall. (2010) The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease. Journal of Cardiovascular Medicine 11:1, 26-33
CrossRef497
Lloyd W. Klein, Fred H. Edwards, Elizabeth R. DeLong, Laura Ritzenthaler, George D. Dangas, William S. Weintraub. (2010) ASCERT: The American College of Cardiology Foundation–The Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies. JACC: Cardiovascular Interventions 3:1, 124-126
CrossRef498
Masami Ochi. (2010) Multidisciplinary Approach to Severe Coronary Artery Disease. Circulation Journal 74:3, 426-427
CrossRef499
Hiromasa Horiguchi, Hideo Yasunaga, Hideki Hashimoto, Shinya Matsuda. (2010) Impact of Drug-Eluting Stents on Treatment Option Mix for Coronary Artery Disease in Japan. Circulation Journal 74:8, 1635-1643
CrossRef500
Yoshihiro Morino. (2010) Modifying the Drug Elution Profile for Neointimal Control. Circulation Journal 74:10, 2054-2055
CrossRef501
Masaru Nishimi, Tadashi Tashiro. (2010) Off-Pump Coronary Artery Bypass vs Percutaneous Coronary Intervention. Circulation Journal 74:12, 2750-2757
CrossRef502
Jiro Aoki. (2010) Application of Drug Eluting Stents to Clinical Practice in Japan. Circulation Journal 74:8, 1532-1533
CrossRef503
Elvin Kedhi, Kaiyum Sheik Joesoef, Eugene McFadden, Jochem Wassing, Carlos van Mieghem, Dick Goedhart, Pieter Cornelis Smits. (2010) Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. The Lancet 375:9710, 201-209
CrossRef504
Mario Bollati, Argyrios Gerasimou, Dario Sillano, Giuseppe Biondi-Zoccai, Paolo Garrone, Claudio Moretti, Filippo Sciuto, Pierluigi Omedé, Gian Paolo Trevi, Imad Sheiban. (2010) Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic function. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef505
XiaoFan Wu, YunDai Chen, Takashi Kubo, ChangJiang Ge, Fang Ren, Xi Wu, WeiJun Chen, Yuan Zhou, Hong Liu, Shuzheng Lv. (2010) Long-Term (4-Year) Outcomes and Predictors of Adverse Cardiac Events After Sirolimus-Eluting Stent Implantation in Unprotected Left Main Coronary Artery. International Heart Journal 51:6, 377-382
CrossRef506
Shunichi Miyazaki, Yu Kataoka, Yoritaka Otsuka, Satoshi Yasuda, Isao Morii. (2010) Percutaneous copronary intervention using sirolimus-eluting stents may improve long-term prognosis of elderly women. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 47:3, 187-190
CrossRef507
Tsuyoshi Shimizu, Takayuki Ohno, Jiro Ando, Hideo Fujita, Ryozo Nagai, Noboru Motomura, Minoru Ono, Shunei Kyo, Shinichi Takamoto. (2010) Mid-Term Results and Costs of Coronary Artery Bypass vs Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease. Circulation Journal 74:3, 449-455
CrossRef508
Venu Menon, Jay D. Sengupta. 2010. Chronic Coronary Artery Disease. , 97-105.
CrossRef509
B.J. Gersh. (2010) Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Yearbook of Medicine 2010, 378-381
CrossRef510
Riya S. Chacko, Joseph P. Carrozza, Duane S. Pinto. 2010. Interventional Cardiology. , 847-866.
CrossRef511
B.J. Gersh. (2010) Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Yearbook of Cardiology 2010, 360-363
CrossRef512
B.J. Gersh. (2010) Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. Yearbook of Cardiology 2010, 379-381
CrossRef513
R. Suri. (2010) Four-Year Outcome of OPCAB No-Touch With Total Arterial Y-Graft: Making the Best Treatment a Daily Practice. Yearbook of Cardiology 2010, 202-205
CrossRef514
Stephen G. Ellis, Gregg W. Stone, David A. Cox, James Hermiller, Charles O'Shaughnessy, Tift Mann, Mark Turco, Ronald Caputo, Patrick J. Bergin, Thomas S. Bowman, Donald S. Baim. (2009) Long-Term Safety and Efficacy With Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions 2:12, 1248-1259
CrossRef515
Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan de Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, José López-Sendón, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen. (2009) Guía de práctica clínica para la valoración del riesgo cardiaco preoperatorio y el manejo cardiaco perioperatorio en la cirugía no cardiaca. Revista Española de Cardiología 62:12, 1467.e1-1467.e56
CrossRef516
Shih-Fan Chen, Keith Somma, Ray V Matthews, Leonardo C Clavijo. (2009) Utility of the SYNTAX score for predicting outcome after percutaneous coronary intervention. Interventional Cardiology 1:2, 155-156
CrossRef517
RABEH GHENIM, JÃRÃME RONCALLI, AMIR M. TIDJANE, VANINA BONGARD, ABDELKADER ZIANI, NICOLAS BOUDOU, NICOLAS DUMONTEIL, BERTRAND MARCHEIX, BERTRAND LÃOBON, DIDIER CARRIÃ. (2009) One-Year Follow-Up of Nonrandomized Comparison between Coronary Artery Bypass Grafting Surgery and Drug-Eluting Stent for the Treatment of Unprotected Left Main Coronary Artery Disease in Elderly Patients (Aged â¥75 Years). Journal of Interventional Cardiology 22:6, 520-526
CrossRef518
Douglass A. Morrison. (2009) Are we totally clear?. Catheterization and Cardiovascular Interventions 74:7, 987-988
CrossRef519
Andrea Colli, Xavier Ruyra. (2009) Routine Intraoperative Completion Angiography After Coronary Artery Bypass Grafting or Routine Intraoperative Transit Time Flow Measurement to Check Graft's Quality?. Journal of the American College of Cardiology 54:24, 2337
CrossRef520
Azeem Latib, Luca Ferri, Alfonso Ielasi, Cosmo Godino, Alaide Chieffo, Valeria Magni, Giorgio Bassanelli, Andrew S.P. Sharp, Robert Gerber, Iassen Michev, Mauro Carlino, Flavio Airoldi, Giuseppe M. Sangiorgi, Matteo Montorfano, Antonio Colombo. (2009) Clinical Outcomes After Unrestricted Implantation of Everolimus-Eluting Stents. JACC: Cardiovascular Interventions 2:12, 1219-1226
CrossRef521
RALF LEHMANN, STEPHAN FICHTLSCHERER, VOLKER SCHÃCHINGER, LAURA HELD, CAROLA HOBLER, GREGOR BAIER, ANDREAS M. ZEIHER, IOAKIM SPYRIDOPOULOS. (2009) Favorable Long-Term Survival in Patients Undergoing Multivessel-PCI Compared to Predicted Prognosis of CABG Estimated by EuroSCORE : Procedural and Clinical Determinants of Long-Term Outcome. Journal of Interventional Cardiology 22:6, 511-519
CrossRef522
Daniel M. Thys. (2009) Cardiac Anesthesia: Thirty Years Later—The Second Annual Arthur E. Weyman Lecture. Anesthesia & Analgesia 109:6, 1782-1790
CrossRef523
Frederick G. Kushner, Mary Hand, Sidney C. Smith, Spencer B. King, Jeffrey L. Anderson, Elliott M. Antman, Steven R. Bailey, Eric R. Bates, James C. Blankenship, Donald E. Casey, Lee A. Green, Judith S. Hochman, Alice K. Jacobs, Harlan M. Krumholz, Douglass A. Morrison, Joseph P. Ornato, David L. Pearle, Eric D. Peterson, Michael A. Sloan, Patrick L. Whitlow, David O. Williams. (2009) 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update). Journal of the American College of Cardiology 54:23, 2205-2241
CrossRef524
Frederick G. Kushner, Mary Hand, Sidney C. Smith, Spencer B. King, Jeffrey L. Anderson, Elliott M. Antman, Steven R. Bailey, Eric R. Bates, James C. Blankenship, Donald E. Casey, Lee A. Green, Alice K. Jacobs, Judith S. Hochman, Harlan M. Krumholz, Douglass A. Morrison, Joseph P. Ornato, David L. Pearle, Eric D. Peterson, Michael A. Sloan, Patrick L. Whitlow, David O. Williams. (2009) 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update). Catheterization and Cardiovascular Interventions 74:7, E25-E68
CrossRef525
Martijn Meuwissen, Maria Siebes, Steven AJ Chamuleau, Bart-Jan Verhoeff, Jose PS Henriques, Jos AE Spaan, Jan J Piek. (2009) Role of fractional and coronary flow reserve in clinical decision making in intermediate coronary lesions. Interventional Cardiology 1:2, 237-255
CrossRef526
Gioel Gabrio Secco, Carlo Di Mario. (2009) Conference Scene: A congress report. Interventional Cardiology 1:2, 161-164
CrossRef527
, D. Poldermans, J. J. Bax, E. Boersma, S. De Hert, E. Eeckhout, G. Fowkes, B. Gorenek, M. G. Hennerici, B. Iung, M. Kelm, K. P. Kjeldsen, S. D. Kristensen, J. Lopez-Sendon, P. Pelosi, F. Philippe, L. Pierard, P. Ponikowski, J.-P. Schmid, O. F.M. Sellevold, R. Sicari, G. Van den Berghe, F. Vermassen, , S. E. Hoeks, I. Vanhorebeek, , A. Vahanian, A. Auricchio, J. J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, K. McGregor, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. Vardas, P. Widimsky, , R. De Caterina, S. Agewall, N. Al Attar, F. Andreotti, S. D. Anker, G. Baron-Esquivias, G. Berkenboom, L. Chapoutot, R. Cifkova, P. Faggiano, S. Gibbs, H. S. Hansen, L. Iserin, C. W. Israel, R. Kornowski, N. M. Eizagaechevarria, M. Pepi, M. Piepoli, H. J. Priebe, M. Scherer, J. Stepinska, D. Taggart, M. Tubaro. (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). European Heart Journal 30:22, 2769-2812
CrossRef528
S. H. Schirmer, A. M. Laan, M. Böhm, F. Mahfoud. (2009) Hotlines and clinical trial updates presented at the European Society of Cardiology Meeting 2009: data from RE-LY, PLATO, MADIT-CRT, PROTECT, SYNTAX, TRITON and more. Clinical Research in Cardiology 98:11, 691-699
CrossRef529
Amit Kumar, Christopher P. Cannon. (2009) Acute Coronary Syndromes: Diagnosis and Management, Part II. Mayo Clinic Proceedings 84:11, 1021-1036
CrossRef530
C. Richard Conti. (2009) Myocardial Revascularization: PCI/Stent or Coronary Artery Bypass GraftâWhat Is Best for Our Patients?. Clinical Cardiology 32:11, 606-607
CrossRef531
Thomas A. Vassiliades, Patrick D. Kilgo, John S. Douglas, Vasilis C. Babaliaros, Peter C. Block, Habib Samady, Christopher U. Cates, S Tanveer Rab, Douglas C. Morris. (2009) Clinical Outcomes After Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 4:6, 299-306
CrossRef532
Raoul Bonan. (2009) Another quest for a solution… and when a dedicated device?. Catheterization and Cardiovascular Interventions 74:5, 691-692
CrossRef533
Jon C. George, George D. Dangas. (2009) European Society of Cardiology Congress 2009. JACC: Cardiovascular Interventions 2:11, 1160-1162
CrossRef534
Nikolaos Bonaros, Dominik Wiedemann, Thomas Schachner, Alfred Kocher. (2009) Reply to the Editor. The Journal of Thoracic and Cardiovascular Surgery 138:5, 1253-1254
CrossRef535
Thierry Carrel, Lars Englberger. (2009) Coronary bypass surgery in patients treated with clopidogrel. Is it safe?. Current Opinion in Cardiology 24:6, 539-543
CrossRef536
(2009) Therapies for Type 2 Diabetes and Coronary Artery Disease. New England Journal of Medicine 361:14, 1407-1410
Full Text537
Jeffrey W. Moses, Martin B. Leon, Gregg W. Stone. (2009) Left Main Percutaneous Coronary Intervention Crossing the Threshold. Journal of the American College of Cardiology 54:16, 1512-1514
CrossRef538
M Faisal Khan, Ganesh Athappan. (2009) Left main coronary artery disease. Interventional Cardiology 1:1, 73-91
CrossRef539
G. Montalescot, D. Brieger, K. A. Eagle, F. A. Anderson, G. FitzGerald, M. S. Lee, Ph. G. Steg, A. Avezum, S. G. Goodman, J. M. Gore, . (2009) Unprotected left main revascularization in patients with acute coronary syndromes. European Heart Journal 30:19, 2308-2317
CrossRef540
Jeffrey W Moses. (2009) On the misinterpretation of clinical trials. Interventional Cardiology 1:1, 3-5
CrossRef541
Seung-Jung Park, Young-Hak Kim. (2009) Percutaneous coronary intervention for unprotected left main coronary artery stenosis. Interventional Cardiology 1:1, 93-106
CrossRef542
John G.T. Augoustides, Hynek Riha. (2009) Recent Progress in Heart Failure Treatment and Heart Transplantation. Journal of Cardiothoracic and Vascular Anesthesia 23:5, 738-748
CrossRef543
Pawel E. Buszman, Piotr P. Buszman, R. Stefan Kiesz, Andrzej Bochenek, Blazej Trela, Magda Konkolewska, David Wallace-Bradley, Mirosław Wilczyński, Iwona Banasiewicz-Szkróbka, Ewa Peszek-Przybyla, Marek Krol, Marek Kondys, Krzysztof Milewski, Szymon Wiernek, Marcin Dębiński, Aleksander Żurakowski, Jack L. Martin, Michał Tendera. (2009) Early and Long-Term Results of Unprotected Left Main Coronary Artery Stenting. Journal of the American College of Cardiology 54:16, 1500-1511
CrossRef544
Won-Jang Kim, Duk-Woo Park, Sung-Cheol Yun, Jong-Young Lee, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park. (2009) Impact of Diabetes Mellitus on the Treatment Effect of Percutaneous or Surgical Revascularization for Patients With Unprotected Left Main Coronary Artery Disease. JACC: Cardiovascular Interventions 2:10, 956-963
CrossRef545
David O. Williams, J. Dawn Abbott. (2009) Diabetes Mellitus Does Not Unsweeten Left Main Intervention. JACC: Cardiovascular Interventions 2:10, 964-966
CrossRef546
C. Jámbor, M. Spannagl, B. Zwissler. (2009) Perioperatives Management von Patienten mit Koronarstents bei nichtherzchirurgischen Eingriffen. Der Anaesthesist 58:10, 971-985
CrossRef547
David E. Kandzari, Antonio Colombo, Seung-Jung Park, Carl L. Tommaso, Stephen G. Ellis, Luis A. Guzman, Paul S. Teirstein, Corrado Tamburino, John Ormiston, Gregg W. Stone, George D. Dangas, Jeffrey J. Popma, Theodore A. Bass. (2009) Revascularization for Unprotected Left Main Disease. Journal of the American College of Cardiology 54:17, 1576-1588
CrossRef548
R. Corti, S. Toggweiler. (2009) PCI in acute left main disease: a paradigm shift or a new reality?. European Heart Journal 30:19, 2295-2296
CrossRef549
W. Wijns, P. Kolh. (2009) Appropriate myocardial revascularization: a joint viewpoint from an interventional cardiologist and a cardiac surgeon. European Heart Journal 30:18, 2182-2185
CrossRef550
Dean J. Kereiakes. (2009) Return to Sender. Journal of the American College of Cardiology 54:10, 908-910
CrossRef551
Frederic S. Resnic, Akshay Desai. (2009) Highlights from the 58th Annual Scientific Sessions of the American College of Cardiology, March 28 to 31, 2009, Orlando, Florida. The Journal of Thoracic and Cardiovascular Surgery 138:3, 795-797
CrossRef552
Carlo Di Mario. (2009) Informed consent in interventional cardiology. EuroIntervention 5:4, 415-416
CrossRef553
Imad Sheiban, Dario Sillano, Giuseppe Biondi-Zoccai, Alaide Chieffo, Antonio Colombo, Sabine Vecchio, Massimo Margheri, Julian P. Gunn, Tushar Raina, Francesco Liistro, Leonardo Bolognese, Michael S. Lee, Jonathan Tobis, Claudio Moretti. (2009) Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Drug-Eluting Stents. Journal of the American College of Cardiology 54:13, 1131-1136
CrossRef554
Wouter Bas Halbersma, Sara Camilla Arrigoni, Gianclaudio Mecozzi, Jan Gerard Grandjean, Arie Pieter Kappetein, Job van der Palen, Felix Zijlstra, Massimo Alessandro Mariani. (2009) Four-Year Outcome of OPCAB No-Touch With Total Arterial Y-Graft: Making the Best Treatment a Daily Practice. The Annals of Thoracic Surgery 88:3, 796-801
CrossRef555
T. Palmerini, D. Sangiorgi, A. Marzocchi, C. Tamburino, I. Sheiban, M. Margheri, G. Vecchi, G. Sangiorgi, M. Ruffini, A. L. Bartorelli, C. Briguori, L. Vignali, F. Di Pede, A. Ramondo, L. Inglese, M. De Carlo, L. Bolognese, A. Benassi, C. Palmieri, V. Filippone, F. Barlocco, G. Lauria, S. De Servi. (2009) Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology. European Heart Journal 30:17, 2087-2094
CrossRef556
John G. Byrne. (2009) Contemporary Issues in Coronary Bypass Surgery: Introduction. Seminars in Thoracic and Cardiovascular Surgery 21:3, 195
CrossRef557
Pedro A. Lemos. (2009) 30-day risk prediction after coronary angioplasty: First step in decision making. Catheterization and Cardiovascular Interventions 74:3, 386-386
CrossRef558
David P. Taggart. (2009) Coronary Revascularization—2009: State of the Art. Seminars in Thoracic and Cardiovascular Surgery 21:3, 196-198
CrossRef559
Michael A. Kutcher. (2009) Drug-eluting stents versus bypass surgery for multivessel coronary disease. Current Cardiovascular Risk Reports 3:5, 331-338
CrossRef560
Issam D. Moussa, S. Chiu Wong, Ted Feldman. (2009) Coronary revascularization for patients with unprotected left main coronary artery disease: Evidence, guidelines, and judgment! making clinical decisions in 2009. Catheterization and Cardiovascular Interventions 74:3, 448-458
CrossRef561
Joanna J. Wykrzykowska, Patrick W. Serruys, Yoshinobu Onuma, Ton de Vries, Gerrit-Anne van Es, Pawel Buszman, Axel Linke, Thomas Ischinger, Volker Klauss, Roberto Corti, Franz Eberli, William Wijns, Marie-Claude Morice, Carlo di Mario, Robert Jan van Geuns, Peter Juni, Stephan Windecker. (2009) Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization With Biolimus-Eluting Stent With Biodegradable Polymer and Sirolimus-Eluting Stent With Durable Polymer. JACC: Cardiovascular Interventions 2:9, 861-870
CrossRef562
S. Michael Gharacholou, Karen P. Alexander. (2009) Evolving role of revascularization in older adults with acute coronary syndrome. Current Cardiovascular Risk Reports 3:5, 355-365
CrossRef563
Joseph John DeRose. (2009) Current State of Integrated “Hybrid” Coronary Revascularization. Seminars in Thoracic and Cardiovascular Surgery 21:3, 229-236
CrossRef564
Vinod Jorapur, Antonio Cano-Gomez, Cesar A. Conde. (2009) Should Saphenous Vein Grafts be the Conduits of Last Resort for Coronary Artery Bypass Surgery?. Cardiology in Review 17:5, 235-242
CrossRef565
Mariann Gyöngyösi, Günter Christ, Irene Lang, Gerhard Kreiner, Heinz Sochor, Peter Probst, Thomas Neunteufl, Rosa Badr-Eslam, Susanne Winkler, Noemi Nyolczas, Aniko Posa, Franz Leisch, Ronald Karnik, Peter Siostrzonek, Stefan Harb, Matthias Heigert, Gerald Zenker, Werner Benzer, Gerhard Bonner, Alexandra Kaider, Dietmar Glogar. (2009) 2-Year Results of the AUTAX (Austrian Multivessel TAXUS-Stent) Registry. JACC: Cardiovascular Interventions 2:8, 718-727
CrossRef566
William Wijns. (2009) The AUTAX (Austrian Multivessel TAXUS-Stent) Registry. JACC: Cardiovascular Interventions 2:8, 728-730
CrossRef567
David J. Moliterno. (2009) Left main and multivessel coronary artery stenting for patients deemed inoperable-A real need for a tandem approach. Catheterization and Cardiovascular Interventions 74:2, 311-312
CrossRef568
Hilary P. Grocott. (2009) Perioperative genomics and neurologic outcome: we can’t change who we are. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 56:8, 562-566
CrossRef569
C. Hamm. (2009) SYNTAX-Studie. Der Kardiologe 3:4, 294-295
CrossRef570
Khaled M. Ziada, Ahmed Abdel-Latif. (2009) Drug-Eluting Stents in Patients With ESRD on Dialysis: A Small Step Forward. American Journal of Kidney Diseases 54:2, 197-200
CrossRef571
RALF LEHMANN, IOAKIM SPYRIDOPOULOS, JANINE KREMER, ANDREAS M. ZEIHER, VOLKER SCHÄCHINGER, STEPHAN FICHTLSCHERER. (2009) Favorable Long-Term Survival in Patients Undergoing Stent PCI of Unprotected Left Main Coronary Artery Compared to Predicted Short-Term Prognosis of CABG Estimated by EuroSCORE: Clinical Determinants of Long-Term Outcome. Journal of Interventional Cardiology 22:4, 311-319
CrossRef572
Davide Capodanno, Piera Capranzano, Maria Elena Di Salvo, Anna Caggegi, Davide Tomasello, Glauco Cincotta, Marco Miano, Martina Patané, Claudia Tamburino, Salvatore Tolaro, Leonardo Patané, Antonio Maria Calafiore, Corrado Tamburino. (2009) Usefulness of SYNTAX Score to Select Patients With Left Main Coronary Artery Disease to Be Treated With Coronary Artery Bypass Graft. JACC: Cardiovascular Interventions 2:8, 731-738
CrossRef573
Patrick Serruys, Scot Garg. (2009) Intervencionismo coronario percutáneo para todos los pacientes con enfermedad coronaria compleja: enfermedad de tres vasos o del tronco izquierdo. ¿Verdadero? ¿Falso? ¿No se sabe?. Revista Española de Cardiología 62:7, 719-725
CrossRef574
L. S. Maier, S. H. Schirmer, K. Walenta, C. Jacobshagen, M. Böhm. (2009) Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2009. Clinical Research in Cardiology 98:7, 413-419
CrossRef575
Larry S. Dean. (2009) Class I Indications for Coronary Artery Bypass Graft Surgery. JACC: Cardiovascular Interventions 2:7, 622-623
CrossRef576
Somjot S. Brar, Gregg W. Stone. (2009) Advances in percutaneous coronary intervention. Current Cardiology Reports 11:4, 245-251
CrossRef577
(2009) Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting. New England Journal of Medicine 360:25, 2672-2675
Full Text578
Boden, William E., Taggart, David P., . (2009) Diabetes with Coronary Disease — A Moving Target amid Evolving Therapies?. New England Journal of Medicine 360:24, 2570-2572
Full Text579
Giuseppe Tarantini. (2009) Coronary artery disease: Complex coronary disease in the post-SYNTAX era. Nature Reviews Cardiology 6:6, 397-398
CrossRef580
Annetine C. Gelijns, Deborah D. Ascheim, Michael K. Parides, K. Craig Kent, Alan J. Moskowitz. (2009) Randomized trials in surgery. Surgery 145:6, 581-587
CrossRef581
Carlo Di Mario. (2009) Ars Longa, Vita Brevis
CrossRef582
A. Martens, A. Haverich. (2009) Drug-eluting Stents. Der Chirurg 80:6, 508-514
CrossRef583
F. Mellert, D. Mallek. (2009) Medizinprodukte und Patientensicherheit aus der Perspektive des Klinikers. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 52:6, 584-588
CrossRef584
Gabriel S. Aldea, Nahush A. Mokadam, Rayland Melford, Douglas Stewart, Charles Maynard, Mark Reisman, Richard Goss. (2009) Changing Volumes, Risk Profiles, and Outcomes of Coronary Artery Bypass Grafting and Percutaneous Coronary Interventions. The Annals of Thoracic Surgery 87:6, 1828-1838
CrossRef585
(2009) Fractional Flow Reserve for Guiding PCI. New England Journal of Medicine 360:19, 2024-2027
Full Text586
B. Struk, M. Gailani, C. Michael Gross. (2009) Die Behandlung der koronaren Mehrgefäßerkrankung: Bypassoperation oder perkutane Katheterintervention?. Clinical Research in Cardiology Supplements 4:S2, 154-159
CrossRef587
Keith Dawkins, Marie-Angèle Morel, Patrick Serruys. (2009) Counting the score: the SYNTAX Score and coronary risk. EuroIntervention 5:1, 33-35
CrossRef588
Peter K. Smith. (2009) Treatment Selection for Coronary Artery Disease: The Collision of a Belief System with Evidence. The Annals of Thoracic Surgery 87:5, 1328-1331
CrossRef589
John Lasala, David Cox, Stephen Lewis, Peter Tadros, Robert Haas, Marc Schweiger, Anil Chhabra, William Untereker, Ruth Starzyk, Stephen Mascioli, Keith Dawkins, Donald Baim. (2009) Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE Registry programme. EuroIntervention 5:1, 67-77
CrossRef590
Peter K. Smith. (2009) Treatment selection for coronary artery disease: The collision of a belief system with evidence. The Journal of Thoracic and Cardiovascular Surgery 137:5, 1050-1053
CrossRef591
Julie Chu. (2009) CABG vs. PCI in Severe Coronary Artery Disease. AJN, American Journal of Nursing 109:5, 64H
CrossRef592
Fernando Alfonso. (2009) Left Main Coronary Artery Stenting. Journal of the American College of Cardiology 53:19, 1769-1772
CrossRef593
William F Fearon. (2009) Expanding role of fractional flow reserve in the cardiac catheterization laboratory. Expert Review of Cardiovascular Therapy 7:5, 447-449
CrossRef594
Patrick Serruys, Yoshinobu Onuma, Scot Garg, Giovanna Sarno, Marcel van den Brand, Arie-Pieter Kappetein, Nic Van Dyck, Michael Mack, David Holmes, Ted Feldman, Marie-Claude Morice, Antonio Colombo, Eric Bass, Katrin Leadley, Keith Dawkins, Gerrit-Anne van Es, Marie-Angèle Morel, Friedrich Mohr. (2009) Assessment of the SYNTAX score in the Syntax study. EuroIntervention 5:1, 50-56
CrossRef595
Eisen, Howard J., . (2009) Surgical Ventricular Reconstruction for Heart Failure. New England Journal of Medicine 360:17, 1781-1784
Full Text596
David P Taggart. (2009) PCI or CABG in coronary artery disease?. The Lancet 373:9670, 1150-1152
CrossRef597
Mark A Hlatky, Derek B Boothroyd, Dena M Bravata, Eric Boersma, Jean Booth, Maria M Brooks, Didier Carrié, Tim C Clayton, Nicolas Danchin, Marcus Flather, Christian W Hamm, Whady A Hueb, Jan Kähler, Sheryl F Kelsey, Spencer B King, Andrzej S Kosinski, Neuza Lopes, Kathryn M McDonald, Alfredo Rodriguez, Patrick Serruys, Ulrich Sigwart, Rodney H Stables, Douglas K Owens, Stuart J Pocock. (2009) Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. The Lancet 373:9670, 1190-1197
CrossRef598
Ted Feldman. (2009) The SYNTAX score in practice: An aid for patient selection for complex PCI. Catheterization and Cardiovascular Interventions 73:5, 618-619
CrossRef599
Lange, Richard A., Hillis, L. David, . (2009) Coronary Revascularization in Context. New England Journal of Medicine 360:10, 1024-1026
Full Text600
Lee, Thomas H., Hillis, L. David, Nabel, Elizabeth G., . (2009) CABG vs. Stenting — Clinical Implications of the SYNTAX Trial. New England Journal of Medicine 360:8,
Full Text601
Taishiro Chikamori. (2009) Management of ischemic heart disease in the elderly. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 46:5, 391-394
CrossRef602
Inga Narbute, Sanda Jēgere, Indulis Kumsārs, Iveta Mintāle, Iļja Zakke, Dace Juhnēviča, Kārlis Trušinskis, Dace Sondore, Aigars Lismanis, Gustavs Latkovskis, Aļona Grāve, Andis Dombrovskis, Andrejs Ērglis. (2009) Long-term Clinical Results for Randomised Comparison of Paclitaxel-eluting versus Bare-metal Stents in Unprotected Left Main Coronary Artery Disease. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 63:4, 243-248
CrossRef603
Sinisa Stojkovic, Miodrag Ostojic, Milan Nedeljkovic, Goran Stankovic, Branko Beleslin, Vladan Vukcevic, Dejan Orlic, Aleksandra Arandjelovic, Jelena Kostic, Miodrag Dikic, Miloje Tomasevic. (2009) Systemic rapamycin without loading dose for restenosis prevention after coronary bare metal stent implantation. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef604
Seung-Jung Park. (2009) Stenting versus Bypass Surgery for the Treatment of Left Main Coronary Artery Disease. Yonsei Medical Journal 50:6, 739
CrossRef605
Inder M. Singh, Steven J. Filby, Fredy El Sakr, Eiran Z. Gorodeski, A. Michael Lincoff, Stephen G. Ellis, Mehdi H. Shishehbor. (2009) Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis. Catheterization and Cardiovascular InterventionsNA-NA
CrossRef
- Letters
